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Abstract
Analyzing the Role of ER Membrane Biogenesis in Mitotic Fidelity
Holly Elizabeth Merta
2021
In cell division, chromosomes align and attach to the mitotic spindle with high
fidelity in order to limit missegregation of chromosomes that form individual
nuclei, termed micronuclei. During cell division, membrane-bound organelles are
cleared to the periphery of the cell; lack of clearance of membranes from
chromosomes leads to chromosome missegregation. Cells regulate the
biogenesis of their membranes throughout the cell cycle. Cancer cells frequently
have upregulation of membrane lipid synthesis and micronuclei, but a connection
between membrane biogenesis and chromosome missegregation leading to
formation of micronuclei has not been established.
In my thesis work, I show that the protein phosphatase CTDNEP1 regulates
membrane biogenesis and indirectly the formation of micronuclei in human cell
lines. I elucidate how CTDNEP1 controls synthesis of ER membranes through its
dephosphorylation and activation of the phosphatidic acid phosphatase lipin 1. I
show that ER membrane abundance is increased in mitotic cells lacking
CTDNEP1, and endoplasmic reticulum (ER) membranes are less cleared in
prometaphase to metaphase. I show that CTDNEP1 has conserved functions for
restricting membranes to the surface of the nuclear envelope during nuclear
envelope assembly and for maintaining nuclear morphology. Using quantification
of mitotic cells in a fixed asynchronous population, I corroborate the results of

previous studies showing that CTDNEP1 is necessary for correct timing of mitotic
progression.
Errors in attachment to the mitotic spindle (that may or not be surveilled by
the spindle assembly checkpoint) lead to chromosome missegregation that
results in formation of micronuclei. Inhibition of the spindle assembly checkpoint
in synchronized cells leads to a small increase in micronuclei in CTDNEP1depleted cells. In contrast, transient spindle disassembly that causes unbalanced
attachment errors not sensed by the spindle assembly checkpoint results in
severely micronucleated nuclei in CTDNEP1-depleted cells, showing that
micronuclei in CTDNEP1-depleted cells form through decreased mitotic error
correction.
Lipidomic analysis of total cellular lipids in CTDNEP1-depleted cells reveals
that phosphatidylcholine/phosphatidylethanolamine are increased with loss of
CTDNEP1. I show that inhibition of fatty acid synthesis suppresses ER
membrane expansion in CTDNEP1-depleted cells. I observe that depletion of the
fatty acid transcriptional regulators sterol regulatory element binding proteins 1
and 2 and stearoyl Co-A desaturase partially suppress ER membrane expansion,
illuminating the role of fatty acid synthesis gene upregulation in expansion of ER
membranes in CTDNEP1-depleted cells. Inhibiting fatty acid synthesis rescues
severe micronucleation after transient spindle disassembly and the incidence of
micronuclei in untreated CTDNEP1-depleted cells. These data elucidate the
mechanism for how CTDNEP1 controls ER lipid synthesis in human cells.
Together, these data support the conclusion that increased fatty acid synthesis

leads to excess ER membranes that interfere with chromosome segregation in
mitosis, leading to formation of micronuclei. This study provides the first
connection to misregulation of lipid synthesis to formation of micronuclei, two
events that are common in cancer cells. This study thus provides a link between
regulation of lipid synthesis and chromosome segregation and informing our
understanding of how they are altered in cancer.
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Chapter 1: General Introduction

1

Cell and organelle membranes
Cells are the fundamental unit of living things, and they rely on faithful
division to propagate all of life. The idea that living things are made of cells was
formed in the 1600s-1800s thanks to the invention of light microscopy
(Mazzarello, 1999; Ribatti, 2018). Further light and electron microscopy studies
identified organelles, or membrane-bound compartments with distinct makeups
and functions that are common to all eukaryotic cells (Golgi, 1898; Palade, 1952,
1956; Porter et al., 1945). Organelles were later found to compartmentalize
cellular functions, and they have specific populations of proteins to support these
functions. Many organelles are encapsulated by membranes with distinct lipid
compositions that also support their functions.
Membranes in cells consist primarily of lipids, molecules with hydrocarbon
chains or rings that impart hydrophobicity. The hydrophobic nature of lipids
causes lipids to self-aggregate within the hydrophilic environment of the cell.
Further, the qualities of cellular lipids allow for the formation of different
structures. Polar lipids, such as glycerophospholipids, self-aggregate in such a
way as to form membranes, which allow the cell to compartmentalize its
organelles and to separate itself from its environment.
In cells, membranes take the form of mostly polar lipid bilayers (Nicolson,
2014). The structure of cell membranes has been well described as a fluid
mosaic, wherein proteins can span (completely or partially) and diffuse within the
lipid bilayer (Nicolson, 2014; Singer and Nicolson, 1975). The lipid makeup of the
lipid bilayers has shown to be important for cell physiology, including membrane
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properties and cell differentiation (Harayama and Riezman, 2018; Levental et al.,
2017).
Types of membrane lipids
The main types of lipids in cells include fatty acids, glycerolipids,
sphingolipids, and sterols (Figure 1.1). Within each type of lipid (except for
sterols), there are classes defined by their headgroups, and within each class
exists hundreds of different possible lipid species based on fatty acid composition
(Harayama and Riezman, 2018).
Fatty acids are made up of a carboxylic acid with a hydrocarbon chain
typically around 16-22 carbons in length in mammalian cells (Figure 1.1)
(Yamashita et al., 2014). These hydrocarbon chains can be saturated (having no
double bonds) or unsaturated (having double bonds). The length and saturation
of fatty acids within membrane lipids is highly important for the biophysical
properties of the membrane (van Meer et al., 2008). Unsaturated fatty acids
impart more fluidity to membranes due to less lipid packing (relatively more
space between adjacent lipids) (Bigay and Antonny, 2012; van Meer et al.,
2008). Longer fatty acids in one leaflet of a bilayer have the potential to
interdigitate with the fatty acids of the other leaflet, increasing lipid packing
(Murate and Kobayashi, 2016).
Glycerolipids consist of a glycerol backbone, fatty acids connected to the
glycerol backbone by an ester linkage, and a head group (in the case of
glycerophospholipids) (Figure 1.1). Diacylglycerol (DAG) and triacylglycerol
(TAG) consist of the glycerol backbone and 2 or 3 fatty acid chains, respectively.
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Glycerophospholipids, such as phosphatidic acid (PA), phosphatidylcholine (PC),
phosphatidylethanolamine (PE), phosphatidylserine (PS), and
phosphatidylinositol (PI), have two fatty acid chains and a head group on the
glycerol backbone connected by a phosphate group. Although their compositions
appear similar, the charges and shapes of glycerophospholipids can help or
hinder the stabilization membrane curvature and the ability of proteins to
associate with the membrane (Harayama and Riezman, 2018). In contrast to
glycerolipids, sphingolipids are less saturated and have longer hydrocarbon
chains that contribute to a taller profile compared to glycerolipids (van Meer et
al., 2008). Sterols, like cholesterol, maintain membrane fluidity at lower
temperatures but permit lipid packing to stabilize membranes at higher
temperatures as well (Dufourc, 2008). The lipid-condensing effect of cholesterol
and long saturated acyl chains of sphingolipids allows them to form relativelymore-solid microdomains of distinct lipid composition within membranes, called
lipid rafts, that can preferentially sequester or change the conformation of
proteins for signaling purposes (Sezgin et al., 2017). The properties of
membrane lipids enable organelles of different lipid compositions to support
diverse populations of proteins for different cellular functions.
Organelle membrane lipid compositions
The membranes of organelles have distinct lipid makeups that play a role
in organelle morphology, membrane activities and protein localization, and
organelle identity. Strides in biochemical and mass spectrometry analysis have
generated key insights about how lipid composition of organelle membranes
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contribute to their functions. Future analyses making use of lipid probes, speciesspecific degradation of leaflets, and more sophisticated purification techniques
will improve our understanding of organelle composition (Ballweg et al., 2020;
Harayama and Riezman, 2018; Lorent et al., 2020; Romanauska and Köhler,
2018).
Generally, the lipid makeup of cells’ organelles has been thought to follow
a gradient of their involvement in the secretory pathway (Bigay and Antonny,
2012). Most of the cell’s lipids are made in the endoplasmic reticulum (ER)
(Jacquemyn et al., 2017) (Figure 1.3). The ER consists of mostly PC and PE, PI
and PS to a lesser extent, and then very small amounts of sphingolipids and
cholesterol (van Meer et al., 2008; Vance, 2015). The nuclear envelope is
thought to be similar in composition to the ER, but interconnected nature of the
nuclear envelope and ER confounds lipid composition analyses utilizing
organelle purification (Bahmanyar and Schlieker, 2020). Recent studies using
lipid probes indicate the inner nuclear membrane could have a distinct
composition from the ER (Romanauska and Köhler, 2018). In contrast to the ER,
the plasma membrane has relatively less PC and greater amounts of PS,
sphingolipids, and abundant cholesterol (Horvath and Daum, 2013). The cis
Golgi is more similar in composition and physical properties to the ER, whereas
the trans Golgi and endosomes are more similar in composition and physical
properties to the cytoplasmic leaflet of the plasma membrane, reflecting how
lipids are trafficked from the ER to the plasma membrane and other organelles
(Bigay and Antonny, 2012). Organelles’ distinct lipid compositions are
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established in part by delivery of lipids that are synthesized by the endoplasmic
reticulum and contiguous nuclear envelope.
The nuclear envelope and endoplasmic reticulum
The nuclear envelope and endoplasmic reticulum make up a contiguous
membrane structure with domains supporting different functions (Watson, 1955)
(Figure 1.2). Their structures and functions are outlined below.
The endoplasmic reticulum (ER)
The ER was first identified by electron microscopy as a contiguous
structure consisting of perinuclear ribosome-studded “rough ER” sheets and
peripheral “smooth ER” tubules (Palade, 1956) (Figure 1.2). We now know that
the ultrastructure of the ER in live cells also includes small peripheral sheets with
embedded nanoholes (Schroeder et al., 2018). The structure of the ER is
supported by ER shaping proteins and interactions with the cytoskeleton (Figure
1.2). Reticulons are tubule-stabilizing proteins that insert a hairpin structure
partially into the ER membrane to support membrane curvature (Hu et al., 2008;
Voeltz et al., 2006) including inside ER nanoholes (Schroeder et al., 2018). ER
sheets are stabilized by ribosomes/translocons and CLIMP-63, which spans the
ER lumen in dimers to stabilize a defined lumen width (Klopfenstein et al., 2001;
Shibata et al., 2010). Interphase ER structure is also defined by the availability of
GTPases that can facilitate ER tubule fusion, such as atlastin and Rab10
(English and Voeltz, 2013; Orso et al., 2009). The fusion activity of atlastin and
tubule-stabilizing functions of reticulons and lunapark cooperate to form an
extended network of ER tubules (Wang et al., 2016b). The maintenance and
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dynamics of peripheral ER structure are also supported by interactions between
ER-resident proteins and microtubules (Bola and Allan, 2009; Waterman-Storer
and Salmon, 1998). STIM1 on ER tubules interacts with EB1 on microtubule plus
ends, leading to ER tubules tracking plus-end microtubule growth (Grigoriev et
al., 2008). In general, peripheral ER tubules co-align with microtubules
(Waterman-Storer and Salmon, 1998). Movement of organelles to which the ER
is tethered also determines its localization and movement (Friedman et al.,
2013). The abundance of ribosomes on rough ER and extensive network of the
smooth ER support the ER’s functions to help maintain other organelles.
The ER performs functions in translation and modification of
transmembrane and secreted/luminal proteins and in lipid synthesis. It connects
with other organelles to deliver proteins, lipids, and function in signaling.
Early electron microscopy and biochemical studies identified that proteins
can be synthesized in the ER and trafficked to other organelles or secreted (Caro
and Palade, 1964; Palade and Siekevitz, 1956; Siekevitz and Palade, 1960).
Transmembrane proteins and proteins destined for secretion or localization to
organelle lumens are translated partially in the cytosol before being targeted to
translocons in the ER membrane, where the protein is translated while being
shunted into the ER lumen through the translocon (or embedded in the ER
membrane) (Rapoport, 2007; Schwarz and Blower, 2015). ER chaperones can
assist in folding these proteins, and some posttranslational modifications are also
performed in the ER, such as signal peptide cleavage, N-linked glycosylation,
and disulfide bond formation (Braakman and Hebert, 2013). The ER also
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synthesizes lipids—fatty acids, cholesterol, triglycerides, sphingolipid precursors,
and most glycerophospholipids—for the cell.
The ER is also highly interconnected with mitochondria, endosomes, the
Golgi apparatus, and the plasma membrane; ER contacts cover up to 5% of
mitochondrial and endosomal outer membranes (Phillips and Voeltz, 2015). It is
now known that ER contact sites are responsible for exchanging proteins, lipids,
and ER-stored Ca2+, and ER contact sites are important for organelle
maintenance, such as in endosome maturation (Csordás et al., 2006; Friedman
et al., 2013; Phillips and Voeltz, 2015). Finally, the ER is also responsible for
organelle biogenesis of peroxisomes and lipid droplets (Hoepfner et al., 2005;
Joshi et al., 2017). The ER’s structures throughout the cell therefore facilitate its
functions in protein and lipid synthesis and delivery of these molecules to other
organelles without relying on relatively slow vesicular transport.
The nuclear envelope
The nuclear envelope is a double membrane sheet that encases the nucleus
(Figure 1.2). The nuclear envelope was first identified to have a double lipid
bilayer by electron microscopy of extracted membranes from Xenopus laevis
oocyte nuclei (Callan and Tomlin, 1950). These bilayers have since been termed
the outer (ONM) and inner (INM) nuclear membranes. Subsequent microscopy
studies have identified connections between the outer nuclear membrane and
ER (Watson, 1955) as well as invaginations of inner (type I) or outer/inner (type
II) nuclear envelope membranes termed nucleoplasmic reticuli (Drozdz and
Vaux, 2017). The nuclear envelope contains nuclear pore complexes (NPCs),
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~100 nm ring-shaped protein assemblies consisting of nucleoporins (Nups) that
span both layers of the nuclear envelope (Bahr and Beermann, 1954; Beck et al.,
2004; D’Angelo and Hetzer, 2008; Hetzer, 2010). The structure of the nuclear
envelope is supported by a meshwork of intermediate filament-type proteins
(lamins) underneath the inner nuclear membrane called the nuclear lamina
(Leeuw et al., 2018). The nuclear lamina is connected to the cytoskeleton
through LINC complexes that span the nuclear envelope and interact with lamins
as well as with actin filaments or microtubules in the cytosol (Sosa et al., 2013).
The nuclear envelope’s functions largely entail its protection of the nuclear
contents. The nuclear envelope is a semipermeable barrier for the nucleus owing
to the nuclear pore complexes’ selective permeability. Molecules of size <30-40
kDa can pass through the nuclear pore complexes by diffusion, while large
proteins require interaction with importins/exportins to enter and leave the
nucleus (Capelson et al., 2010; Hetzer, 2010). This barrier allows the cell to
partition transcription from translation, adding a layer of regulation to protein
synthesis (Orphanides and Reinberg, 2002). Compartmentalizing the cell’s
genome allows the nuclear envelope to protect DNA from cytosolic nucleases
and the innate immune signaling pathways that allow the cell to detect and rid
itself of viral nucleic acids (Ma et al., 2020; Paludan and Bowie, 2013; Semenova
et al., 2019). The nuclear envelope also plays an important role in
mechanotransduction, as alterations in force applied to a cell lead to nucleusmediated changes in gene expression (Kaminski et al., 2014).
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Though they are contiguous, nuclear envelope functions are thought to be
removed from ER functions; however, emergent evidence implicates the nuclear
envelope in regulation of lipid synthesis. Studies using nuclear-localized lipid
sensors in budding yeast show that the inner nuclear membrane has a distinct
lipid composition and that lipid synthesizing enzymes localize to the inner nuclear
membrane (Romanauska and Köhler, 2018). In human cells, the nuclear
envelope protein lamin B receptor (LBR) catalyzes an intermediate step in
cholesterol synthesis from lanosterol and is required for human cell growth in
cholesterol-deficient media (Tsai et al., 2016). Nucleoplasmic reticuli have shown
to originate from newly synthesized glycerophospholipid incorporation into reticuli
at the inner nuclear membrane during interphase (Drozdz et al., 2017;
Goulbourne et al., 2011). Nuclear lipid droplets are droplets of mostly
triacylglycerol and cholesterol that appear to originate from the ER lumen,
nuclear envelope lumen, the inner nuclear membrane, or type I nucleoplasmic
reticuli (Lagrutta et al., 2017; Layerenza et al., 2013; Ohsaki et al., 2016;
Romanauska and Köhler, 2018; Sołtysik et al., 2019). Altering lipid synthesis at
the INM controls nuclear lipid droplet formation in yeast (Romanauska and
Köhler, 2018). Recent work showed for the first time that formation of nuclear
lipid droplets is conserved in human cells. However, in contrast to budding yeast,
they form in the absence of the triglyceride-sequestering lipid droplet maturation
protein seipin, indicating that the mechanism of nuclear lipid droplet formation
differs from that of ER-derived lipid droplets (Sołtysik et al., 2020; Wang et al.,
2016a; Zoni et al., 2020). While the function of nuclear lipid droplets is not fully
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known, evidence has implicated them in hepatocyte (liver) lipid homeostasis
(Lagrutta et al., 2017; Ohsaki et al., 2016). The nuclear envelope is thus an
active player in regulating and performing lipid synthesis in spite of its continuity
with the ER.
Many lipid synthesis-regulating functions of the nuclear envelope involve
CTP:phosphocholine cytidyltransferase α (CCTα). CCTα localizes to the inner
nuclear envelope and catalyzes the synthesis of CDP-choline, which is the rate
limiting step of phosphatidylcholine (the most abundant structural
glycerophospholipid in metazoan cells) synthesis (Cornell and Antonny, 2018).
CCTα does not constitutively localize to the inner nuclear membrane, however. In
response to curvature elastic stress of the inner nuclear membrane, the M
helices of CCTα move away from an autoinhibitory conformation to insert into the
surface of the lipid bilayer, and linkers facilitate close apposition of the catalytic
domain to the membrane to provide an anhydrous milieu for its activity (Haider et
al., 2018; Knowles et al., 2019; Ramezanpour et al., 2018). Recent evidence
suggests that hepatocyte nuclear lipid droplets recruit CCTα to membranes,
perhaps in response to bilayer stress (Ohsaki et al., 2016; Sołtysik et al., 2019).
Acute induction of nucleoplasmic reticuli formation also depends on the
localization and activity of CCTα (Gehrig et al., 2008; Goulbourne et al., 2011).
Recent evidence suggests CCTα’s localization is regulated posttranslationally, as
phosphorylation of CCTα’s membrane binding domain limits its localization to the
INM and nuclear lipid droplets (Yue et al., 2020). Given its functions in sensing
lipid composition of the INM and nuclear lipid droplets, CCTα links the lipid
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composition of the nuclear envelope to regulation of lipid synthesis. How the
nuclear envelope regulates lipid synthesis through mechanisms other than CCTα
has yet to be fully elucidated.
Lipid synthesis in the endoplasmic reticulum
Lipid synthesis pathways in the ER
The bulk of membrane lipids are synthesized in the ER, and this process
is controlled by nutritional inputs and uses substrates of nutrient metabolism
(Figure 1.3). All lipids that are made in the ER de novo are made from acetylCoenzyme A (acetyl-CoA), which is produced by conversion of citrate from the
Krebs cycle, breakdown of fatty acids, or breakdown of amino acids (Pietrocola
et al., 2015). Glycerolipids additionally require glycerol-3-phosphate, which is
made from glycerol derived from glyceraldehyde-3-phosphate made during
glycolysis (Lunt and Vander Heiden, 2011) or glycerol from glyceroneogenesis
(Hanson and Reshef, 2003). In mammalian cells, the decision to synthesize
membrane lipids is controlled by pro-growth signaling that is largely controlled by
mammalian target of rapamycin (mTOR) (Ben-Sahra and Manning, 2017).
Nutrients such as amino acids, glucose, and growth factors lead to downstream
mTORC1 activation, which leads to activation of sterol regulatory element
binding proteins (SREBPs), transcription factors that lead to upregulation of fatty
acid and cholesterol synthesis genes through an unknown mechanism (BenSahra and Manning, 2017). In yeast, transcription of fatty acid synthesis genes
mediated by the transcription factors Ino2 and Ino4 occurs during exponential
growth and under nutrient conditions that lead to increased ER PA
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concentrations (by sequestering the transcriptional repressor Opi1, which binds
PA) (Henry et al., 2012; Hofbauer et al., 2018; Loewen et al., 2004). Increased
fatty acid synthesis leads to increased de novo lipid synthesis in these progrowth contexts to support cell proliferation.
Additional signals for ER lipid synthesis are changes in intracellular
membrane physical properties, such as packing (Jacquemyn et al., 2017). CCTα
localizes to the surface of the inner nuclear membrane in response to packing
defects to perform the rate-limiting step for PC synthesis (Cornell and Antonny,
2018). The PA phosphatase lipin localizes to membranes more readily with
increased PA and PE concentration (Eaton et al., 2013; Karanasios et al., 2010).
In yeast, membrane saturation is sensed by Mag2 and controls transcription of
the fatty acid desaturase gene Ole1 (Ballweg et al., 2020). SREBPs are
additionally regulated by cholesterol in ER membranes (which is usually scarce
to begin with); low cholesterol leads to increased SREBP processing that
generates mature, functional SREBPs (Shimano and Sato, 2017). Lipid synthesis
in the ER thus takes nutrient availability and membrane properties as signaling
inputs for generating lipids for cell growth and maintenance.
ER-derived lipids all start from acetyl-CoA (Holthuis and Menon, 2014)
(Figure 1.3). Acetyl-CoA is then converted to either malonyl-CoA in the
committed step for fatty acid synthesis (feeding into glycerolipid or sphingolipid
synthesis) or acetoacetyl-CoA in the committed step for cholesterol synthesis
(Holthuis and Menon, 2014; Tong, 2005) (Figure 1.3). In cholesterol synthesis,
sequential steps lengthen and cyclize intermediates into cholesterol in ER
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membranes. In fatty acid synthesis, malonyl-CoA is elongated by fatty acid
synthase into the fatty acid palmitate, which can be elongated and desaturated
into other fatty acyl-CoA species (Figure 1.3). For sphingolipid synthesis, fatty
acids are formed into long chain bases, then are additionally acylated to form
ceramides, and these can be additionally processed in the Golgi to form other
sphingolipids such as sphingomyelin (Breslow, 2013) (Figure 1.3).
Committed glycerolipid synthesis begins with formation of lysophosphatidic
acid (LPA) from fatty acyl Co-A and glycerol-3-phosphate (Jacquemyn et al.,
2017). LPA can be additionally acylated to form PA. In metazoans, PA can form
phosphatidylinositol through the CDP-DAG pathway, or it can be
dephosphorylated to form diacylglycerol by phosphatidic acid phosphatases
(PAPs), including lipins (Zhang and Reue, 2017). DAG can form PC or PE or
triglycerides through the Kennedy pathway (Gibellini and Smith, 2010; Kennedy
and Weiss, 1956). The synthesis of either PA- or DAG-derived lipids depends on
PA phosphatase activity, which is mediated by lipins in mammalian cells.
CTDNEP1 and lipin 1 control of ER lipid synthesis
The phosphatidic acid phosphatase lipin 1 (Pah1 in budding yeast; Ned1
in fission yeast; LPIN-1 in nematodes) and its phosphatase C terminal domain
nuclear envelope phosphatase 1 (CTDNEP1) (Nem1 in budding and fission
yeast; CNEP-1 in nematodes) regulate the synthesis of PA- and DAG-derived
lipids (Figure 2.1A). Lipin is conserved from yeast to humans, and isoforms of
lipin are known to be phosphoregulated in yeast, nematodes, flies, mice, and
humans (Bahmanyar et al., 2014; Eaton et al., 2013; Grimsey et al., 2008; Harris
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et al., 2007; O’Hara et al., 2006; Santos-Rosa et al., 2005; Tange et al., 2002). In
budding yeast, Pah1 was found to be a Mg2+-dependent phosphatidic acid
phosphatase (PAP) that dephosphorylates PA to form DAG (Han et al., 2006).
Nem1 was found to be a haloacid dehalogenase (HAD) superfamily phosphatase
that dephosphorylates lipin to activate it (Kim et al., 2007; O’Hara et al., 2006;
Santos-Rosa et al., 2005). In mouse cells, the nutrient-sensing kinase complex
mTORC1 phosphorylates lipin (Peterson et al., 2011). Because other
glycerophospholipid species can be formed from PA and DAG (Figure 2.1A), the
activation state of lipin regulated by Nem1/CNEP-1/CTDNEP1 determines which
glycerolipid species are made in the ER.
Depletion of Nem1/CNEP-1 in budding yeast and C. elegans alters cellular
lipid composition and ER and nuclear envelope membrane structures
(Bahmanyar et al., 2014; Siniossoglou et al., 1998). In budding and fission yeast,
loss of lipin catalytic activity leads to a proliferation of nuclear envelope and ER
membranes, drastically altering the nucleus’ shape from round to lobed
(Siniossoglou et al., 1998; Tange et al., 2002). In LPIN-1- or CNEP-1-deficient C.
elegans early embryos, PA and PI are increased, resulting in an increase in ER
sheets and deficient nuclear envelope breakdown (Bahmanyar et al., 2014;
Golden et al., 2009; Gorjánácz and Mattaj, 2009). Cultured mouse cell nuclei
become oblong rather than round when exposed to conditions causing lipin
dephosphorylation (Peterson et al., 2011). In mice, active lipin is also thought to
negatively regulate transcriptional regulation of fatty acid synthesis and positively
regulate lipid breakdown and adipocyte maturation, and these mechanisms may
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occur through local PA concentration changes or in some cases lipin interaction
with transcriptional regulators (Finck et al., 2006; Péterfy et al., 2005; Peterson et
al., 2011; Phan et al., 2004; Zhang et al., 2012). The functions of lipin 1 and
CTDNEP1 in regulating lipid synthesis in human cells are not well understood.
Key features of human diseases involving loss of function of lipin 1 or CTDNEP1
are not seen in mouse models of lipin 1 deficiency, so studies of human
CTDNEP1/lipin 1 are warranted (Jones et al., 2012; Pelosi et al., 2017). In what
is known so far in all organisms, however, lipin and CTDNEP1 generally act to
limit membrane glycerolipid synthesis and abundance.
Lipid synthesis alterations in cancer
Cancer is a disease is caused and aggravated by genetic or epigenetic
changes to a cell’s DNA that cause a cell to divide continuously in an
uncontrolled manner. Cancer is often characterized by hallmarks, common
characteristics that facilitate transformation of benign cells into malignant cells
and that make malignant cells even more so, all at the expense of surrounding
healthy cells (Fouad and Aanei, 2016). Recently redefined hallmarks include
alterations within the cell— advantages for growth and proliferation, survivalpromoting stress responses, and adaptive metabolic alterations— along with
others involving tumor interaction with surrounding tissue to promote metastasis,
or spreading to other tissues (Fouad and Aanei, 2016). Changes in lipid
synthesis are part of the adaptive metabolic alterations that support growth and
proliferation in cancer cells.
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Lipid synthesis is necessary for cell division. Cells accumulate membrane
lipids prior to mitosis to supply membranes for organelles for both daughter cells
(Jackowski, 1994). Cancer cells frequently show increased lipid synthesis to
support increased cell proliferation (Currie et al., 2013). Consistent with their role
upstream of sphingolipid and glycerolipid synthesis, the components of fatty acid
synthesis are highly upregulated in cancer (Cheng et al., 2018). SREBPs,
SREBP processing components, and SREBP target genes are all upregulated in
a variety of tumors, as are proteins responsible for generating acetyl-CoA, such
as ATP citrate lyase and acetyl-CoA synthetases (Cheng et al., 2018). SREBP1
targets fatty acid synthase and stearoyl-CoA desaturase are especially known to
be upregulated in cancer (Igal, 2010; Kuhajda et al., 1994). Upregulation of these
fatty acid synthesis pathway components bypasses the pro-growth signaling that
works through mTOR to lead to SREBP activation and target gene upregulation,
all in support of uncontrolled cell proliferation. Because the complex functions
and dynamics of organelles are all supported by lipid synthesis, the total impact
of increased lipid synthesis in cancer cells is not understood.
Nuclear envelope and endoplasmic reticulum dynamics during cell division
In open mitosis in mammalian cells, the nuclear envelope breaks down; its
membranes are absorbed into the ER, while nuclear envelope-resident proteins
distribute throughout the ER (if transmembrane) or cytosol (if soluble) (Figure
1.4). During mitotic exit, nuclear envelope membranes are reassembled from ER
membranes (Figure 1.4). In this section, nuclear envelope and ER dynamics in
mitosis will be discussed.
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Nuclear envelope breakdown
In nuclear envelope breakdown, the nuclear pore complexes, nuclear
lamina, DNA-associated proteins, and inner nuclear membrane proteins are
phosphorylated by mitotic kinases, and nuclear envelope membranes
disassemble (Ungricht and Kutay, 2017). Nuclear envelope breakdown begins
with phosphorylation and disassembly of nuclear pore complexes in a sequential
manner that leads to slow initial inward diffusion of cytosolic molecules (Dultz et
al., 2008; Lénárt et al., 2003; Terasaki et al., 2001). Cyclin dependent kinase 1
(Cdk1), Polo-like kinase 1, and NIMA-related kinase 1 phosphorylate the FG
(soluble) nucleoporin Nup98 leading it to be disassociated from the nuclear pore
complexes first, facilitating disassembly of other Nups in protein complexes
(Dultz et al., 2008; Laurell et al., 2011; Macaulay et al., 1995). The nuclear
lamina is then phosphorylated by protein kinase C (PKC) and Cdk1-cyclin B,
leading to its disintegration (Goss et al., 1994; Mall et al., 2012; Ottaviano and
Gerace, 1985; Peter et al., 1990). Dynein pulling forces from the nascent mitotic
spindle forming under mammalian cell nuclei also contribute to breakdown of the
lamina (Beaudouin et al., 2002). Phosphorylation of proteins that link DNA and
the lamina to the inner nuclear membrane leads to dissociation of chromosomes
from the nuclear envelope (Hirota et al., 2005; Molitor and Traktman, 2014;
Tseng and Chen, 2011).
Nuclear envelope clearance from mitotic spindle and chromosomes
After disassembly of nuclear envelope-associated proteins by mitotic
phosphorylation, the nuclear envelope membranes are removed from the vicinity
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of chromosomes to ensure that the assembling mitotic spindle can access
chromosomes. Multiple mechanisms appear to play a role in removing
membranes from chromatin. Depletion of LINC complex components or NudE/EL
(which promotes dynein association to the nuclear envelope during mitotic entry)
reduces the removal of nuclear envelope membranes from chromatin (Turgay et
al., 2014). ER-associated proteins REEP3/REEP4 also limit membranes from
being associated with mitotic chromosomes (Schlaitz et al., 2013). Nuclear
envelope breakdown is also influenced by mitotic ER structure or ER/nuclear
envelope membrane composition. Maintenance of mitotic ER structure by
reticulon expression or expression of the membrane fusion GTPase Rab5 is
required for proper nuclear envelope breakdown in the C. elegans early embryo
(Audhya et al., 2007). Depletion of lipin or CNEP-1/CTDNEP1 in C. elegans and
human cells leads to defective or delayed nuclear envelope breakdown
(Bahmanyar et al., 2014; Golden et al., 2009; Gorjánácz and Mattaj, 2009; Mall
et al., 2012). After nuclear envelope breakdown and removal of membranes from
chromatin, the nuclear envelope membranes are absorbed into ER membranes
(Yang et al., 1997). The nuclear envelope and ER in mitosis are a contiguous
membrane system, with nuclear envelope transmembrane proteins being
distributed throughout the ER (Ellenberg et al., 1997; Yang et al., 1997).
ER and endomembrane exclusion from mitotic spindle and chromosomes
During prometaphase through mitotic exit, the mitotic ER localizes
primarily to the cell cortex, and this localization is important for mitotic fidelity. In
Drosophila S2 cells, the membranes are thought to form a “spindle matrix” that
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concentrates factors critical for building the mitotic spindle (Schweizer et al.,
2015). Disruption of the spindle matrix causes disorganized spindle formation
that leads to chromosome missegregation (Schweizer et al., 2015). The ERresident protein STIM1 is phosphorylated in mitosis to abolish its association with
the microtubule plus end-interacting protein EB1 (Smyth et al., 2012). REEP3/4
on ER membranes also facilitate removal of ER membranes from chromatin;
though REEP3/4 interact with microtubules and ER membranes exhibit minusward movement, REEP3/4 do not interact with the minus-ward motor dynein
(Schlaitz et al., 2013). It is not known how REEP3/4 drive membrane dissociation
from mitotic chromosomes along microtubules. What remains to be described for
mitotic ER localization is how lateral contacts between ER membranes and
spindle microtubules are avoided, as ER membranes interact with microtubules
(MTs) along their lengths by ER-resident MT-binding proteins and interactions
with cargo motors (Bola and Allan, 2009). Other membranous organelles also
localize to the cell cortex during mitosis to facilitate coordinated division and
organelle inheritance (Carlton et al., 2020). Persistence of membranes on
chromosomes during mitosis leads to chromosome segregation errors,
highlighting the importance of the cortical localization of ER membranes in
mitosis (Champion et al., 2019; Schlaitz et al., 2013). It is not known how
membrane biogenesis by the ER is coordinated with membrane dynamics during
cell division, although clearance of membranes to the cell periphery in mitosis
may ensure proper mitotic progression.
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In addition to abolition of ER-MT contacts, ER membranes restructure
during mitosis. Some have observed transition of ER structure to mainly sheetlike cisternae (Lu et al., 2009; Wang et al., 2013), while others have observed a
transition to tubule-like structures, dependent on cell type (Puhka et al., 2007,
2012). REEP3/4 have shown to be important for maintaining ER structure in
mitosis independently from their function to clear ER membranes from
metaphase chromatin. Cells upregulate REEP4 expression by 50% in mitosis
compared to interphase, and mitotic cells lacking REEP3/4 have large extended
ER sheets instead of a network of tubules and sheets (Kumar et al., 2019).
Abundance of ER-shaping proteins (specifically reticulons) has shown to
influence the rate of reestablishment of the nuclear permeability barrier during
mitotic exit, showing how ER structure in mitosis may regulate the progression of
mitotic events (Anderson and Hetzer, 2008).
Nuclear envelope reassembly
During mitotic exit, the nuclear envelope reassembles from ER
membranes (Figure 1.4). After anaphase onset and cyclin B degradation, protein
phosphatases reverse phosphorylation of nuclear envelope proteins to facilitate
nuclear envelope reformation (Asencio et al., 2012; Schmitz et al., 2010).
Transmembrane INM proteins in ER membranes interact with DNA directly or
through DNA-binding proteins like barrier to autointegration factor (BAF) or
heterochromatin protein 1 to initiate nuclear envelope reassembly (Anderson and
Hetzer, 2007; Schellhaus et al., 2015; Ulbert et al., 2006). ER membranes are
recruited to chromatin in distinct regions based on spindle microtubule
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localization (Haraguchi et al., 2008; Liu et al., 2018) (Figure 1.4). In the “noncore” region that is distal from spindle microtubules, almost all nuclear envelope
proteins are present on the reforming nuclear envelope, including the nuclear
pore complexes that assemble during mitotic exit (Clever et al., 2012; Haraguchi
et al., 2000, 2008; Lee et al., 2001; Liu et al., 2018). In contrast, the “core” region
where spindle microtubules are located possesses inner nuclear membrane
proteins and most of the proteins involved in nuclear sealing but is bereft of
NPCs (Haraguchi et al., 2000, 2008; Lee et al., 2001; Liu et al., 2018). Lamin A
is associated with the “core” region, whereas lamin B is associated with the
“noncore” region (Haraguchi et al., 2008). BAF, a traditionally “core” protein,
localizes to the entire reforming nuclear envelope but is enriched close to the
spindle later on in the reassembly process, indicating that “core” regions could
correspond to all surfaces of chromatin, with only “non-core” proteins being
spatially restricted by the spindle (Samwer et al., 2017). In agreement with this
idea, missegregating chromosomes located close to the spindle inherit only
“core” proteins when they form micronuclei, while micronuclei forming from
chromosomes in the cell periphery have the full complement of nuclear proteins
(Liu et al., 2018).
During and after recruitment of ER membranes, the membranes spread
and nuclear pore complexes assemble (Anderson and Hetzer, 2007; Schooley et
al., 2012). ER membranes progressively cover the surface of chromatin; in the
presence of an intact ER network, membrane fusion by GTPases is not
necessary for reforming the nuclear envelope (Anderson and Hetzer, 2007).
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Local lipid synthesis at the nuclear envelope could also provide the substrate for
nuclear envelope reassembly, as newly synthesized phosphatidylcholine is
selectively incorporated into the nascent nuclear envelope (Henry and Hodge,
1983; Rodriguez Sawicki et al., 2019). It is not fully understood how lipid
synthesis before and during mitosis are coordinated to allow proper nuclear
assembly. A combination of preexisting membranes spreading and local
synthesis of new lipids could contribute to the rapid formation of a nuclear
envelope, which is performed on the order of 10 minutes in mammalian cells
(Anderson and Hetzer, 2008; Lu et al., 2011).
Nuclear pore complexes also assemble in a mechanism distinct from
interphase NPC insertion (Schooley et al., 2012). First, soluble MEL28/ELYS
interacts with chromatin and recruits NUP107-160 (Franz et al., 2007). Then,
POM121 on ER membranes interacts with NUP160 (Mitchell et al., 2010).
Additional soluble nucleoporins are incorporated to form the functional NPC
(Schooley et al., 2012). The membrane topology of this process is such that
NPCs are built into holes in the nuclear envelope membrane that shrink and then
dilate to accommodate the nucleoporins (Otsuka et al., 2018). Nuclear pore
complexes are transport-competent before they are fully built and begin importing
from the “non-core” regions before the nuclear envelope is completely assembled
(Lu et al., 2011; Otsuka et al., 2018). The nuclear envelope is not sealed at this
point, preventing a spatially uniform increase in imported material in the
reforming nucleus.
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Toward the end of nuclear envelope reassembly, the nuclear envelope is
sealed, and DNA-bound microtubules are severed. Nuclear sealing is performed
by ESCRT-III complexes (Olmos et al., 2015; Vietri et al., 2015). LEM2 on ER
membranes interacts with BAF on chromatin and recruits the ESCRT component
CHMP7 (Gu et al., 2017), which also binds membrane PA (Thaller et al., 2021).
LEM2 has shown to condense to a separated liquid phase around spindle
microtubules that will be severed, creating a ring-like seal (von Appen et al.,
2020). This seal facilitates assembly of ESCRT-III spiral filaments that constrict
and lead to membrane fusion by VPS4 and hole resolution (von Appen et al.,
2020; Olmos et al., 2015; Vietri et al., 2015). The spindle microtubule is severed
by spastin (Vietri et al., 2015). Coordination of membrane lipid synthesis by
CNEP-1/CTDNEP1 facilitates proper nuclear sealing (Penfield et al., 2020). After
completion of nuclear sealing, the daughter nuclei are transport-competent and
fully sealed, and the nuclei expand to their interphase size as additional pores
are incorporated (Carlton et al., 2020; Ungricht and Kutay, 2017). The
coordination of membrane dynamics from nuclear envelope breakdown to
nuclear sealing are crucial for limiting abnormal nuclear formation.
Micronuclei
Micronuclei are small nuclei that form from missegregated chromosomes
or chromosome fragments that form their own nuclear envelope separate from
the primary nucleus (Fenech et al., 2011) (Figure 1.5). Micronuclei are commonly
found in cancer and serve as prognostic markers for cancer progression
(Adhikari, 2019). Micronuclei are also used as a biomarker for exposure to
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genotoxic agents suspected to cause DNA damage or chromosomal instability
(Adhikari, 2019; Nikolouzakis et al., 2019). Therefore, understanding the
mechanisms by which micronuclei form is important for understanding cancer
progression and underlying chromosomal instability.
Mechanisms of formation of micronuclei
Chromosome fragments can form micronuclei (Figure 1.5). Chromosome
fragments form when non-homologous end joining repairs DNA double strand
breaks in such a way that two breaks that do not belong together are joined;
these fragments can subsequently have zero or two centromeres (Fenech et al.,
2011). Erroneous repair leads to chromosome fragmentation in other situations
as well. Chromosome fragmentation resulting in micronuclei can also occur in
chromosome bridges, wherein a chromatid or chromosome attached to two sides
of the spindle spans and links the segregating chromosome masses (Fenech et
al., 2011; Gisselsson, 2008; Janssen et al., 2011). However, chromosome
bridges do not form micronuclei if the missegregated chromosome is
incorporated into one or both primary nuclei (Pampalona et al., 2016).
Chromosome fragments can also arise from chromothripsis, a catastrophic
genetic event in which 3 or more double strand breaks rearrange at once to lead
to randomly strung together fragments (Leibowitz et al., 2015). These are not
mutually exclusive, as chromosome bridges from dicentric chromosomes can
also undergo chromothripsis (Maciejowski et al., 2015).
Micronuclei can also occur from missegregation of whole chromosomes
and chromatids (Figure 1.5). Micronuclei caused by chromosome missegregation
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occur when the lagging chromosomes are excluded from primary nuclei before
the nuclear envelope reassembles. Lagging chromosomes can be caused by
defective spindle assembly checkpoint activity, merotelic (unbalanced)
kinetochore-microtubule attachments, or faulty chromosome alignment. Spindle
assembly checkpoint proteins limit chromosome missegregation by surveying
attachments of spindle microtubules to kinetochores. Chromosomes attached to
one spindle pole (or neither spindle pole) are sensed by the spindle assembly
checkpoint. Deficiency in the surveillance parts of the spindle assembly
checkpoint permits the cell to progress from metaphase to anaphase before all
chromosomes are attached (Fenech et al., 2011). Defects in centromere or
kinetochore architecture can also contribute to chromosome missegregation by
causing misattachments to not be surveilled properly by the spindle assembly
checkpoint (Fenech et al., 2011). Merotely is another major mechanism that
generates lagging chromosomes (Cimini et al., 2001). Merotelic attachments
occur when a kinetochore of a chromosome is attached to microtubules from
both spindle poles, leading to a tug-of-war instead of poleward movement for that
chromatid at anaphase onset (Gregan et al., 2011). It is important to note that
although the spindle assembly checkpoint surveils for unattached kinetochores,
merotelic attachments satisfy the checkpoint. Because the attachment is
imbalanced, merotelically attached chromosomes lag in anaphase and form
micronuclei (Figure 1.5, “Merotely”). Merotely can be recovered during
prometaphase and metaphase, indicating that lack of recovery is part of the
mechanism for lagging chromosome formation (Cimini, 2003; Wang et al., 2017).
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The extent to which the number of microtubules attached to a merotelically
attached kinetochore from each side is unbalanced also influences whether or
not the chromosome will missegregate during anaphase (Cimini et al., 2004;
Thompson and Compton, 2011).
Chromosome misalignment is another mechanism by which micronuclei
can form through chromosome missegregation. Alignment occurs during
chromosome congression in prometaphase, when chromosomes attached to the
mitotic spindle move toward the metaphase plate. Congression is performed by
chromokinesins, kinesin motor proteins that interact with chromosomes and
spindle microtubules and generate chromosome movement (Almeida and
Maiato, 2018). Loss of kinesin KIF18A, which suppresses kinetochore dynamics
to promote congression, leads to increased formation of micronuclei (Fonseca et
al., 2019). The micronuclei form from missegregated but normally attached
chromosomes that arise from having to travel longer distances during anaphase
(Fonseca et al., 2019). These data suggest that having chromosomes lined up at
the metaphase plate allows all chromosomes to travel together upon anaphase
onset so that all chromosomes can be incorporated into primary nuclei before the
nuclear envelope reassembles. Consistent with this idea, it has been proposed
that late-aligning chromosomes are more likely to become lagging chromosomes
after anaphase onset (Kuniyasu et al., 2019).
It is important to note that p53, a tumor suppressor very frequently lost in
cancer, is thought to arrest the cell cycle of cells with aneuploidy resulting from
chromosome fragments (Soto et al., 2017). In contrast, aneuploidy from
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missegregation of whole chromosomes is tolerated by p53 with regards to cell
cycle progression (Soto et al., 2017). p53 is mutated in 42% of cancers overall,
though the frequency ranges from 2.2% to 95% depending on the tissue of origin
(Bykov et al., 2018). Therefore, in cases where cells have intact p53, whole
chromosome missegregation may contribute further to chromosomal instability.
Consequences of formation of micronuclei
Nuclear envelope reassembly in micronuclei differs from in the main
nucleus, and this has consequences for nuclear envelope integrity. It has been
proposed that nuclear envelope reassembly occurs more slowly (by NUP107
fluorescence tracking) on lagging chromosomes due to a limiting Aurora B
gradient in the spindle midzone (Afonso et al., 2014). Live and fixed cell imaging
with more nuclear envelope markers has since revealed that the nuclear
envelope reforms on micronuclei at the same time as the main nucleus, (Liu et
al., 2018). However, in lagging chromosomes in the spindle midzone, only “core”
nuclear envelope proteins are recruited, in contrast to recruitment of the full
complement of nuclear envelope proteins, including NPCs, in lagging
chromosomes located in the cell periphery (Liu et al., 2018). The mechanism for
two modes of nuclear assembly is due to presence of tightly-bundled spindle
microtubules in the midzone restricting membrane access, as opposed to an
Aurora B gradient restricting protein localization (Liu et al., 2018).
This finding might shed light on a discrepancy in findings regarding the
fate of micronuclei depending on how the lagging chromosome formed.
Chromatids in micronuclei generated by merotely do not replicate DNA and have

28

shown to missegregate often in future divisions (Crasta et al., 2012; Soto et al.,
2018), whereas chromatids in micronuclei generated by misalignment may
missegregate less often (Fonseca et al., 2019). Merotelic chromosomes can be
seen as lagging chromosomes within the spindle midzone (Cimini, 2003; Cimini
et al., 2004), whereas this is not always the case with misaligned chromosomes
(Fonseca et al., 2019). Micronuclei generated by misaligned chromosomes away
from the spindle midzone may be more likely to have functioning NPCs and may
thereby be able to import factors that allow DNA replication and functional
kinetochore assembly. Further studies will illuminate whether different
mechanisms of chromosome missegregation lead to micronuclei that contribute
to aneuploidy more or less due to different levels of completeness in nuclear
envelope reassembly. This is especially important to understand because
micronuclei are additionally subject to adverse events that may lead to mutations.
DNA within micronuclei is subject to damage, innate immune detection,
deficient replication, and missegregation. It has been shown that micronuclei can
undergo a loss in compartmentalization characterized by infiltration of the
chromosome by ER membranes and increased DNA damage; this collapse is
influenced by lamin B levels in micronuclei (Crasta et al., 2012; Hatch et al.,
2013; Vietri et al., 2020). Chromothripsis has also shown to occur in micronuclei,
leading to complex rearrangements and indels in the chromosome contained in
the micronucleus (Zhang et al., 2015). Collapse of the nuclear envelope in
micronuclei leads to recognition of micronuclear cytosolic DNA by cGAS, which
leads to downstream upregulation of type I interferon response genes
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(MacKenzie et al., 2017). Nuclear rupture in micronuclei also cannot be repaired
in a coordinated manner as in primary nuclei (Vietri et al., 2020). Finally, as
mentioned previously, DNA in micronuclei may not replicate properly and often
missegregates during mitosis (Crasta et al., 2012; Soto et al., 2018). Even if the
DNA is incorporated into a primary daughter nucleus in the subsequent division,
the cell runs the risk of damaged DNA from the micronucleus being propagated
in future divisions (Giam and Rancati, 2015). The high prevalence of micronuclei
in aggressive cancers likely reflects their role in increasing genome instability.
Role of membrane dynamics in formation of micronuclei
Membrane dynamics have been implicated in chromosome missegregation
that can lead to formation of micronuclei. Preventing clearance of ER
membranes from chromatin by knocking down REEP3 and REEP4 leads to
chromosome missegregation, including lagging chromosomes and chromosome
bridges (Schlaitz et al., 2013). Artificially tethering ER membranes to chromatin
prior to anaphase onset likewise prevents proper chromosome segregation
(Champion et al., 2019). These data support the idea that membranes can
impede proper chromosome segregation and raise the question of how
membrane abundance and dynamics in mitosis regulate mitotic progression.
Despite the importance of membrane dynamics in mitosis influencing
chromosome segregation, the role of lipid synthesis regulation of membrane
abundance in regulation chromosome segregation has not been studied.
Mammalian cells accumulate lipids prior to entry into mitosis (Jackowski, 1994),
but it is not known if limiting membrane lipid synthesis impacts mitotic fidelity.
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Here, I identify a link between regulation of ER membrane biogenesis and
formation of micronuclei through the lipin phosphatase CTDNEP1. In Chapter 2, I
characterize ER and nuclear envelope protein localization and functions using
CRISPR-Cas9 gene editing in human cell lines, and I use a CRISPR-edited cell
line to show that CTDNEP1 limits ER membrane abundance through its catalytic
activity on lipin 1 and limits formation of micronuclei. In Chapter 3, I use live cell
imaging time lapses to characterize the membrane dynamics of CTDNEP1depleted cells during cell division. I show that membranes are more abundant
and less cleared in mitotic cells depleted of CTDNEP1. In Chapter 4, I investigate
specific mechanisms of chromosome missegregation in CTDNEP1-depleted cells
using small molecule inhibitors to show that specific errors that are not sensed by
the spindle assembly checkpoint are less corrected in CTDNEP1-depleted cells.
In Chapter 5, I elucidate the mechanism by which CTDNEP1 limits membrane
biogenesis using lipidomic analysis, small molecule inhibition of fatty acid
synthesis, and RNAi modulation of fatty acid synthesis gene expression. I show
that CTDNEP1 limits flux into fatty acid and ER membrane lipid synthesis to limit
membrane biogenesis. I additionally show that inhibition of fatty acid synthesis
suppresses formation of micronuclei in CTDNEP1-depleted cells, which links the
excess membranes in mitosis to error correction defects seen with loss of
CTDNEP1. In Chapter 6, I discuss remaining questions and possibilities for
future experiments.
Together, these show that the protein phosphatase CTDNEP1 restricts ER
membrane biogenesis through lipin 1 to facilitate mitotic error correction that
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limits the formation of micronuclei in human cell lines. These data link regulation
of lipid synthesis to chromosome segregation errors resulting in micronuclei,
which can inform as to how chromosomal instability can occur in cancer cells
with increased lipid synthesis.
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Figure 1.1 Types of cellular lipids and their properties
Schematic of types of membrane lipids. Organization of glycerolipids,
sphingolipids and cholesterol into membrane microdomains shown. Head groups
of lipids are shown in blue, backbones are shown in red, and fatty acid chains are
shown in yellow.
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Figure 1.2 The nuclear envelope and endoplasmic reticulum
Organization of nuclear envelope and ER (focusing on peripheral ER) is shown.
The nuclear lamina and chromatin are anchored to the inner nuclear membrane
through inner nuclear membrane proteins. Nuclear pore complexes span the inner
and outer nuclear membrane, and the LINC complex spans the nuclear
membranes and connects the nuclear envelope to the cytoskeleton. In the ER,
curvature-stabilizing proteins stabilize curvature at tubules, tubule junctions, sheet
edges, and on ER nanohole edges. Sheet-stabilizing proteins localize to the center
of sheets and stabilize the luminal width. ER structure is also dependent on
contacts with the cytoskeleton and contact sites with other organelles (tethered
lipid droplet shown).
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Figure 1.3 Lipid synthesis pathways in the ER
Schematic of lipid synthesis pathways in the ER (steps occurring in the ER are
outlined in green). Citrate is converted to acetyl-CoA by ATP citrate lyase (ACLY).
Acetyl-CoA is converted to acetoacetyl-CoA, and subsequent steps result in
synthesis of cholesterol. Acetyl-CoA is also formed into fatty acids starting with
conversion to malonyl Co-A by acetyl-CoA carboxylase (ACAC). Fatty acid
synthase (FASN) elongates malonyl-CoA to palmitate, which is then converted to
palmitoyl-CoA. Fatty acids are desaturated at the Δ9 position by stearoyl-CoA
desaturase (SCD) and/or additionally desaturated by fatty acid desaturases
(FADs) or elongated by ELOVs (Elongation of very long chain fatty acids proteins).
These acyl-CoAs can be incorporated into sphingolipids or glycerolipids. Acyl-CoA
is combined with glycerol-3-phosphate by glycerol-3-phosphate acyltransferase
(GPAT) to form LPA. LPA can be additionally acylated by 1-acylglycerol-3phosphate-O-acyltransferase (AGPAT) to form PA. PA can be converted to CDPDAG by CDP-DAG synthase (CDS) and then PI by PI synthase (PIS). PI can be
phosphorylated to form phosphatidylinositol phosphate derivatives (PIPs). PA can
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be dephosphorylated by PAPs (including lipins) to DAG. DAG can be formed to
TAG by diacylglycerol acyltransferase (DGAT) or PC or PE by choline or
choline/ethanolamine phosphotransferase (CPT, CEPT); PC and PE can be
converted to PS.

Figure 1.4 Nuclear envelope and ER dynamics in mitosis
Schematic of ER and nuclear envelope dynamics from nuclear envelope
breakdown through mitotic exit. The nuclear envelope is intact in interphase, and
centrosomes are unduplicated. During prometaphase, the nuclear envelope
breaks down, and the nuclear envelope membranes are absorbed into ER
membranes. Membranes are cleared from chromosomes and cleared to the cell
periphery, excluded from the spindle. After anaphase, nuclear membranes contact
chromosomes and reform the nuclear envelope. The membranes are sealed by
the ESCRT-III complex.
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Figure 1.5 Mechanisms of formation of micronuclei
Schematic of mechanisms for how micronuclei can form. Chromosome
abnormalities and attachment abnormalities in metaphase are shown with insets
showing kinetochore-microtubule attachments and tension/pulling forces (black
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arrows). The result for chromosome segregation in anaphase is shown, as well as
the consequence for interphase primary and micro-nuclei. In “SAC failure,” insets
show a) no attachment, b) monotely, and c) syntely.
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Chapter 2: Nuclear envelope-localized human CTDNEP1 regulates ER
membrane biogenesis, nuclear morphology and formation of micronuclei
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Introduction
The structure of organelle membranes is important for organelle function.
Tissue-specific functions rely on unique and highly adapted organelle structures,
such as long ER tubules in neurons (Yalçın et al., 2017) or multilobed, flexible
nuclei in some immune cells (Skinner and Johnson, 2017). Maintenance of
organelle structure is shown to be specifically disrupted in many human
diseases, highlighting the importance of understanding how organelle structure is
established and maintained.
Organelle structure can be maintained by membrane-shaping proteins. In
the ER, reticulons stabilize membrane curvature through insertion of two
hydrophobic helices (Voeltz et al., 2006). Reticulons oligomerize and cooperate
with other ER-shaping proteins to stabilize new and existing curvature, including
sheet edges and nanoholes (Hu et al., 2008; Schroeder et al., 2018; Shibata et
al., 2010; Wang et al., 2016b). Ectopic reticulon overexpression causes formation
of long, unbranched peripheral ER tubules, whereas knockdown of reticulons
leads to an increase in ER sheets and decrease in tubules (Anderson and
Hetzer, 2008; Schroeder et al., 2018; Shibata et al., 2010; Voeltz et al., 2006).
Both reticulon overexpression and downregulation can be observed in
neurodegenerative diseases, reflecting how tuning ER structure is important for
cell function (Chiurchiù et al., 2014).
Organelle structure is also determined by ER lipid synthesis.
Overabundance of membranes through increased fatty acid synthesis without
increased reticulon expression leads to ER sheet formation (Shibata et al., 2010).
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Increased synthesis of PI, PC, and PE in yeast and PA and PI in C. elegans by
deletion of the lipin phosphatase CTDNEP1 leads to ER membrane expansion
and sheet formation, respectively, while nuclear envelope structure is also
affected (Bahmanyar et al., 2014; Kim et al., 2007; Siniossoglou et al., 1998). For
this study, we primarily focused on the function of human CTDNEP1 for
maintaining ER and nucleus morphology through lipin 1 dephosphorylation.
In metazoans, lipin’s catalytic activity determines whether glycerolipid
species derived from PA or DAG are made in the ER. Lipin has also shown to
have transcriptional regulation activities, in some cases indirectly through
regulation of PA levels. In mice, lipin 1 has shown to positively regulate PPARα
and PPARγ-dependent transcription to activate lipid breakdown and adipocyte
differentiation (through transcription factor or repressor binding) (Finck et al.,
2006; Phan et al., 2004; Zhang et al., 2012). Nuclear lipin 1 represses SREBPdependent fatty acid synthesis gene transcription through an unknown
mechanism (Peterson et al., 2011). Lipin 1 is sensitive to metabolic status
through insulin-dependent phosphorylation by the nutrient-sensing kinase mTOR
(Huffman et al., 2002; Peterson et al., 2011). Lipin 1 isoforms α and β
transcriptional regulation permits differentiation of adipocytes through modulating
PA levels (Grimsey et al., 2008; Koh et al., 2008; Phan et al., 2004; Zhang et al.,
2012), and consistent with this role, lipin 1-deficient mice and flies exhibit
lipodystrophy (Péterfy et al., 2001; Ugrankar et al., 2011). Lipin 1’s transcriptional
regulation activity is dependent on its localization; dephosphorylated lipin
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localizes to the nucleus, while phosphorylated lipin is retained in the cytoplasm
and degraded (Peterson et al., 2011; Shimizu et al., 2017).
CTDNEP1 and lipin 1 are both HAD superfamily phosphatases with
canonical DXDX(T/V) active sites (Seifried et al., 2013) (Figure 2.1B-2.1C).
CTDNEP1 has an N-terminal transmembrane domain and localizes to nuclear
envelope and ER membranes (Bahmanyar et al., 2014; Han et al., 2012;
Siniossoglou et al., 1998), while Pah1/lipin 1 is a cytosolic/nuclear protein that
binds to PA in membranes for its PAP activity (Eaton et al., 2013; Han et al.,
2006). Lipin’s polybasic domain is important for its PA binding and is thought to
serve as its nuclear localization signal (Eaton et al., 2013; Ren et al., 2010)
(Figure 2.1C). CTDNEP1 localization and activity is allowed through interaction
with its obligate binding partner, NEP1R1 (ySpo7) (Han et al., 2012; Siniossoglou
et al., 1998). While CTDNEP1 and lipin 1 are HAD superfamily phosphatases,
the phosphatase domain of lipins was recently found to be split into the NLIP and
CLIP domains, which fold together to form the functional phosphatase domain
(Khayyo et al., 2020) (Figure 2.1B-2.1C). Lipin 1 linker phosphorylation is now
thought to prevent functional assembly of the phosphatase domain (Khayyo et
al., 2020).
The functions of human CTDNEP1 and lipin 1 are not fully known. Unlike
the mouse model of lipodystrophy, human patients with lipin 1-inactivating
mutations do not have lipodystrophy but instead present with rhabdomyolysis,
episodic breakdown of muscle tissue leading to myoglobinuria, during childhood
(Michot et al., 2010; Zeharia et al., 2008). Truncating mutations in CTDNEP1 are
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found in Group 3/4 and uncharacterized medulloblastomas, cancers of the
cerebellum (Jones et al., 2012; Northcott et al., 2017). Patients in these
subgroups of medulloblastoma frequently have loss of heterozygosity at Chr17p
where CTDNEP1 (and prominent tumor suppressor TP53) are located, while
TP53 is unaltered, making CTDNEP1 a tumor suppressor candidate in this
region (Jones et al., 2012). The disease mechanisms for loss of function of
CTDNEP1 and lipin 1 are not understood. Unlike in lipin-deficient mice, adipose
tissue of patients lacking functional lipin 1 has normal composition, though lipid
droplets are smaller, and adipogenic gene expression is upregulated (Pelosi et
al., 2017). Human adipose tissue may have compensatory mechanisms in place
that are not present in mice, or lipin’s functions in human adipose tissue may not
be fully conserved. These differences warrant study of lipin 1 and CTDNEP1 to
further understand their regulation of lipid synthesis in human cells.
Here, I show that CTDNEP1 is required for limiting ER membrane
biogenesis in a human cancer cell line. I establish methods for quantifying ER
membrane abundance and qualitatively assessing changes in ER structure
through modulating reticulon levels versus ER abundance through CTDNEP1
and lipin. I also demonstrate that CTDNEP1 and lipin 1 catalytic activity are
required for limiting ER membrane abundance. I also show that CTDNEP1 has a
conserved role for maintaining nuclear shape. These data show that regulation of
ER membrane biogenesis and nuclear morphology in human cells through
CTDNEP1 and lipin 1 converges with limiting ER biogenesis in other model
organisms, despite differences in lipid synthesis pathways and lipid synthesis
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regulation between organisms. These data also uncover a previously unknown
role for CTDNEP1 in regulating formation of micronuclei.
Results
CRISPR-Cas9 strategies for targeting nuclear envelope and ER proteins reveals
role for reticulons in ER nanohole formation/stability
To determine the role of reticulons in the formation or stabilization of
curvature within ER sheets in ER nanoholes, I generated a CRISPR knockout
cell line of all isoforms of reticulon 4 (Figure 2.2A-B). The sgRNA targeted the
sequence corresponding to a hydrophobic region within the reticulon homology
domain, in order to disrupt the synthesis of stable reticulon 4 isoforms (Figure
2.2A). Consistent with the depletion of reticulon isoforms, reticulon 4 B/D were
unable to be detected by immunoblot in RTN4KO U2OS cells (Figure 2.2B).
Immunostaining RTN4KO cells with an antibody targeting the reticulon 4 N
terminus (targeting RTN4A/B/D) did not show any specific staining unlike in
unmodified U2OS cells (data not shown). Triple knockdown of reticulons 1,3, and
4 induces ER sheet formation (Anderson and Hetzer, 2008). With L. K.
Schroeder, I imaged U2OS or RTN4KO U2OS cells treated with control or
RTN1/3-targeting siRNA by confocal and stimulated emission depletion (STED)
nanoscopy (Figure 2.2C). Nanoholes can be seen in ER sheets in control cells
(Figure 2.2C, above inset and arrows), whereas sheets in reticulon-depleted cells
are devoid of nanoholes (Figure 2.2C, below inset). On the population level,
control U2OS cells have more small peripheral sheets that are non-uniform in
appearance, whereas reticulon-depleted cells have extended ER sheets that are
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uniform in appearance throughout (Schroeder et al., 2018). Thus, reticulons are
involved in ER nanohole formation or maintenance.
To determine nanohole size relative to other membrane features by live
STED nanoscopy, a homozygous endogenous marker of a well-defined feature
was needed. Nuclear pore complexes have a defined size of ~100 nm and vary
little in size, making them an ideal candidate. I targeted the Y complex
nucleoporin NUP160 because NUP160 fusion proteins are functional in multiple
model organisms, which is particularly important in the case where every copy of
the gene is tagged. Using homology-directed repair with CRISPR-Cas9, I tagged
all alleles of endogenous NUP160 with the coding sequence for the dye ligand
covalent binding partner HaloTag7 (Figure 2.3A-2.3B). Endogenously-tagged
NUP160 localized to the nuclear envelope in a punctate localization, as expected
(Figure 2.3C). A coverslip-level section highlights the punctate localization of the
protein (Figure 2.3C). STED nanoscopy of NUP160-Halo revealed a consistent
~100 nm size of nuclear pore complex membrane holes, which contrasts with a
large range of ER nanohole sizes (Schroeder et al., 2018).
CRISPR-Cas9 strategies for targeting human CTDNEP1
To understand the cellular functions of human lipin 1 and CTDNEP1 in this
study, I targeted human CTDNEP1 for generation of tagging knock-in and
knockout cell lines (Figure 2.4, Figure 2.6). Targeting CTDNEP1 is preferable to
targeting lipin due to the presence of 3 lipins in human cells with some functional
redundancy, and targeting lipin activation is less detrimental to cell health than
lipin deletion to permit functional studies (Bahmanyar et al., 2014; Donkor et al.,
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2007; Gorjánácz and Mattaj, 2009). Depleting cells of CTDNEP1 also allows us
to study the roles of lipin’s S/T phosphorylation state, as there are posttranslational modifications of lipin not regulated by CTDNEP1 that cannot be
ruled out by targeting lipin alone (Liu and Gerace, 2009; Song et al., 2020).
I generated a CTDNEP1 knockout clonal U2OS human osteosarcoma cell
line using CRISPR-Cas9 (Figure 2.4A). This knockout cell line has a
homozygous truncating single-nucleotide insertion in exon 3 just past the DLDET
active site (Figure 2.4B). Although the active site is intact, this truncating
mutation makes CTDNEP1 transcripts in this cell line candidates for nonsensemediated decay, as CTDNEP1 mRNA levels in CTDNEP1KO U2OS cells are
decreased by >80%, similar to knockdown of CTDNEP1 in U2OS and RPE-1
cells (Figure 2.5A). This cell line is deficient in CTDNEP1 phosphatase activity,
as J. W. Carrasquillo Rodríguez found that lipin 1 in CTDNEP1KO cells is
hyperphosphorylated and less abundant (Merta et al., 2021).
Localization of endogenous CTDNEP1
The localization of CTDNEP1 in human cells is not known but has the
potential to inform the mechanism for how lipin 1’s localization to the nucleus is
regulated – Nem1 in yeast localizes to nuclear envelope/ER membranes, but
CNEP-1 in C. elegans is enriched at the nuclear envelope (Bahmanyar et al.,
2014; Siniossoglou et al., 1998). Generation of a CTDNEP1-specific antibody
has proven difficult (S. Bahmanyar, G. Celma, T. Vitale, Y. Kim,
correspondence). A commercial CTDNEP1 peptide antibody, a commissioned
commercial peptide antibody, and an antibody made using CTDNEP1 with 3
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internal deletions to improve solubility all failed to show specific staining by
immunoblot or immunofluorescence (data not shown; with Tevis Vitale and Gunta
Celma). To determine the localization of endogenous human CTDNEP1, I
generated a CRISPR knock-in U2OS cell line in which all copies of CTDNEP1
are tagged with GFP (Figure 2.6). Live spinning disk confocal imaging of GFP
signal in U2OS CTDNEP1EN-GFP cells reveals that CTDNEP1 localizes to the
nuclear envelope with some cytoplasmic localization likely corresponding to ER
membranes (Figure 2.7A, left). Knockdown of CTDNEP1 in U2OS CTDNEP1ENGFP cells abrogates GFP fluorescence at the nuclear envelope (data not
shown). Fluorescent punctae are also seen in the perinuclear region of cells
(Figure 2.7A, left). Imaging immunostained GFP in U2OS CTDNEP1EN-GFP cells
shows nuclear envelope localization and perinuclear diffuse staining, perhaps
localizing to ER membranes (Figure 2.7A, right). The perinuclear punctate
fluorescence seen in live imaging of CTDNEP1-GFP is not seen in
immunostained cells, indicating that this could be an artifact of high exposure
needed to visualize low-expressing CTDNEP1. If not, this localization could
correspond to lipid droplets, which CTDNEP1 has shown to localize to in yeast
(Choudhary et al., 2020). Future colocalization studies will reveal if CTDNEP1 in
human cells localizes to compartments other than the nuclear envelope, as well
as what face of the nuclear envelope CTDNEP1 localizes to, to further enlighten
its functions.
CTDNEP1 controls ER membrane abundance in human cells
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Deletion of CTDNEP1 in yeast (yNem1) leads to a proliferation of ER and
nuclear envelope membranes (Kim et al., 2007; Siniossoglou et al., 1998). I
transiently expressed GFP-KDEL in U2OS CTDNEP1KO cells to visualize ER
morphology. Control U2OS cells have an ER morphology consisting of dense ER
sheets close to the nucleus and a peripheral network of mostly tubules arranged
in 3-way junctions (Figure 2.8A, top and top inset). In contrast, CTDNEP1KO
U2OS ER appears to be expanded and dense uniformly throughout the cell,
extending to the periphery (Figure 2.8A, bottom). ER tubules and sheets can be
seen in the cell periphery (Figure 2.8A, bottom inset). This phenotype is highly
penetrant, occurring in 93.7 ± 3.9 % of cells (Figure 2.8B). To rule out the
possibility that this “expanded ER” phenotype is exclusive to GFP-KDEL
overexpression, I fixed U2OS cells with formaldehyde and glutaraldehyde to
preserve membrane structure and stained them with a calnexin antibody to mark
ER membranes. Staining of this endogenous ER marker also revealed that the
ER is more packed and denser in CTDNEP1KO U2OS cells compared to control
cells (Figure 2.8C).
Two subsequent attempts to generate of a second clonal CTDNEP1KO cell
line using a different guide RNA sequence (targeting exon 1) were unsuccessful.
To control for the possibility that the expansion of ER membranes in CTDNEP1KO
cells could be due to non-CTDNEP1 mutations in the clonal cell line, I knocked
down CTDNEP1 in unmodified U2OS cells (Figure 2.5A, right; Figure 2.9). Cells
subject to CTDNEP1 RNAi showed expanded ER membranes (Figure 2.9A).
With a knockdown to 9.3 ± 0.43% of CTDNEP1 mRNA transcript levels
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determined by qRT-PCR, 77.5 ± 6.42% of cells treated with CTDNEP1 siRNA
had expanded ER, closely resembling the phenotype penetrance in CTDNEP1KO
U2OS cells (Figure 2.5A, right; Figure 2.9B).
To determine if the effect of depleting CTDNEP1 leading to expansion of ER
membranes is cell line-specific, I chose RPE-1 cells to replicate this phenotype.
Although U2OS cells are amenable to imaging organelles due to their size and
spread-out shape, U2OS is a cancer cell line, and cancer cell lines can have
upregulated expression of fatty acid synthesis genes (Cheng et al., 2018). This
could possibly sensitize them to alterations in lipid synthesis pathways. RPE-1
cells are non-transformed, non-cancer, and mostly karyotypically normal, and
they are ideal for ruling out the possibility of cancer cell specificity for CTDNEP1
depletion phenotypes. RPE-1 cells have a smaller ER tubular network per cell
area compared to U2OS cells (Figure 2.10A, left), but expansion of ER
membranes can still be seen when CTDNEP1 is knocked down (Figure 2.10A,
right). This presents as a disappearance of the peripheral tubular network and
bright ER filling the cell to the cell edge, obscuring individual ER features, like
tubules (Figure 2.10A, right). This phenotype was also highly penetrant in RPE-1
cells (Figure 2.10B). In addition to replicating expansion of ER membranes with
CTDNEP1 depletion in RPE-1 cells, E. Guinn and S. Lee have found that
depletion of CTDNEP1 leads to ER expansion in COS-7 (African green monkey
kidney) and DLD-1 (human colorectal adenocarcinoma) cells (data not shown).
These data support the conclusion that CTDNEP1 limits the abundance of ER
membranes in human cells from multiple tissue types and origins.
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Quantitative and qualitative assessment of ER membrane morphology and
abundance
To assess penetrance of the expanded ER phenotype in cell lines, I used
scoring and incidence of the phenotype to report our findings. However,
quantification of ER membrane expansion is needed to confirm the findings and
to assess if a continuum of phenotypes exists. Segmentation of fluorescent ER
signal has been used to discern the percentage of ER-positive pixels belonging
to ER tubules or sheets to show which how a membrane fusion-regulating protein
is required for tubule fusion and reducing ER sheets (English and Voeltz, 2013).
In this study, the authors made maximum projections of ER signal, reduced the
bit depth from 16-bit to 8-bit, and segmented both total ER and sheet-like ER
using the Renyi entropy thresholding algorithm before quantifying sheet-like ER
versus total ER (English and Voeltz, 2013). The advantage of this approach is
that reducing the bit depth and making the image a maximum projection of ER
signal makes it easier to segment total ER, which takes on a variety of
morphologies of different brightnesses due to different thicknesses and, in some
cases, non-uniform distribution of fluorescent markers or ms-scale ER movement
(Nixon-Abell et al., 2016; Schroeder et al., 2018). I sought to adapt this technique
to quantify changes in ER membrane overall abundance rather than structure.
To quantify changes in the amount of membranes in cells with altered lipid
synthesis by depletion of CTDNEP1, I measured the area fractions of cells that
are taken up by ER membranes. Starting with 16-bit spinning disk confocal
image stacks of GFP-KDEL (live) or calnexin (fixed) signal that encompassed the
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entire cell volume, I reduced the bit depth to 8-bit and made maximum intensity
projections of the image stacks. To ensure that peripheral tubules would be
segmented as well as brighter ER features, I applied an unsharp masking filter to
the maximum projection images, which subtracts a Gaussian blurred image (here
with a radius of 0.2 and mask of 0.6) from the unaltered image to sharpen it
(Figure 2.11A). I then thresholded the image using the Huang algorithm, which
relies on measures of image fuzziness (Huang and Wang, 1995) (Figure 2.11A).
Fuzziness in images refers to the extent of lack of belonging to the object or the
background (Huang and Wang, 1995). The Huang algorithm in ImageJ finds the
threshold at which fuzziness is minimized. I rationalized using the Huang
algorithm for segmenting total ER because there is a wide dynamic range of
maximum projection ER brightness due to morphology differences throughout the
cell, and maximizing object-belonging is desirable to segment dim tubules with
bright perinuclear ER. In practice, this thresholding segments total ER well
(Figure 2.11A, images). I then manually drew outlines of the cell border and
nucleus and then measured the percent area of the cytoplasm occupied by ER
membranes (Figure 2.11A). Using this method, I show that CTDNEP1KO U2OS
cells have higher occupancy of the cytoplasm with ER membranes compared to
control U2OS cells (Figure 2.11B). Cells depleted of CTDNEP1 by RNAi also
have a higher percentage of ER-positive pixels taking up the cytoplasm area
compared to cells treated with control siRNA (Figure 2.11B). The spread of
individual values in control U2OS cells is large compared to the spread of values
in CTDNEP1KO cells (~55-85% in control cells versus ~85-100% in CTDNEP1KO
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cells) reflecting how CTDNEP1KO cells’ ER takes up a large proportion of the
cytoplasm (Figure 2.11B). Cells treated with CTDNEP1 siRNA also have a larger
spread of individual values and lower overall occupancy of ER in the cytoplasm
compared to CTDNEP1KO cells, likely due to a lesser extent of CTDNEP1
depletion with RNAi knockdown (Figure 2.11B).
To distinguish between expansion of ER membranes due to increased
membrane abundance and alteration of ER morphology, I compared cells
depleted of CTDNEP1 to cells depleted of reticulons 1, 3, and 4 (Figure 2.12).
Depletion of reticulons 1, 3, and 4 causes the ER to form more membrane sheets
that lack nanoholes, as well as thicker ER tubules (Anderson and Hetzer, 2008;
Schroeder et al., 2018) (Figure 2.2C; Figure 2.12A, below, yellow arrow). In all
cells, perinuclear ER is brightest and appears most dense (Figure 2.12A, blue
arrows). In control U2OS and reticulon-depleted U2OS, peripheral ER tubules
can be seen at the edge of cells, and ER sheets of roughly the same brightness
as tubules can be seen in reticulon-depleted cells (Figure 2.12, left and below,
yellow arrows). In contrast, the ER in CTDNEP1KO cells is more uniformly bright
in all areas of the cell, reflecting increased membranes rather than a shift in
structure of existing membranes (Figure 2.12, right, yellow arrow). Thus, the
appearance of expanded ER membranes in CTDNEP1KO cells can be
distinguished from a change in ER membrane structure by assessment of
uniform ER brightness through the whole cell.
CTDNEP1 and lipin 1 phosphatase activities are required for limiting ER
membrane abundance
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To determine if the expansion of ER membranes in CTDNEP1KO cells is due
to loss of CTDNEP1 phosphatase activity, I transiently overexpressed
CTDNEP1-HA wild type and mutant constructs with and without its obligate
binding partner NEP1R1 (Figure 2.13A-B). Overexpressed CTDNEP1 and
NEP1R1 localize to the nuclear envelope and ER membranes (Figure 2.13A).
Expression of wild type CTDNEP1-HA alone (Figure 2.13A-B, “WT”) partially
suppressed the incidence of expansion of ER membranes in CTDNEP1KO cells
(Figure 2.13B). Consistent with its role in stabilizing CTDNEP1 localization and
activity, NEP1R1 overexpression with expression of catalytically active
CTDNEP1 rescued expansion of ER membranes to a greater extent (SantosRosa et al., 2005) (Figure 2.13B). CTDNEP1 in which the DLDET active site is
mutated to ELDET (D67E; “PD”) to render it phosphatase dead does not rescue
ER expansion when co-expressed with NEP1R1, indicating that it is loss of active
CTDNEP1 that is responsible for expansion of ER membranes in CTDNEP1KO
cells (Figure 2.13A-B).
Transient overexpression of CTDNEP1 in U2OS cells leads to localization
that is not consistent with localization of endogenous CTDNEP1 (Figure 2.7;
Figure 2.13A). Therefore, I quantified the incidence of ER expansion and
occupancy of ER membranes in CTDNEP1KO cells stably expressing wild type
CTDNEP1 (Figures 2.13C-D, “WT (stable)”). Stable overexpression of
CTDNEP1-HA substantially reduced the incidence of expanded ER in
CTDNEP1KO cells (Figure 2.13C). Stable overexpression of CTDNEP1-HA also
reduced the occupancy of ER membranes in the cytoplasm of CTDNEP1KO cells

53

(Figure 2.13D). Together, these data support the conclusion that expansion of
ER membranes in CTDNEP1KO cells is due to loss of CTDNEP1 catalytic activity.
CTDNEP1’s primary known substrate for dephosphorylation is the
phosphatidic acid phosphatase lipin (Santos-Rosa et al., 2005). Since lipin
controls ER membrane lipid synthesis (Figure 2.1A), I sought to determine if the
expansion of ER membranes in CTDNEP1KO cells is caused by loss of lipin 1
control of lipid synthesis. I overexpressed lipin 1 in CTDNEP1KO cells (Figure
2.14A). Mouse lipin 1β is the most well-studied mammalian lipin and has a
variety of known mutants for studying its activity and localization (Harris et al.,
2007; Peterson et al., 2011). Further, unlike in humans, the S/T phospho-sites of
lipin 1 in mouse are confirmed by multiple mass spectrometry studies and are
well-characterized (Harris et al., 2007; Peterson et al., 2011). I overexpressed
FLAG-lipin 1β constructs in CTDNEP1KO cells and visualized ER morphology
with calnexin staining (Figure 2.14A). Wild type lipin 1β overexpression partially
suppressed the incidence of expanded ER in CTDNEP1KO U2OS cells (Figure
2.14A-B). This rescue is likely partial because CTDNEP1 is not present to
dephosphorylate the overexpressed lipin. Therefore, I overexpressed a mutant
form of lipin 1β in which 19 of the S/T sites identified by mass spectrometry as
being known or probable insulin-dependent phosphosites are mutated to alanine
(“19S/T to A”, Figure 2.1A/B). This construct drives nuclear localization of lipin 1β
in mouse cells (Peterson et al., 2011). Consistent with this finding, lipin 1β 19S/T
to A localizes more to the nucleus than wild type lipin 1β in U2OS cells (Figure
2.14A, 2.15C). In order to determine if the loss of membrane biogenesis
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regulation in CTDNEP1KO cells is specifically due to loss of lipin 1 phosphatidic
acid phosphatase activity, I overexpressed a mutant form of mouse lipin 1β that
has 19 S/T residues mutated to A but also has two mutations in the DXDXT
active site (DIDGT>EIEGT) that renders it phosphatase dead (Figure 2.14A2.14B, “19S/T to A PAP dead”). Overexpression of this construct does not
suppress the incidence of ER expansion in CTDNEP1KO cells (Figure 2.14B).
Based on these data, I conclude that the expansion of ER membranes is due to
loss of CTDNEP1 dephosphorylation of lipin 1 to potentiate its catalytic activity.
Lipin 1 is known to regulate multiple transcription-based mechanisms of lipid
homeostasis in a manner that is dependent on its localization to either the
nucleus or cytoplasm (Finck et al., 2006; Peterson et al., 2011; Phan et al., 2004;
Zhang et al., 2012). PPAR-mediated gene transcription is thought to be activated
by lipin 1 binding a transcription factor or binding and sequestering a nuclear
repressor (Finck et al., 2006; Phan et al., 2004; Zhang et al., 2012). Conversely,
SREBP-mediated gene transcription is negatively regulated by nuclear lipin 1,
although the mechanism for this is not clear (Peterson et al., 2011). To determine
the impact of localization of lipin on the abundance of ER membranes in
CTDNEP1KO U2OS cells, I transiently expressed constructs of mouse lipin 1β
with either a nuclear localization signal or nuclear export signal appended to the
C terminus (Figure 2.15A). These signals were introduced to the C termini of the
lipin constructs to minimize interference with the endogenous NLS located near
the N terminus (that is also important for PA binding and thus lipin activity) (Eaton
et al., 2013) (Figure 2.1C). In contrast to wild-type lipin 1β, which localizes to
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mostly the cytoplasm, lipin 1β-NES localized more to the cytoplasm, and lipin 1βNLS localized more to the nuclear compartment (Figure 2.15C).
Overexpression of wild type lipin 1β partially suppressed the incidence of
expanded ER in CTDNEP1KO cells (54.6 ± 8.1% in transfected cells vs 93.2 ±
4.4% in untransfected cells; Figure 2.14B). Appending either an NLS or NES to
lipin 1β did not increase the extent of rescue of expanded ER in CTDNEP1KO
cells (64.2 ± 0.1% in lipin 1β-NLS-transfected cells vs 83.3 ± 2.5% in
untransfected cells; 58.9 ± 3.7% in lipin 1β-NES-transfected cells vs 83.5 ± 1.5%
in untransfected cells; Figure 2.15B). This finding is surprising given that lipin’s
localization has shown to be important for mediating transcription of fatty acid
synthesis genes (Peterson et al., 2011). These data suggest that restoring lipin
1β activity overall in the cell is what is important for regulating ER abundance
rather than localization of lipin alone. Alternatively, minor pools of lipin in cellular
compartments may be sufficient to limit the synthesis of ER membranes.
An alternative mechanism for the etiology of ER membrane expansion in
CTDNEP1-depleted cells is that PPARα activation by lipin is lowered, leading to
decreased lipid breakdown (Finck et al., 2006). There is a known PPARα-binding
motif, LXXIL, in lipin 1β, and mutation of this motif to LXXFF reduces the
interaction with PPARα (Finck et al., 2006). This mutation also greatly reduces
lipin 1β PAP activity, likely because the LXXIL motif is 6 residues away from the
active site (Finck et al., 2006). We reasoned that if ER expansion is mediated
through PPARα activation, overexpression of the binding mutant lipin would not
rescue ER expansion to any extent, despite the PAP activity being reduced.
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Unexpectedly, overexpression of lipin 1β with 19 S/T residues mutated to A and
the LXXIL motif mutated to LXXFF partially suppressed ER membrane expansion
in CTDNEP1KO cells (Figure 2.15B), indicating that lack of PPARα transcriptional
regulation is not the major mechanism of ER expansion in CTDNEP1KO cells.
Since phosphatase-deficient lipin 1β does not rescue ER membrane expansion
at all, we conclude that lipin 1β 19xA LXXFF is at least partially functional.
Mutation of S/T residues to alanine greatly increases PAP activity because
dephosphorylation increases PAP activity (Eaton et al., 2013); the 19xA
mutations may have a larger positive effect on the PAP activity of lipin 1β than
the negative effect of the LXXFF mutation. These data together support the
conclusion that ER membrane expansion in CTDNEP1KO U2OS cells is due to
loss of lipin 1β catalytic activity that is not dependent on lipin 1β localization and
may not involve PPARα-dependent transcription. Thus, when CTDNEP1 is
present, dephosphorylated, active lipin 1β limits ER membrane biogenesis.
Expression of endogenous ER proteins in CTDNEP1KO cells
The expansion of ER membranes in CTDNEP1KO cells raises the question of
whether CTDNEP1-depleted cells contain more ER-resident proteins. Further, a
mouse model of lipin 1 depletion in only muscle tissue exhibits accumulation of
neutral lipids and ER stress of the sarcoplasmic reticulum (muscle cell ER), with
consistently increased expression of the ER protein folding chaperone Binding
immunoglobulin Protein (BiP) (Rashid et al., 2019). To establish whether ERresident protein levels are increased in CTDNEP1KO cells, I determined the
expression of ER-resident proteins calnexin, calreticulin, and BiP by immunoblot

57

(Figure 2.16). Calnexin and calreticulin are protein folding chaperones that bind
and stabilize glycosylated proteins to facilitate folding and oligosaccharide
processing (Williams, 2006). Levels of calnexin and calreticulin in CTDNEP1KO
U2OS cells are not increased relative to control levels (Figure 2.16A). BiP levels
are also not increased in CTDNEP1KO cells (Figure 2.16B). Thus, ER-resident
protein levels appear to not be increased with loss of CTDNEP1. Future studies
will clarify if other ER stress pathways are upregulated with loss of CTDNEP1.
As stated previously, it has been hypothesized that the morphology of the ER
depends on membrane abundance and concentration of curvature/morphologystabilizing proteins (Shibata et al., 2010). To determine reticulon expression in
CTDNEP1KO cells, I immunoblotted for reticulon 4B/D (Figure 2.16C). In
immunoblotted control cell lysates, two bands can be seen (Figure 2.16C).
Surprisingly, a third, higher molecular-weight species was present in
CTDNEP1KO lysates, and the RTN4B/D species that were also in control cells
were less abundant (Figure 2.16C). This higher molecular weight species is
unlikely to be a reticulon oligomer due to its size (~55 kDa vs 50 kDa). RTN4B
can be phosphorylated on S16 by cyclin-dependent kinases and on S107 with
oxidative stress induction (Rodríguez-Feo et al., 2015; Schweigreiter et al.,
2007), so these species might represent phosphorylated RTN4B or RTN4B/D
with other post-translational modifications. Future studies will clarify if reticulon
levels or post-translational modifications are altered with loss of CTDNEP1 and
how these changes interact with lipid synthesis alterations to regulate ER
morphology.
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CTDNEP1 has a conserved function for maintaining nuclear shape
Loss of CTDNEP1 leads to altered nuclear morphology in multiple model
systems. Expansion of ER and nuclear envelope membranes in budding and
fission yeast with loss of Nem1 leads to lobulated nuclear structures
(Siniossoglou et al., 1998; Tange et al., 2002). I sought to determine if regulation
of nuclear structure by CTDNEP1 is conserved in human cells. Nuclear shape
was measured by assessing solidity of DAPI-stained nuclei (Figure 2.17A).
Solidity is defined as the area fraction of a convex hull for an object; more circular
nuclei have solidity values closer to 1.0, whereas highly lobulated nuclei have
solidity values less than 1 and decreasing with lobulation (Figure 2.17A). Nuclei
of CTDNEP1KO cells have lower solidity compared to nuclei from control U2OS
cells (Figure 2.17B). An established measure for the percentage of nuclei in a
population that have low solidity is the percentage of nuclei that have solidity
values less than one standard deviation from the mean control solidity value
(Fonseca et al., 2019). By this standard, a higher percentage of CTDNEP1KO
cells have low nuclear solidity values compared to control cells (31.7 ± 14.3 % of
CTDNEP1KO cells compared to 12.9 ± 5.3 % of control cells; Figure 2.17C). To
determine if this change in nuclear shape is due to loss of CTDNEP1, I measured
nuclear solidity in CTDNEP1KO cells stably overexpressing CTDNEP1-HA (Figure
2.18). Overexpression of CTDNEP1 suppresses the low solidity of CTDNEP1KO
cells, both by measuring the population averages and percentage of nuclei with
low solidity (12.8 ± 1.3 % of CTDNEP1-overexpressing CTDNEP1KO cells
compared to 39.3 ± 5.5 % of CTDNEP1KO cells; Figure 2.18A-2.18B). These data
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support the conclusion that CTDNEP1 has a conserved function for maintaining
nuclear morphology.
CTDNEP1 limits formation of micronuclei
While observing nuclear morphology, I noticed that nuclei of CTDNEP1KO
cells frequently had micronuclei (Figure 2.19A, arrow in inset). I quantified the
percentage of nuclei with micronuclei and found that more CTDNEP1KO cells had
micronuclei than control cells (10.2 ± 2.9 % of CTDNEP1KO cells compared to 4.3
± 0.8% of control cells; Figure 2.19B, above). To determine if the increase in
micronuclei in CTDNEP1KO cells is due to loss of CTDNEP1 function, I quantified
the incidence of micronuclei in CTDNEP1KO cells stably overexpressing
CTDNEP1-HA. Overexpression of CTDNEP1 suppressed formation of
micronuclei in CTDNEP1KO cells (2.6 ± 1.3 % of CTDNEP1-expressing
CTDNEP1KO cells compared to 13.2 ± 5.1 % of CTDNEP1KO cells; Figure 2.19B).
Thus, CTDNEP1 limits formation of micronuclei.
Discussion
This work defines the roles of CTDNEP1 and lipin 1 in regulating ER
membrane biogenesis (Figure 2.20) and nuclear structure (Figure 2.21) in human
cells. Using human cell lines edited using CRISPR-Cas9 to tag endogenous
CTDNEP1 loci with GFP, we show that CTDNEP1 is enriched at the nuclear
envelope as CNEP-1 is in C. elegans early embryos (Bahmanyar et al., 2014).
Using RNAi depletion of CTDNEP1 and a U2OS cell line in which CTDNEP1 was
knocked out using CRISPR-Cas9, we show that CTDNEP1 limits the abundance
of ER membranes. Quantitation of ER membrane segmentation confirms this
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finding and provides a tool for future assessment of genetic modifications that
alter lipid synthesis to determine if ER membrane abundance is affected.
Qualitative comparison of CTDNEP1-depleted cells to ER shaping proteindepleted cells reveals that densely packed ER in CTDNEP1-depleted cells
appears different from ER with more sheets. Overexpression of CTDNEP1
constructs in CTDNEP1KO cells confirms a role for NEP1R1 in human cells for
stabilizing CTDNEP1 as in yeast (Han et al., 2012; Santos-Rosa et al., 2005) and
confirms that expansion of ER membranes in CTDNEP1KO cells is due to loss of
CTDNEP1 catalytic activity. Overexpression of mouse lipin 1β constructs in
CTDNEP1KO cells reveals that ER membrane expansion is due to loss of lipin 1
catalytic activity. Together, these data show that CTDNEP1 and lipin 1 control
ER membrane biogenesis in human cells.
The finding that lipin 1 localizing to either the nucleus or cytoplasm
partially rescue ER expansion in CTDNEP1KO cells to a similar extent as nonspecifically localized lipin is surprising given the nuclear envelope localization of
endogenous CTDNEP1, which suggests local regulation of lipin. One
consequence of CTDNEP1 depletion is that lipin levels are reduced (Merta et al.,
2021) (finding by J.W. Carrasquillo Rodríguez). It is possible that overexpressed
catalytically active lipin satisfies a requirement of raising levels of lipin in the cell
to raise overall cellular PA, which then re-balances ER lipid synthesis (Figure
2.20A-B). In yeast, lipin localizes to the nuclear envelope (to the nuclear-vacuolar
junction) under starvation conditions and produces DAG for TAG synthesis
(Barbosa et al., 2015), so a similar mechanism may be in place for lipin and
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CTDNEP1 localization to control lipid synthesis. We additionally found that a
PPARα binding site mutant of dephospho-mimic 19xA lipin 1β appears to be
catalytically active in that it partially suppresses ER expansion with loss of
CTDNEP1, in contrast to previous findings. As previously mentioned, the
dephosphorylation-mimic mutations may counteract the effects of reducing PAP
activity that is caused by mutating the PPARα binding site. Future studies will
illuminate the specific effects of lipin localization and post-translational
modification in regulating its catalytic activity and ER lipid synthesis in human
cells.
An open question that remains is whether the catalytic activity of lipin 1 limits
ER membrane biogenesis by limiting synthesis of certain lipids, or shifting flux of
lipid synthesis toward triglycerides and away from membrane biogenesis, or by
influencing a combination of these (Bahmanyar et al., 2014; Grillet et al., 2016).
In transcriptionally quiescent C. elegans early embryos, loss of CNEP-1 leads to
an increase in PA and PI and increased ER sheets (Bahmanyar et al., 2014). In
yeast, depletion of Nem1p leads to increased nuclear envelope and ER
membrane biogenesis (Barbosa et al., 2015; Santos-Rosa et al., 2005;
Siniossoglou et al., 1998). Loss of lipin 1 (yPah1) catalytic activity alone can
explain the expansion of ER membranes in yeast, because yeast can utilize the
CDP-DAG pathway to make PC and PE in addition to PI (the major membrane
glycerophospholipid in yeast) (Barbosa et al., 2015). It has been hypothesized
that lipin activity balances energy storage (as triglycerides) and membrane
biogenesis (as PC and PE synthesis) in mammalian cells (Grillet et al., 2016). In
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this model, increased lipin activity leads to greater DAG stores and higher TAG
synthesis. Loss of lipin activity leads to increased synthesis of CDP-choline to in
turn form PC because increased PA leads to increased CCTα activation (Grillet
et al., 2016). In Arabidopsis, lipin (PAH1) depletion leads to increased ER sheets,
and this occurs through increased PA activating CCTα to upregulate PC
synthesis (Craddock et al., 2015). Evidence of PA activating CCTα in mammalian
cells is lacking. It is known in multiple organisms, however, that CCTα senses
membrane packing to increase CDP-choline synthesis (Cornell and Ridgway,
2015). DAG is also required for PC synthesis through the Kennedy pathway; in
Arabidopsis, DAG levels in lipin mutants are not limiting for PC synthesis
(Craddock et al., 2015), though it is not known if this is the case in mammals.
Thus, the contribution of CCTα to increasing PC synthesis in human cells lacking
lipin 1 catalytic activity is unclear. In all organisms, however, CTDNEP1 and lipin
1 orthologues limit ER membrane biogenesis through limiting synthesis of certain
glycerolipids, though the mechanism appears to differ between yeast, worms,
and plants. In human cells, CTDNEP1 (with its obligate binding partner NEP1R1)
dephosphorylates lipin 1 (Figure 2.20A). CTDNEP1 regulates lipin 1 activation to
control ER lipid synthesis, and multiple levels of lipin 1 regulation of lipid
synthesis could contribute to limiting ER membrane biogenesis (Figure 2.20B-C).
Whether lipin 1 limits ER membrane biogenesis through enzymatic,
transcriptional, or indirect enzymatic regulation remains to be seen.
CTDNEP1 has a conserved function of maintaining nuclear structure (Figure
2.21). In yeast, loss of Pah1 catalytic activity leads to increased PA that feeds
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into upregulation of fatty acid synthesis through Ino2/Ino4 derepression, and PA
can form membrane glycerophospholipids that feed into membrane synthesis as
opposed to TAG production (Figure 2.21A-B). This leads to an expansion of ER
membranes but also a proliferation of nuclear envelope membranes
(Siniossoglou et al., 1998). In human cells, despite differences in lipid synthesis
pathways, CTDNEP1’s function of controlling nuclear structure is conserved
(Figure 2.21C-D).
CTDNEP1 also limits formation of micronuclei in human cells (Figure
2.19). CTDNEP1 has not been implicated in regulating formation of micronuclei
in other organisms. CTDNEP1’s role in limiting formation of micronuclei may be
part of why it is commonly mutated in medulloblastoma subgroups associated
with chromosomal instability, as micronuclei are a common consequence of
chromosomal instability in cancer (Giam and Rancati, 2015; Jones et al., 2012).
The remainder of this work will investigate the mechanism for formation of
micronuclei with loss of CTDNEP1. The next chapter will describe investigation of
the dynamics of expanded ER membranes during cell division to uncover how
CTDNEP1 controls nuclear shape and limits formation of micronuclei.
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Figure 2.1 CTDNEP1 and lipin 1 control of lipid synthesis
A) Overview of CTDNEP1/lipin 1-controlled ER lipid synthesis. Direct activities of
CTDNEP1 and lipin 1 are outlined with a dashed box. Membrane
glycerophospholipids are circled in green, and lipid droplet glycerolipids are circled
in orange. P, phosphate; Pi, inorganic phosphate. B) Domain architecture of
human CTDNEP1. HAD, haloacid dehalogenase. C) Domain architecture of
human lipin 1. NLS, nuclear localization sequence.
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Figure 2.2 depletion of reticulons 1,3, and 4 reveals role for
formation/stabilization of ER nanoholes
A) Domain architecture of reticulon 4 isoforms, with the region targeted by the
RTN4 sgRNA to generate a RTN4KO cell line shown. B) Immunoblot of endogenous
RTN4B/D from whole cell lysates derived from control and RTN4KO U2OS cells. C)
Scanning confocal (left) and stimulated emission depletion (STED) (inset, right)
images of SNAP-KDEL signal in cell lines treated as indicated. Scale bars, 10 μm
(left) and 2 μm (inset).
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Figure 2.3 Localization of endogenous NUP160 in human cells
A) Domain architecture of endogenous NUP160-Halo. B) Immunoblot of HaloTag
in whole cell lysates derived from indicated cell lines. “Bulk pop.” refers to a bulk
population of Cas9/guide/homology repair template-transfected cells. C) Spinning
disk confocal images of HaloTag-TMR signal in NUP160EN-Halo U2OS cells. Scale
bar, 10 μm.
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Figure 2.4 Generation of CTDNEP1KO U2OS cells
A) Domain architecture of CTDNEP1 mapped to the gene architecture of
CTDNEP1. sgRNA, single guide RNA. 5’ and 3’ untranslated regions marked in
yellow, exons as white or marked boxes, and introns as lines. Colors indicate
exons coding for parts of domains. B) Schematic of single nucleotide insertion and
subsequent consequence for the CTDNEP1 protein sequence induced by
CRISPR-Cas9 in CTDNEP1KO U2OS cells. Untranslated regions and exons
marked in colored bars as in (A).
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Figure 2.5 CTDNEP1KO U2OS cells and CTDNEP1 siRNA-treated cells have
reduced levels of CTDNEP1 mRNA
A) qRT-PCR of CTDNEP1 transcript levels in human cell lines with indicated
treatments. U2OS siRNA-treated cells are overexpressing GFP-KDEL and are
from the same experiment as Figures 2.9 and 2.11. RPE-1 siRNA-treated cells are
overexpressing GFP-KDEL and are from the same experiment as Figure 2.10.
Values are normalized to GAPDH expression. Results are expressed as the fold
change in expression and relative to mean of control U2OS or siCtrl-treated U2OS
or RPE-1 values. Expression data from control U2OS and CTDNEP1KO U2OS
collected by J. W. Carrasquillo Rodríguez. P values, paired t tests of ΔCt values.
Means ± SDs shown. N = 3 experimental repeats.
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Figure 2.6 Generation of endogenously-tagged CTDNEP1EN-GFP cells
A) Schematic of strategy for homology-directed repair by CRISPR-Cas9 to tag
endogenous CTDNEP1 with a C-terminal GFP tag. 5’ and 3’ untranslated regions
marked in yellow, exons as white or marked boxes, and introns as lines. Colors
indicate exons coding for parts of domains. B) Domain architecture of
CTDNEP1EN-GFP in U2OS cells.
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Figure 2.7 Endogenous localization of human CTDNEP1
A) Left, live spinning disk confocal microscopy image of GFP in live U2OS
CTDNEP1EN-GFP cells. Right, confocal microscopy image of GFP staining in fixed
U2OS CTDNEP1EN-GFP cells. Scale bars, 10 μm.
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Figure 2.8 Expansion of ER membranes in CTDNEP1KO U2OS cells
A) Spinning disk confocal microscopy images of GFP-KDEL transiently expressed
in U2OS cells. Scale bars, 10 µm. B) Quantification of incidence of expanded ER
phenotype in cells from (A). n = number of cells, N = 3 experimental repeats. Mean
± SD shown. P value, Fisher’s exact test of total incidences. C) Spinning disk
confocal microscopy image of calnexin signal in immunostained U2OS cells. Inset
brightness adjusted relative to uncropped image to highlight fine ER morphology.
Scale bars, 10 μm.
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Figure 2.9 Expansion of ER membranes in U2OS cells treated with
CTDNEP1 siRNA
A) Spinning disk confocal microscopy images of GFP-KDEL transiently expressed
in U2OS cells. Scale bars, 10 µm. Inset brightness adjusted relative to uncropped
image to highlight fine ER morphology. Scale bars, 10 μm. B) Quantification of
incidence of expanded ER phenotype in cells from (A). n = number of cells, N = 3
experimental repeats. Mean ± SD shown. P value, Fisher’s exact test of total
incidences.
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Figure 2.10 Expansion of ER membranes in RPE-1 cells treated with
CTDNEP1 siRNA
A) Spinning disk confocal microscopy images of GFP-KDEL in transientlyexpressing RPE-1 cells treated with indicated siRNAs. Inset brightness adjusted
relative to uncropped image to highlight fine ER morphology. Scale bars, 10 μm.
B) Quantification of incidence of expanded ER phenotype in cells from (A). n =
number of cells, N = 3 experimental repeats. Mean ± SD shown. P value, Fisher’s
exact test of total incidences.
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Figure 2.11 Quantification of ER membrane abundance using ER
fluorescent signal segmentation
A) Spinning disk confocal mages of GFP-KDEL in transiently-expressing cells were
processed as described and quantified for percent of pixels in cytoplasm area
positive for segmented ER signal pixels. Scale bar, 10 μm. B) Plot of percentage
of ER-positive pixels in cytoplasm area in cells (n) under the indicated conditions.
N = 3 experimental replicates. Means ± SDs shown. P values, paired t tests of
replicate means. Note y axis truncation.
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Figure 2.12 Qualitative comparison of ER morphology between CTDNEP1depleted and reticulon 1,3,4-depleted U2OS cells
A) Spinning disk confocal microscopy images of transiently-expressed GFP-KDEL
in cells in the indicated conditions. Blue arrows point to morphologies in the
perinuclear ER, and yellow arrows point to morphologies in the peripheral ER.
Lower image is from a separate experiment from the left 2 images. In all images,
brightness is adjusted so that perinuclear ER is slightly saturated.
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Figure 2.13 Stable or transient overexpression of catalytically active
CTDNEP1 suppresses ER membrane expansion in CTDNEP1KO cells
A) Spinning disk confocal microscopy images of GFP (KDEL), HA (CTDNEP1),
and FLAG (NEP1R1) staining in U2OS cells overexpressing the indicated
constructs, including empty vector (-), wild-type CTDNEP1-HA (WT), or
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phosphatase dead D67E CTDNEP1 (PD). Scale bar, 10 μm. B) Quantification of
incidence of expanded ER phenotype in cells from (A). n = number of cells, N = 3
experimental repeats. Mean ± SD shown. P values, Fisher’s exact tests of total
incidences. C) Quantification of incidence of expanded ER phenotype in cells with
indicated conditions. WT (stable) refers to stable cell line overexpressing
CTDNEP1-HA. N = number of cells, N = 3 experimental repeats. Mean ± SD
shown. P value, Fisher’s exact test of total incidences. D) Plot of percentage of
ER-positive pixels in cytoplasm area in cells (n) under the indicated conditions. N
= 3 experimental replicates. P value, paired t test of replicate means. Note y axis
truncation.
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Figure 2.14 Transient overexpression of catalytically active lipin 1
suppresses ER membrane expansion in CTDNEP1KO cells
A) Spinning disk confocal microscopy images of calnexin and FLAG staining in
U2OS cells overexpressing the indicated constructs and GFP-KDEL as a cotransfection marker (not shown). 19 S/T to A refers to 19 serine/threonine sites
mutated to dephospho-mimic alanine residues. PAP dead refers to phosphatase
dead lipin 1. Scale bar 10 μm. B) Quantification of incidence of expanded ER
phenotype in cells from (A). “-“ and “+” refer to cells not expressing and expressing
lipin 1 and the co-transfection marker in the same experiment, respectively. n=
number of cells, N = 3 experimental repeats. Mean ± SD shown. P values, Fisher’s
exact tests of total incidences.
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Figure 2.15 Localization of lipin 1 and suppression of ER membrane
expansion in CTDNEP1KO cells
A) Spinning disk confocal microscopy images of calnexin and FLAG staining in
U2OS cells overexpressing the indicated constructs and GFP-KDEL as a cotransfection marker (not shown). 19 S/T to A refers to 19 serine/threonine sites
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mutated to dephospho-mimic alanine residues. NLS = nuclear localization signal
and NES = nuclear export signal. PPAR binding mutant has LXXIL PPARα binding
motif mutated to LXXFF (Finck et al., 2005). Scale bar 10 μm. B) Quantification of
incidence of expanded ER phenotype in cells from (A). “-“ and “+” refer to cells not
expressing and expressing lipin 1 and the co-transfection marker in the same
experiment, respectively. n = cells, N = 3 experimental repeats. Mean ± SD shown.
P values, Fisher’s exact tests of total incidences. C) Incidence of nuclear
localization phenotypes for indicated FLAG constructs. n = number of cells from N
= 3 experimental repeats.

Figure 2.16 Expression of ER-resident proteins in CTDNEP1KO cells
A, B, C) Immunoblot (using indicated antibodies) from whole cell lysates derived
from control and CTDNEP1KO U2OS cells.
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Figure 2.17 CTDNEP1KO cells have decreased nuclear solidity
A) Epifluorescence images of DAPI/Hoechst staining in control and CTDNEP1KO
cells showing nuclear morphologies and their corresponding solidity values. Scale
bar 10 μm. B) Plot of solidity of nuclei (n) from cells as in (A). N = 3 experimental
repeats. Individual values and means ± SDs shown. P value, paired t test of
replicate means. C) Quantification of incidence of solidity less than 1 SD from the
mean of control nuclei solidity (0.944). n = number of nuclei, N = 3 experimental
repeats. Mean ± SD shown. P value, Fisher’s exact test of total incidences.
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Figure 2.18 Stable overexpression of CTDNEP1 rescues nuclear solidity of
CTDNEP1KO cells
A) Plot of solidity of nuclei (n) of cells from indicated conditions. “WT (stable)” refers
to cells stably overexpressing CTDNEP1-HA. N = 3 experimental repeats. Means
± SDs shown. P value, paired t test of replicate means. B) Quantification of
incidence of solidity less than 1 SD from the mean of control nuclei solidity n =
number of nuclei, N = 3 experimental repeats. Mean ± SD shown. P value, Fisher’s
exact test of total incidences.
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Figure 2.19 CTDNEP1 limits formation of micronuclei, and stable
overexpression of CTDNEP1 in CTDNEP1KO cells suppresses
formation of micronuclei
A) Epifluorescence images of DAPI/Hoechst in cells from indicated conditions.
Scale bars, 10 μm. B) Quantification of incidence of micronuclei in cells in indicated
conditions. WT refers to stable overexpression of CTDNEP1-HA. n = number of
cells from N = 3 experimental repeats. Means ± SDs shown. P values, Fisher’s
exact tests of total incidences. Top two and bottom two rows are from separate
experiments.
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Figure 2.20 Role of CTDNEP1 in limiting expansion of ER membranes
A) Schematic of proposed lipin 1 dephosphorylation and activation at the nuclear
envelope by CTDNEP1/NEP1R1 (dark gray). B) Schematic of potential
mechanisms for how CTDNEP1 control of lipid synthesis could lead to increased
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membrane abundance. C) Schematic showing how membrane abundance is
impacted by loss of CTDNEP1.

Figure 2.21 Roles of CTDNEP1 in maintaining nuclear shape
A,C) Lipid synthesis pathways in yeast and human cells and nuclear shape during
lipid homeostasis. B,D) Lipid synthesis alterations with loss of Nem1p and
CTDNEP1 and concomitant changes in nuclear shape resulting from increased
membrane biogenesis.
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Introduction
Membrane biogenesis and dynamics are tightly controlled throughout the cell
cycle (Storck et al., 2018). Coordination of phosphatidylcholine synthesis with
ramping down glycerophospholipid breakdown leads to an accumulation of
glycerophospholipids during S phase (Jackowski, 1994). ER membranes are
cleared to the cell periphery during mitosis; limiting clearance from mitotic
chromosomes throughout mitosis leads to chromosome segregation defects
(Champion et al., 2019; Schlaitz et al., 2013).
In C. elegans early embryos, CNEP-1 is known to regulate membrane
dynamics in mitosis and mitotic progression. Loss of lipin or CNEP-1 activity
leads to deficient nuclear envelope breakdown that leads to lack of mixing of
parental genomes and the persistence of two ‘twinned’ nuclei or oblong single
nuclei (Bahmanyar et al., 2014; Golden et al., 2009; Gorjánácz and Mattaj,
2009). In cnep-1Δ embryos, this is accompanied with an increase in ER sheets,
and the nuclear envelope at nuclear envelope breakdown has an additional
membrane layer enwrapping the nuclear envelope (Bahmanyar et al., 2014).
During nuclear reformation in meiosis II, membrane extensions can be seen in
nuclei of cnep-1Δ embryos, and the nuclei are more permeable than those of
control embryos (Penfield et al., 2020). The nuclear envelope and ER
phenotypes in cnep-1Δ embryos can be rescued by suppression of PI synthesis
(Bahmanyar et al., 2014; Penfield et al., 2020). Thus, flux of ER lipid synthesis
controlled by lipin limits membrane clearance and limits abnormal localization of
membranes in and around nuclei in mitosis.
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In human cells, depletion of lipin or CTDNEP1 by RNAi leads to delayed
lamin B1 disassembly and delayed mitotic progression (including delayed
chromosome congression) (Mall et al., 2012). The delay in nuclear envelope
breakdown can be rescued by exogenous supplementation with lipin’s product,
DAG, and the delay in mitotic progression is partially rescued with DAG
supplementation (Mall et al., 2012). The authors conclude that lack of DAG limits
protein kinase C activation to phosphorylate lamin and facilitate nuclear envelope
breakdown. It is unclear if any other consequences of lipin inactivation, such as
flux toward PI synthesis, affect mitotic progression. The role of human CTDNEP1
and lipin 1 in regulating mitotic progression after nuclear envelope breakdown,
especially during chromosome congression in prometaphase, is unclear.
Here, we show that CTDNEP1 regulates membrane abundance and
clearance during mitosis to facilitate mitotic progression during prometaphase.
We show that CTDNEP1KO cells have a higher percentage of prometaphase cells
within the mitotic cell population, and membranes are more abundant and less
cleared in prometaphase and metaphase CTDNEP1KO cells. ER membranes can
be seen enwrapping aligning chromosomes in prometaphase to metaphase, and
ER membranes are not restricted from the nuclear interior upon mitotic exit. We
show that CTDNEP1-depleted cells additionally show increased nuclear size and
faster reestablishment of nuclear import upon mitotic exit. These data show that
CTDNEP1-controlled membrane biogenesis limits abnormal membrane
localization in mitosis in mammalian cells.
Results
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Higher incidence of prometaphase cells in mitotic CTDNEP1-deleted cells
Previous work showed that depletion of CTDNEP1 or lipins in human cells leads
to delayed mitotic progression, including delayed nuclear breakdown and
delayed chromosome congression (Mall et al., 2012). To determine if mitotic
progression is altered in CTDNEP1KO cells, I imaged a fixed asynchronous
population of control or CTDNEP1KO U2OS cells and quantified the incidence of
cells in each mitotic stage from prometaphase to telophase within the mitotic cell
population (Figure 3.1A). Consistent with the previous findings, CTDNEP1KO cells
had a higher proportion of mitotic cells in prometaphase and lower proportion in
other stages, which suggests that prometaphase could be lengthened (Figure
3.1B). Live imaging of CTDNEP1KO cells can determine the timing by which loss
of CTDNEP1 delays mitotic progression, which is not able to be determined with
imaging an asynchronous cell population. These results are consistent with the
previous finding that depletion of loss of CTDNEP1 delays mitotic progression.
Prometaphase ER membrane localization and relation to chromosomes
I next sought to determine if ER membrane clearance in CTDNEP1depleted human cells is delayed and to investigate the dynamics of ER
membranes during prometaphase. I imaged a population of control and
CTDNEP1KO cells expressing the ER marker GFP-KDEL, enriched for
prometaphase and metaphase cells by drugless mitotic shakeoff and using DIC
to determine mitotic staging and chromosome localization (Figure 3.2A). I blindly
scored these images with categories based on the prevalence of intracellular ER
membranes (“cleared”, “partially cleared”, and “not cleared”, Figure 3.2) and
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found that a higher proportion of CTDNEP1KO cells lacked GFP-KDEL clearance
from the region occupied by chromosomes compared to control cells (47.4 ± 6.8
% of CTDNEP1KO cells compared to 25.4 ± 11.4 % of cells categorized as “not
cleared”, Figure 3.2B). To assess whether chromosomes interact with ER
membranes during chromosome congression, I imaged control and CTDNEP1KO
cells transiently expressing GFP-KDEL/H2B-mCherry after washout from a Cdk1
inhibitor-mediated G2/M arrest (Figure 3.3A). We observed that, over the course
of chromosome congression, unaligned chromosomes could be seen within
peripheral ER of control and CTDNEP1KO cells before aligning to the metaphase
plate (Figure 3.3A, yellow arrows). In CTDNEP1KO prometaphase cells, ER
tubules could also be seen within the spindle region leading up to chromosomes
at the metaphase plate (Figure 3.3A, cyan arrows). These data show that
CTDNEP1 activity facilitates clearance of membranes after nuclear envelope
breakdown.
Excess ER membranes fill mitotic cytoplasm in CTDNEP1KO cells and
CTDNEP1-depleted cells
I previously showed that CTDNEP1 limits ER membrane abundance in
human cells. To determine if expansion of ER membranes persists in CTDNEP1depleted cells in mitosis, I imaged U2OS cells stably expressing the ER
transmembrane marker GFP-Sec61β and chromatin marker H2B-mCherry
treated with control or CTDNEP1 siRNA from anaphase onset through telophase
(Figure 3.4A). Membranes are largely cleared to the cell periphery by anaphase
onset (“0 min”, Figure 3.4A), so measurement of relative ER membrane
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abundance in mitotic cells can be performed by measuring the thickness of the
cortical ER membranes at a consistent location in the cells. I measured the
percent of the cell diameter at the metaphase plate that is occupied by Sec61β
signal by measuring the full width at half max of Sec61β signal (Figure 3.4B).
Consistent with our findings in interphase cells, a greater percentage of the cell
diameter was taken up by ER membranes in mitotic CTDNEP1-depleted cells
compared to cells treated with control siRNA (Figure 3.4B-C). Individual traces of
ER and chromatin marker signal additionally revealed that greater occupancy by
ER membranes at the metaphase plate leaves less space for chromosomes to
localize (Figure 3.4B).
To confirm these findings in cells in which every cell is depleted of
CTDNEP1, I imaged control and CTDNEP1KO cells transiently expressing GFPKDEL and stained with the live Hoechst dye SiR-DNA to mark chromosomes
from anaphase onset (Figure 3.5A; SiR not shown). I measured the percentage
of cell diameter occupied by GFP-KDEL and found that CTDNEP1KO cells had a
greater occupancy of the cell diameter by ER membranes (Figure 3.5B-3.5C).
M. I. Anjur-Dietrich (under the supervision of D. Needleman) introduced
magnetic beads about the size of a mitotic chromosome (~2-3 μm) into
CTDNEP1KO cells and measured bead displacement upon pulling with defined
force using magnetic tweezers and found that the cytoplasm is more viscous in
CTDNEP1KO cells than in control cells (Merta et al., 2021). Further,
chromosomes in prometaphase have a lower average velocity in CTDNEP1KO
cells compared to control cells (Merta et al., 2021) (finding by M. I. Anjur-
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Dietrich). Because uncleared membranes occur more frequently in
prometaphase CTDNEP1KO cells, these data suggest that expanded ER
membranes can limit chromosome movements. The decreased space taken up
by chromosomes at the metaphase plate because of increased space taken up
by ER membranes in CTDNEP1KO cells supports this idea (Figure 3.4B).
Together, these data support the conclusion that more abundant and
uncleared ER membranes in mitosis in CTDNEP1KO cells contribute to viscous
forces exerted on mitotic chromosomes to limit chromosome motions. With
CTDNEP1, membrane biogenesis is limited to maintain mitotic membrane
clearance, contain cytoplasmic viscosity, and facilitate chromosome movement.
Conserved function for CTDNEP1 in limiting membrane extensions into postmitotic nuclei
In meiosis II of C. elegans early embryos deleted of CNEP-1, membrane
extensions can be seen inside of newly reformed nuclei; these extensions are
exacerbated by additional depletion of the ESCRT-III sealing factor CHMP7 and
can be rescued by suppressing PI synthesis (Penfield et al., 2020). I thus sought
to determine if human CTDNEP1 restricts membrane localization from the
nuclear interior following mitotic exit. I imaged control and CTDNEP1KO cells
transiently expressing GFP-KDEL and enriched for mitotic cells by drugless
mitotic shakeoff from anaphase onset through telophase (Figure 3.6A). After
nuclear envelope reformation, at 25 min after anaphase onset, CTDNEP1KO cell
nuclei had more membrane extensions as determined by GFP-KDEL
fluorescence (Figure 3.6A, inset and arrows; Figure 3.6B). These membrane
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extensions were fainter than nuclear envelope signal, which is consistent with
findings in C. elegans embryo post-meiotic nuclei (Penfield et al., 2020).
I next sought to determine if nuclear membrane extensions formed in mitosis
persist in interphase cells. I imaged CTDNEP1KO and control U2OS cells
transiently expressing GFP-KDEL in long-term (8-12 hr) time-lapse format
(Figure 3.7A). A greater proportion of CTDNEP1KO cells in early G1 had nuclear
membrane extensions compared to control cells (Figure 3.7A, pink arrows;
Figure 3.7B). Unlike invaginations of the outer and inner nuclear membranes,
which are as bright as the rest of the nuclear envelope and are common in
control U2OS cells (Figure 3.7A, green arrows), nuclear membrane extensions
are fainter than the rest of the nuclear envelope (Figure 3.7A, pink arrows).
Future studies will determine if the nuclear membrane extensions in CTDNEP1depleted human cells are derived from the inner nuclear membrane. Together,
these data support the conclusion that human CTDNEP1 has a conserved role
for limiting membrane extensions from forming inside of newly reassembled
nuclei.
CTDNEP1 limits reestablishment of nuclear import and nuclear size during
mitotic exit
To determine if altered membrane dynamics during nuclear envelope
reassembly impacts nuclear import or growth, I imaged U2OS cells stably
expressing a single importin β binding domain of importin α fused to GFP (IBBGFP) and H2B-mCherry, treated with control or CTDNEP1 siRNA. IBB localizes
to the nucleus during interphase, then to the cytoplasm after nuclear envelope
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breakdown, then to the nucleus again as nuclear pores are rebuilt and import is
re-established (Figure 3.8A). Cells treated with CTDNEP1 siRNA appeared to
have faster colocalization of IBB with chromatin after anaphase onset, and nuclei
appeared slightly larger (Figure 3.8B). I measured the integrated intensity of IBB
signal in the nucleus and expressed it as fold increase over integrated intensity 3
min after anaphase onset (a time point >5 min prior to initiation of nuclear import)
(Lu et al., 2011) ( Figure 3.8C). The integrated intensity of IBB signal in nuclei
was higher in CTDNEP1-depleted cells compared to control cells starting at
around 15 min after anaphase onset, which corresponds to when membranes
are finished wrapping around chromosomes by visualization of Sec61β
fluorescence (Lu et al., 2011) (Figure 3.8C). Measurements of H2B signal
surface area revealed a similar timing for CTDNEP1-depleted cell nuclei
expanding faster than control cell nuclei (Figure 3.8D). One caveat of these
results is that the images were taken at low resolution and with low signal to
noise. IBB is not imported uniformly in the reforming nucleus but is imported at
“non-core” regions before “core” regions (Lu et al., 2011), so higher magnification
imaging with better signal to noise is needed to confirm these findings. Another
notable caveat of these results is that the a single IBB domain fused to GFP (~33
kDa) is small enough to freely diffuse through the nuclear pore and likely through
unsealed nuclear envelope holes, so the reestablishment of nuclear import being
measured in this study is of net nuclear import. Additionally, postmeiotic nuclei of
C. elegans early embryos lacking CNEP-1 are leaky most likely due to unsealed
nuclear envelope holes (Penfield et al., 2020); leakiness of nuclei in this cell line

95

would not be detected due to the size of the IBB reporter. To address these
caveats, a triple-GFP IBB reporter can be used, as it is large enough to be
retained in the nucleus without diffusing back through pores (Hatch et al., 2013).
Together, these results suggest that CTDNEP1 limits reestablishment of nuclear
import and nuclear growth during mitotic exit.
Discussion
These data reveal multiple roles for CTDNEP1-controlled membrane
biogenesis in regulating mitotic events. We confirmed that CTDNEP1 limits
mitotic progression during prometaphase and found that CTDNEP1 limits excess
membranes in mitosis and regulates membrane clearance during prometaphase
and metaphase. Excess membranes can contribute to viscous forces exerted on
chromosomes, and chromosome movements are dampened in CTDNEP1KO
cells. We additionally show that CTDNEP1 limits reestablishment of nuclear
import and nuclear growth and restricts membrane localization from the nuclear
interior during mitotic exit.
The finding that depletion of CTDNEP1 limits reestablishment of nuclear
import and nuclear growth suggests that ER membrane access might be limiting
for postmitotic nuclear pore complex assembly. Overexpression of CTDNEP1 or
its obligate binding partner NEP1R1 in fly fat body cells leads to less
fluorescence labeling of FG-Nups by the nucleoporin antibody mAb414, although
pore density appears to be unaffected; the authors conclude that CTDNEP1
limits pore maturation (Jacquemyn et al., 2020). Future studies will determine the
mechanisms by which CTDNEP1 limits nuclear pore complex assembly or
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maturation to regulate nuclear import following mitosis. In sea urchin embryos,
availability of perinuclear ER membranes allows nuclear expansion (Mukherjee
et al., 2020). Nuclear growth also scales with nuclear import (Levy and Heald,
2010). Because CTDNEP1 limits ER membranes and also appears to limit
nuclear pore complex assembly/maturation, it is unclear what is the mechanism
for how CTDNEP1 regulates nuclear growth. Future studies uncoupling import
from membrane availability will illuminate how these factors regulate nuclear size
with loss of CTDNEP1.
CTDNEP1 has a conserved role for restricting ER membranes to the
surface of the nuclear envelope during and after mitotic exit. Membrane
extensions are likely not seen earlier in nuclear envelope reformation because
chromosomes are crosslinked together by barrier to autointegration factor (BAF)
which does not crosslink chromosomes during mitotic exit (Samwer et al., 2017).
The mechanism for how nuclear membrane extensions are made or persist in the
nucleus is not fully understood. CTDNEP1 interacts genetically with the ESCRTIII sealing factor CHMP7, revealing that coordination of lipid synthesis acts with
nuclear envelope sealing to keep membranes from the nuclear interior (Penfield
et al., 2020). These data support the idea that nuclear extensions could be
produced during nuclear sealing by uncoordinated lipid synthesis with ESCRT-III
activity. Other cases exist in which uncoordinated ESCRT-III activity leads to
nuclear membrane abnormalities. Micronuclei lack the ability to spatially restrict
ESCRT-III sealing and often have several membrane intrusions upon nuclear
rupture (Vietri et al., 2020). CHMP7 has shown to bind PA in the inner nuclear
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membrane in yeast (Thaller et al., 2021). Future studies will illuminate if lipid flux
by lipin controlled by CTDNEP1 serves to regulate targeting of CHMP7 to the
inner nuclear membrane to coordinate sealing and limit the formation of nuclear
envelope extensions.
CTDNEP1 regulation of membrane biogenesis facilitates prometaphase and
metaphase ER membrane clearance from the region around chromosomes in
human cells (Figure 3.2; Figure 3.9). Expansion of ER membranes of CTDNEP1depleted cells persists into mitosis, leading to an excess of membranes that are
not cleared as fast as membranes in control cells. It is not clear if the membranes
are less cleared because of the sheer amount of membranes overwhelming
clearing mechanisms like REEP3/4, but future studies can determine if this is the
case. Together, these data support the idea that uncleared membranes can
impede proper mitotic progression.
ER membranes appear to contribute to the viscosity of the mitotic
cytoplasm. These results show that ER lipid synthesis is limited to contain
cytoplasmic viscosity in mitosis. Prometaphase chromosome velocity is also
dampened in CTDNEP1KO U2OS cells. High cytoplasmic viscosity due to
increased ER membranes may limit the movements of chromosomes being
pushed and pulled by the mitotic spindle in prometaphase.
Micronuclei are not observed in S. cerevisiae or C. elegans depleted of
CTDNEP1, despite alterations in ER membrane biogenesis present in these cells
(Bahmanyar et al., 2014; Siniossoglou et al., 1998). We hypothesize that
differences in mitoses may account for the differences in chromosome
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segregation (Figure 3.10). S. cerevisiae have closed mitosis, in which the spindle
assembles and chromosome segregation occurs inside of the nucleus (Figure
3.10, above). C. elegans have semi-open mitosis, in which nuclear envelope
membranes become permeable and are detached from chromosomes, but the
spindle assembles inside of nuclear envelope (Figure 3.10, middle). In human
cells, membranes are totally cleared from chromosomes and the mitotic spindle
(Figure 3.10, below). In the absence of membrane clearance, interference by
membranes may inhibit proper chromosome segregation, leading to formation of
micronuclei (Figure 3.10, below). This suggests that nuclear envelope breakdown
and membrane clearance may be coordinated to occur before the spindle
assembles in human cells to allow unimpeded spindle assembly to promote
proper chromosome segregation.
It is unclear exactly how excess membranes in mitosis in CTDNEP1KO cells
could lead to formation of micronuclei, given that error correction mechanisms
are in place to limit chromosome missegregation in human cells. The next
chapter will discuss data that assess chromosome segregation in CTDNEP1KO
with respect to multiple aspects of mitotic error correction to determine how
micronuclei can form.
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Figure 3.1 CTDNEP1KO cells have a higher incidence of prometaphase cells
A) Confocal images of DAPI/Hoechst and tubulin staining in U2OS cells used for
mitotic staging. Scale bar = 10 μm. B) Plot of quantification of percent of mitotic
cells in each stage of mitosis in control and CTDNEP1KO U2OS cells. Means ± SDs
of proportions shown. n = number of cells, N = 3 experimental repeats. P value,
Fisher’s exact test of incidences of prometaphase cells vs incidences of cells in
other mitotic stages.
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Figure 3.2 Prometaphase and metaphase CTDNEP1KO cells have more
uncleared membranes in proximity to chromosomes
A) Confocal image of GFP-KDEL or DIC in transiently-expressing U2OS
CTDNEP1KO cells subject to mitotic shakeoff, with phenotypic categorization.
Scale bar 10 μm. B) Plot of incidence of indicated phenotypes in cells imaged as
in (A). Means ± SDs shown. n = number of cells, N = 3 experimental repeats. P
value, Chi squared test of total incidences.

Figure 3.3 Chromosomes in prometaphase cells can be embedded in ER
membranes during mitotic progression in control and CTDNEP1KO
cells
A) Select images from confocal time lapse of GFP-KDEL and H2B-mCherry in
transiently-expressing U2OS CTDNEP1KO cells subject to Cdk1 inhibitor washout.
Yellow arrows point to unaligned chromosomes; cyan arrows point to ER tubules
extending into the metaphase plate. Scale bar, 10 μm.
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Figure 3.4 Excess ER membranes fill mitotic cytoplasm in CTDNEP1depleted U2OS cells, and chromosomes take up less space
A) Selected spinning disk confocal images of GFP-Sec61β and H2B-mCherry from
a time lapse movie of U2OS cells treated with indicated siRNAs. Scale bar 10 μm.
B) Graphs plotting fluorescent intensities of GFP-Sec61β (gray) and mCherry-H2B
(magenta) along a 10-pixel line profile drawn along the equatorial region at
anaphase onset for indicated conditions. Values are normalized to minimum and
maximum values for each channel and to the percentage of the cell diameter. Blue
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lines indicate percentage of the cell diameter at the half maximum value for GFPSec61β. C) Plot of percent of cell diameter occupied by Sec61β-positive pixels in
cells treated with indicated siRNA as in (A) and (B). Means ± SDs shown. n =
number of cells, N = 7 experimental repeats. P value, Mann-Whitney 2-tailed
unpaired t test.

Figure 3.5 Excess ER membranes fill mitotic cytoplasm in CTDNEP1KO
U2OS cells
A) Confocal images of GFP-KDEL signal from a time lapse movie of U2OS cells
at anaphase onset as determined by SiR-DNA staining (not shown). Scale bar 10
μm. B) Graphs plotting fluorescent intensities of GFP-KDEL along a 10-pixel line
profile drawn along the equatorial region at anaphase onset for indicated
conditions. Values are normalized to minimum and maximum values for each
channel and to the percentage of the cell diameter. Blue lines indicate percentage
of the cell diameter at the half maximum value for GFP-Sec61β. C) Plot of percent
of cell diameter occupied by KDEL-positive pixels in cells treated with indicated
siRNA as in (A). Means ± SDs shown. n = number of cells, N = 3 experimental
repeats. P value, Mann-Whitney 2-tailed unpaired t test.
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Figure 3.6 Membrane extensions in CTDNEP1KO U2OS cells during mitotic
exit
A) Selected spinning disk confocal images of GFP-KDEL signal (inverted) from a
time lapse movie of U2OS cells after mitotic shakeoff. Mitotic staging determined
by SiR-DNA staining (not shown). Arrows point to intranuclear membrane
extensions. Scale bar 10 μm. B) Plot of incidence of membrane extensions in
postmitotic nuclei. Means ± SDs shown. n = number of daughter cell pairs, N = 3
experimental repeats. P value, Fisher’s exact test of total incidences.
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Figure 3.7 Persistence of membrane extensions in early G1 CTDNEP1KO
U2OS cells
A) Selected spinning disk confocal images of GFP-KDEL (inverted) from a time
lapse movie of U2OS cells in early G1. Mitotic staging determined by SiR-DNA
staining (not shown). Arrows point to intranuclear membrane extensions. Scale bar
10 μm. B) Plot of incidence of membrane extensions in post-mitotic G1 nuclei.
Means ± SDs shown. n = number of daughter cell pairs from N = 5 experimental
repeats. P value, Chi squared test of total incidences.
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Figure 3.8 siCTDNEP1-treated cells show faster reestablishment of net
nuclear import and faster nuclear growth during mitotic exit
A) Schematic of importin β-binding domain of importin α (IBB) localization with
chromatin (H2B) during the cell cycle. B) Images from spinning disk confocal time
lapse movie of IBB and H2B signal during mitotic exit. Scale bar, 10 μm. C) Plot of
fold increase of integrated IBB intensity in the chromatin-containing region over
time in cells treated with the indicated siRNA. Fold increase is compared to value
at t = 3 min. Means ± SD shown. D) Plot of fold increase in nuclear surface area
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over time in cells treated with the indicated siRNA. Fold increase is compared to
value at t = 3 min. Means ± SD shown. For all, N = 4 experimental repeats.

Figure 3.9 Coordination of membrane clearing is obfuscated by increased
lipid synthesis controlled by CTDNEP1
A) Schematic for how membranes are cleared to the cell periphery after nuclear
envelope breakdown and cell rounding. This process is disrupted with excess ER
membranes in CTDNEP1KO cells, leading to persistence of uncleared membranes
in prometaphase to metaphase cells. Light green = ER, dark green = nuclear
envelope; pink = DNA, and blue = mitotic spindle.
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Figure 3.10 Comparison of closed vs semi-open vs open mitosis and
implications for improper membrane clearance for chromosome
segregation
A) Schematic showing differences between nuclear envelope membrane
dynamics during mitosis in yeast, worm, and human cells. Dark green = nuclear
envelope; pink = DNA, and blue = mitotic spindle. ER (light green) also shown in
human cell to demonstrate membrane clearing to cell periphery. Bottom, deficient
membrane clearance leads to formation of micronuclei in open mitosis.
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Chapter 4: CTDNEP1 is required for correction of errors in mitosis
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Introduction
We have shown that CTDNEP1 limits ER membrane biogenesis to limit
membrane abundance and clearance in mitosis. We have also shown that mitotic
cells without CTDNEP1 have higher cytoplasmic viscosity and lower
prometaphase average chromosome velocity. What remains to be shown is how
micronuclei can form in CTDNEP1-depleted cells. In this chapter, I investigate
known mechanisms of chromosome missegregation in CTDNEP1-depleted cells
to determine how CTDNEP1 limits formation of micronuclei.
Micronuclei can form from either missegregation of non-centromerecontaining chromosome fragments induced by DNA damage/breaks or
missegregation of whole chromosomes (Fenech et al., 2011). We have found
that CTDNEP1KO U2OS cells exhibit excess ER membranes and less ER
membrane clearance in mitosis. Previous studies implicating membrane
clearance in chromosome segregation have found that poor clearance of
membranes from chromatin resulted in anaphase bridges and chromosome
missegregation (Schlaitz et al., 2013), both of which involve chromosomes with
intact centromeres (Pampalona et al., 2016). Therefore, we hypothesize that
missegregation of whole chromosomes is more likely to be the culprit than
missegregation of chromosome fragments.
Missegregation of whole chromosome fragments can occur by failed
congression, merotely, or premature spindle assembly checkpoint (SAC)
inactivation, or a combination of these (Fenech et al., 2011). Failed chromosome
congression can occur by chromosomes not aligning on the metaphase plate,
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then being unable to reach the main chromosome mass to reform into the main
nucleus after anaphase onset (Fonseca et al., 2019). Merotely occurs when one
or both kinetochores of a chromosome are attached to microtubules emanating
from both spindle poles, instead of only one (Cimini et al., 2001). If the abnormal
attachment is strong enough to sufficiently counter the tension from the correct
attachments, the chromosome lags and does not incorporate with the main
chromosome mass during anaphase (Cimini et al., 2004). Merotely can occur
when spindle geometry is altered; for example, multipolar spindles that cluster
centrosomes to become bipolar later (transient multipolarity) frequently have
merotelic attachments biased toward the spindle pole with two centrosomes
(Silkworth and Cimini, 2012). Cells with delayed spindle pole separation also
have more merotelically attached chromosomes (Cimini, 2003; Silkworth and
Cimini, 2012). Altered kinetochore architecture has also been shown to
contribute to merotely (Gregan et al., 2011). Merotely is a common occurrence in
prometaphase cells, and merotelic attachments are typically repaired before
anaphase onset (Cimini et al., 2004). Prolonging metaphase reduces the
proportion of wrongly attached microtubules to correctly attached microtubules
and decreases the overall incidence of merotelic attachments (Cimini et al.,
2004). Aurora B has been implicated in mediating merotelic attachment
correction; an Aurora B-generated phosphorylation gradient around centrosomes
allows spatially controlled motor protein and attachment-regulating protein
activities to promote correct attachments and destabilize incorrect ones (Cimini et
al., 2006; DeLuca et al., 2006; Gregan et al., 2011). Merotelic attachments are
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not sensed by the spindle assembly checkpoint (Gregan et al., 2011), making
these distinct mechanisms contributing to formation of micronuclei.
Premature inactivation of the spindle assembly checkpoint also leads to
formation of micronuclei (Liu et al., 2018). The spindle assembly checkpoint
monitors for unattached and improperly attached kinetochores and prevents
sister chromatids from separating and cell cycle progression into anaphase
(Musacchio, 2015). Broadly, the spindle assembly checkpoint prevents cyclin B
(part of the cyclin dependent-kinase 1/cyclin B kinase complex) and securin (a
protein that inhibits separase, which mediates chromatid dissociation through
cohesin dissociation) from being degraded (Musacchio, 2015). At unattached
kinetochores, the mitotic checkpoint complex (MCC) inhibits the anaphase
promoting complex/cyclosome (APC/C), which would otherwise ubiquitinate
cyclin B and securin (Hayward et al., 2019; Musacchio, 2015). MCC assembly
and recruitment to unattached kinetochores appears to be a tunable response
based on the frequency of unattached kinetochores (Collin et al., 2013), yet one
unattached kinetochore is sufficient to activate the spindle assembly checkpoint
(Dick and Gerlich, 2013). Aurora B recruits the checkpoint kinase MPS1 to
kinetochores, and MPS1 phosphorylates kinetochore proteins to create a docking
site for spindle assembly checkpoint players that make up or support the MCC
(Hayward et al., 2019; Musacchio, 2015). When all kinetochores are properly
attached, these steps are reversed; and passive and active SAC silencing
mechanisms facilitate MCC dissociation from the kinetochore and from APC/C
(Hayward et al., 2019; Musacchio, 2015). APC/C then ubiquitinates cyclin B and
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securin to allow chromatids to separate and anaphase to proceed (Musacchio,
2015). Premature inactivation of the spindle assembly checkpoint occurs in some
cancer cells and contributes to aneuploidy and formation of micronuclei
(Bharadwaj and Yu, 2004; Fenech et al., 2011).
Here we show that CTDNEP1 is required for mitotic error correction. We
show that CTDNEP1-depleted cells have more lagging chromosomes and have
longer spindles. Prematurely inactivating the spindle assembly checkpoint
modestly increases the number of micronuclei in CTDNEP1KO cells compared to
control cells. On the other hand, increasing merotelic attachments by subjecting
cells to transient spindle disassembly causes severe micronucleation in
CTDNEP1KO cells and CTDNEP1-depleted cells. This severe micronucleation is
suppressed by CTDNEP1/NEP1R1 or catalytically active lipin 1 overexpression.
These data show that CTDNEP1 limits correction of merotelic errors, illuminating
the mechanism for how chromosome segregation changes can lead to formation
of micronuclei in cells lacking CTDNEP1 and informing how CTDNEP1 mutations
might contribute to chromosomal instability in cancer.
Results
Lagging chromosomes in CTDNEP1-depleted cells
To confirm that CTDNEP1-depleted cells have increased rates of
chromosome missegregation that can contribute to formation of micronuclei, I
sought to quantify kinetochore or centromere localization during anaphase
relative to chromosome and spindle markers. I used a U2OS cell line stably
expressing GFP-Centrin 2 (centrosome marker), GFP-CENPA (centromere
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marker), and mCherry-α tubulin (Yu et al., 2019) and RNAi-depleted of
CTDNEP1 (Figure 4.1). To enrich for mitotic cells for live imaging, I performed a
drugless mitotic shakeoff and plated and imaged cells immediately. In mid-late
anaphase and early telophase cells, lagging chromosomes could be visualized
as GFP punctae localized away from the segregating chromosomes, either in the
spindle midzone or in the cell periphery, (Figure 4.1A, yellow arrow). One caveat
of this experiment is that the cells had CENPA and Centrin 2 fluorescing at the
same wavelength. However, Centrin 2 punctae were brighter than CENPA
punctae and had associated bright tubulin signal that occurs at centrosomes
(Figure 4.1A, cyan arrow), making them easily distinguishable for this analysis.
By blind categorization, I quantified the percentage of anaphase/telophase cells
with GFP-CENPA punctae apart from chromosome masses and found that cells
treated with CTDNEP1 siRNA had significantly more lagging chromosome
punctae than control cells (32.6 ± 5.2 % in CTDNEP1 RNAi-depleted cells vs 9.6
± 6.5 % of cells treated with control siRNA; Figure 4.1B). These results show that
depletion of CTDNEP1 results in an increase in lagging chromosomes, which can
contribute to formation of micronuclei.
Bypassing the spindle assembly checkpoint in CTDNEP1-depleted cells
increases formation of micronuclei
An increase in lagging chromosomes can indicate that errors that are sensed
by the spindle assembly checkpoint are increased in CTDNEP1-depleted cells.
To determine the rate of attachment errors, one can use an inhibitor of the
spindle assembly checkpoint on a synchronized cell population; cells will enter
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anaphase with improperly attached kinetochores, and the cells will form
micronuclei in the subsequent interphase (Liu et al., 2018) (Figure 4.2A). To test
if CTDNEP1 depletion leads to increased erroneous kinetochore attachments, I
synchronized control and CTDNEP1KO cells at the G2/M transition using a Cdk1
inhibitor, RO-3306 (Ki = 35 nM for Cdk1/cyclin B1 and Ki = 110 nM for
Cdk1/cyclin A (Calbiochem)), and released the cells from the G2 block in the
presence of an inhibitor of the checkpoint kinase MPS1 (NMS-P715, Ki = 0.99
nM (Calbiochem)) (Liu et al., 2018) (Figure 4.2A-4.2B). CTDNEP1KO cells had a
higher incidence of micronuclei compared to control cells with MPS1 inhibition
(43.3 ± 4.9 % of CTDNEP1KO cells compared to 39.9 ± 1.9 % of control cells;
Figure 4.2C). Although significant, the small magnitude of this difference led us to
conclude that increased kinetochore attachment errors sensed by the SAC is
likely not the major mechanism that contributed to lagging chromosomes and
formation of micronuclei in cells lacking CTDNEP1, and so we assessed other
mechanisms that cause lagging chromosomes.
Recovery from transient spindle disassembly leads to abnormal hypermicronucleation in CTDNEP1-depleted cells that is suppressed with
CTDNEP1/lipin expression
Increased formation or decreased correction of merotelic attachments is
another mechanism by which lagging chromosomes and micronuclei can form.
Transient disassembly of the mitotic spindle is known to increase merotelic
attachments and is used to enrich for micronuclei (Cimini, 2003; Cimini et al.,
2001; Liu et al., 2018) (Figure 4.3). During recovery from spindle
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depolymerization, a delay in establishing spindle bipolarity and stretching of
kinetochores leads to increased merotelic attachments that persist into anaphase
(Cimini, 2003). To determine if correction of merotelic errors is deficient in
CTDNEP1-deleted cells, I treated cells with a low dose of nocodazole and
performed mitotic shakeoff, then allowed cells to recover from nocodazole
treatment (“nocodazole washout”) (Liu et al., 2018); I then performed
immunofluorescence processing on the cells in interphase to score cells for the
presence of micronuclei (Figure 4.3A; Figure 4.4A). In control cells, recovery
from spindle depolymerization by nocodazole washout led to an increase in
micronuclei (Figures 4.4A-4.4B; compare 10.6 ± 2.0 % in Figure 2.19B to 4.3 ±
0.8 % in Figure 4.4B). In CTDNEP1KO cells, a significant proportion of nuclei
appeared severely multilobed/micronucleated, a phenotype we refer to as “hypermicronucleated” nuclei (40.0 ± 8.5 % in CTDNEP1KO cells compared to 4.3 ± 1.2
% of control cells; Figure 4.4A-4.4B). To confirm that this phenotype is not
exclusive to U2OS cells, I also performed nocodazole washout on RPE-1 cells
RNAi-depleted of CTDNEP1 (Figure 4.5A). Consistent with the previous results,
RPE-1 cells depleted of CTDNEP1 exhibited more hyper-micronucleated nuclei
(21.5 ± 2.6 % in CTDNEP1-depleted cells compared to 9.2 ± 2.4 % of control
cells; Figure 4.5B). To determine if loss of CTDNEP1 is responsible for
controlling formation of hyper-micronucleated nuclei in CTDNEP1KO cells, I
transiently overexpressed CTDNEP1-HA and FLAG-NEP1R1 and subjected cells
to nocodazole washout and found that CTDNEP1/NEP1R1 expression reduces
the number of hyper-micronucleated nuclei compared to overexpression of a
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control vector (Figure 4.6A-4.6B). Together, these data show that CTDNEP1 is
required for the correction of merotelic attachment errors.
I next sought to determine if CTDNEP1 control of lipin 1 plays a role in
regulating correction of merotelic attachments, because CTDNEP1
dephosphorylation of other unknown substrates could also control this regulation.
I transiently expressed the mouse lipin 1β construct with 19 S/T sites mutated to
alanine, which rescues ER expansion in CTDNEP1KO cells (Figure 2.14A-2.14B),
as well as the PAP dead version of this construct, and performed nocodazole
washout. Overexpression of lipin 1β 19xA suppressed formation of hypermicronucleated nuclei, whereas overexpression of the PAP dead construct did
not (8.7 ± 1.0 % with FLAG-lipin 1β 19xA compared to 30.7 ± 1.4 % in control;
26.2 ± 2.8 % with phosphatase-dead FLAG-lipin 1β 19xA compared to 25.3 ± 3.4
% in control, Figure 4.7A-4.7B). Thus, loss of lipin 1 catalytic activity upon
CTDNEP1 depletion allows hyper-micronucleated nuclei formation with
nocodazole washout. These data show that CTDNEP1 control of lipin 1
phosphorylation allows correction of merotelic attachments in mitosis.
Mitotic exit in CTDNEP1KO cells recovering from transient spindle disassembly
The appearance of multiple large micronuclei in hyper-micronucleated
cells is suggestive of multiple chromosomes segregating into micronuclei during
recovery from spindle depolymerization in CTDNEP1KO cells. I performed
nocodazole washout on control and CTDNEP1KO U2OS cells and fixed cells 4560 min after mitotic shakeoff and release from nocodazole to capture cells in
mitotic exit (Liu et al., 2018) (Figure 4.8A). Consistent with previous results that
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CTDNEP1 depletion leads to a prometaphase delay, a larger proportion of
CTDNEP1KO cells were still in prometaphase after 1 hour of nocodazole washout
compared to control cells (Figure 4.8B). Among anaphase and telophase cells,
CTDNEP1KO cells recovering from nocodazole treatment frequently had masses
of chromosomes and concomitant tubulin staining in the periphery of cells (55.2 ±
5.0 % of CTDNEP1KO cells compared to 7.8 ± 7.9 % of control cells, Figure
4.9A). These data support the conclusion that lack of CTDNEP1 control of lipin 1
allows merotelic attachments to persist and lead to chromosome missegregation
that results in severe micronucleation.
Longer spindle lengths in CTDNEP1-depleted U2OS mitotic cells
I previously showed that CTDNEP1-depleted cells exhibit sensitivity to
spindle depolymerization and dampened prometaphase chromosome
movements. These findings prompted us to observe chromosome dynamics and
mitotic spindles in CTDNEP1-depleted cells stably expressing Centrin-2, CENPA,
and mCherry-α tubulin in metaphase (Figure 4.10A, left). Chromosome alignment
was not significantly decreased in CTDNEP1-depleted metaphase cells
compared to control cells (data not shown). I found that the pole-pole distance of
mitotic spindles in CTDNEP1-depleted metaphase cells was increased compared
to the spindle lengths in control cells (Figure 4.10A, right).
Discussion
These data show that CTDNEP1 is required for mitotic error correction and
proper chromosome segregation. We show that kinetochore attachment errors
that are sensed by the spindle assembly checkpoint are not greatly increased in
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CTDNEP1KO cells. CTDNEP1-deleted cells are greatly sensitized to merotelic
kinetochore attachment errors that are brought about by transient spindle
disassembly, and this sensitization is due to loss of lipin 1 catalytic activity.
I previously described data showing that CTDNEP1 controls membrane
abundance and clearing during mitosis. In CTDNEP1KO cells, the cytoplasmic
viscosity is increased, and prometaphase chromosome movements are
decreased. Merotelic errors are resolved by detaching microtubules from the
incorrect spindle pole, which involves rotation of the chromosome to keep
microtubules from the same incorrect spindle pole from reattaching (Cimini,
2003). Thus, dampened chromosome movements in CTDNEP1KO cells could
contribute to reduced mitotic error correction.
It is not clear why metaphase spindles appear longer in CTDNEP1-depleted
cells. A previous computational modeling study has shown that an elastic,
deformable membrane around the spindle can assist with focusing minus ends of
microtubules by forming pockets for filaments to gather, promoting longer spindle
length (Poirier et al., 2010). Future studies can determine if expanded
membranes are more elastic (more able to retain their shape) in CTDNEP1KO
cells and whether this might contribute to spindle microtubule focusing.
Alternatively, a membranous spindle matrix has been proposed to surround the
mitotic spindle and concentrate components of the spindle (Schweizer et al.,
2014, 2015). I previously showed that CTDNEP1-depleted mitotic cells have a
greater occupancy by ER membranes, with less room for chromosomes to
occupy (Figure 3.4B). The expanded membranes and increased cytoplasmic
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viscosity in the region where membranes are present in mitotic CTDNEP1KO cells
could lead to higher concentration of spindle components that allows spindles to
grow longer. Future studies can confirm these results and test these hypotheses
to determine how lipid synthesis regulation by CTDNEP1 might control mitotic
spindle length.
Another remaining question is to what extent mitotic errors that are not
related to merotelic attachments could be impacted by CTDNEP1 depletion. For
example, the possibility of missegregation of chromosome fragments in
CTDNEP1-depleted cells still needs to be ruled out. In nocodazole washout,
transient spindle multipolarity is more common, and this leads to more merotelic
attachments. Longer spindles in CTDNEP1-depleted cells, slower chromosome
movement, and the peripheral localization of lagging chromosomes and tubulin in
CTDNEP1KO cells during telophase after nocodazole washout hint that spindle
dynamics are altered with loss of CTDNEP1, while persistence of merotelic
attachments could result from this. Future studies can determine if spindle
architecture is challenged by the presence of excess membranes in mitosis and
what additional mechanisms can contribute to formation of micronuclei.
These data show that CTDNEP1 promotes proper chromosome segregation
by permitting merotelic attachment correction. What remains to be seen is how
regulation of lipid synthesis by CTDNEP1 plays a role in regulating mitotic error
correction.
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Figure 4.1 CTDNEP1-depleted cells have a higher incidence of lagging
chromosomes
A) Spinning disk confocal images of Centrin2/CENPA/α tubulin fluorescence signal
in stably-expressing live cells treated with indicated siRNAs. Scale bar, 10 μm. B)
Quantification of incidence of lagging CENPA punctae in cells in indicated
conditions. Means ± SDs shown. n = number of cells, N = number of experimental
repeats. P value, Fisher’s exact test of total incidences.
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Figure 4.2 Bypassing the spindle assembly checkpoint in CTDNEP1KO cells
does not highly increase formation of micronuclei compared to
control cells
A) Schematic of generating micronuclei using synchronization with RO-3306
(Cdki) and spindle assembly checkpoint bypass with NMS-P719 (MPS1i). DNA is
pink, mitotic spindle is in blue, and nuclear envelope is in green. B) Confocal
images of emerin and DAPI/Hoechst staining in fixed cells treated as in (A). Scale
bars, 10 μm. C) Quantification of incidence of indicated phenotypes in cells treated
as shown. n = number of cells, N = 3 experimental repeats. Means + SDs shown.
P value, Chi squared test of total incidences.
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Figure 4.3 Using recovery from nocodazole treatment to assess sensitivity
to acute spindle depolymerization for formation of micronuclei
A) Schematic of generating micronuclei using transient spindle disassembly with
nocodazole. DNA is pink, mitotic spindle is in blue, and nuclear envelope is in
green.
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Figure 4.4 Recovery from transient spindle disassembly leads to abnormal
hyper-micronucleation in CTDNEP1KO U2OS cells
A) Epifluorescence (DAPI/Hoechst) and confocal (emerin) images of
immunostained cells treated as in Figure 4.3A. Scale bar 10 μm. B) Quantification
of incidence of indicated phenotypes in cells treated as shown. n = number of cells,
N = 3 experimental repeats. Means + SDs shown. P value, Chi squared test of
total incidences.
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Figure 4.5 Recovery from transient spindle disassembly leads to abnormal
hyper-micronucleation in CTDNEP1-depleted RPE-1 cells
A) Schematic of combined nocodazole washout and RNAi; epifluorescence
(DAPI/Hoechst) and confocal (emerin) images of immunostained cells treated as
shown in the schematic. Scale bar 10 μm. B) Quantification of incidence of
indicated phenotypes in cells treated as shown. n = number of cells, N = 3
experimental repeats. Means + SDs shown. P value, Chi squared test of total
incidences.
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Figure 4.6 Overexpression of CTDNEP1/NEP1R1 suppresses hypermicronucleation in CTDNEP1KO cells upon recovery from transient
spindle disassembly
A) Epifluorescence (DAPI/Hoechst) and confocal (FLAG, HA) images of
immunostained cells transfected with indicated vectors and subject to nocodazole
washout for 18 hrs as in Figure 4.3A. Scale bar 10 μm. B) Quantification of
incidence of indicated phenotypes in cells treated as shown. n = number of cells,
N = 3 experimental repeats. Means + SDs shown. P value, Chi squared test of
total incidences.
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Figure 4.7 Overexpression of catalytically active lipin 1 suppresses hypermicronucleation in CTDNEP1KO cells upon recovery from transient
spindle disassembly
A) Epifluorescence (DAPI/Hoechst) and confocal (FLAG, emerin) images of
immunostained cells transfected with indicated vectors and subject to nocodazole
washout for 18 hrs as in Figure 4.3. Scale bar 10 μm. 19 S/T to A refers to 19
serine/threonine sites mutated to dephospho-mimic alanine residues. PAP dead
refers to phosphatase dead lipin 1. B) Quantification of incidence of indicated
phenotypes in cells treated as shown. “-“ refers to non-construct-expressing, and
“+” refers to construct-expressing cells in the same experiment. n = number of
cells, N = 3 experimental repeats. Means + SDs shown. P values, Chi squared
tests of total incidences.
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Figure 4.8 CTDNEP1KO cells have a higher incidence of prometaphase cells
upon recovery from transient spindle disassembly
A) Schematic for transient spindle disassembly with washout from acute
nocodazole treatment. B) Plot of quantification of percent of mitotic cells in each
stage of mitosis in control and CTDNEP1KO U2OS cells treated as shown. Means
± SDs shown. n = number of cells, N = 3 experimental repeats. P value, Fisher’s
exact test of total incidences of prometaphase cells.

Figure 4.9 Anaphase and telophase CTDNEP1KO cells recovering from
transient spindle disassembly have more frequent chromosome
masses and tubulin apart from the main nuclei and spindle
A) Spinning disk confocal images of DAPI/Hoechst and tubulin-stained telophase
cells subject to nocodazole washout for 45-60 min as in Figure 4.3. Cells were
treated with Ca2+-buffer to depolymerize non-kinetochore microtubules just before
fixation. Quantification of indicated phenotype shown. n = number of cells from N
= 3 experimental repeats. Means ± SDs shown. P value, Fisher’s exact test of total
incidences.
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Figure 4.10 Longer spindle lengths in CTDNEP1-depleted U2OS
prometaphase-metaphase cells
A) Confocal images of Centrin2, CENPA, and α tubulin signal in metaphase U2OS
cells treated with the indicated siRNAs and subject to mitotic shakeoff. Scale bar,
5 μm. B) Plot of spindle pole-pole distance in cells as in (A). n = number of cells.
N = 4 experimental repeats. Individual data points and means ± SDs shown. P
value, paired t test of replicate means.
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Chapter 5: A CTDNEP1-lipin 1 regulatory network controls fatty acid
synthesis to limit ER membrane biogenesis, nuclear morphology defects,
and formation of micronuclei
Some of this work is included and/or modified from the manuscript:
Holly Merta*, Jake W. Carrasquillo Rodríguez*, Maya I. Anjur-Dietrich, Mitchell E.
Granade, Tevis Vitale, Thurl E. Harris, Dan Needleman, Shirin Bahmanyar. A
CTDNEP1-lipin 1-mTOR regulatory network restricts ER membrane biogenesis
to Enable Chromosome Motions Necessary for Mitotic Fidelity. bioRxiv (2021).
doi: https://doi.org/10.1101/2021.03.02.433553
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Introduction
We have shown that CTDNEP1 limits ER membrane biogenesis and
controls membrane dynamics in mitosis. CTDNEP1 additionally limits
cytoplasmic viscosity, allows prometaphase chromosome movements, and
promotes mitotic error correction to limit formation of micronuclei. Major
questions that remain are the mechanism by which CTDNEP1 limits ER
membrane synthesis, as well as the connection between CTDNEP1’s control of
lipid synthesis and regulation of chromosome segregation.
One possibility for how CTDNEP1 can control ER membrane biogenesis is
through regulation of sterol regulatory element binding protein (SREBP)dependent transcription, mediated through lipin. The primary mechanism of
controlling fatty acid synthesis in human cells is through SREBP-dependent
transcription (Figure 5.1). SREBPs change cellular localization from ER
membrane-bound to soluble and nuclear in response to changes in ER
membrane cholesterol levels (Inoue and Sato, 2013) (Figure 5.1A). At normal ER
membrane cholesterol levels, SREBP cleavage-activating protein (SCAP)
remains bound to cholesterol and Insulin-sensitive gene (Insig) (Inoue and Sato,
2013). When cholesterol levels in the ER are reduced, SCAP binds to SREBP via
its basic helix-loop-helix (bHLH) domain and causes it to be taken up for
anterograde trafficking to the Golgi through COPII proteins Sec23/24 and Sar1
(Inoue and Sato, 2013). In the Golgi, SREBP is cleaved by proteases S1P and
S2P to free the bHLH domain to enter the nucleus and activate SREBPdependent transcription (Inoue and Sato, 2013). SREBP1 target genes control
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fatty acid synthesis (Figure 5.1B, above), while SREBP2 target genes control
steps in cholesterol synthesis (Figure 5.1B, below).
Lipin has shown to control fatty acid pools on multiple fronts, including
synthesis (regulated by mTOR and mediated through SREBP transcriptional
regulation) and breakdown (mediated through PPARα transcriptional regulation)
(Finck et al., 2006; Peterson et al., 2011). Lipin has repeatedly been shown to be
phosphoregulated with insulin and nutrient stimulation, demonstrating that it
responds to metabolic inputs (Harris et al., 2007; Huffman et al., 2002; Peterson
et al., 2011). mTOR (specifically, mTORC1) has been identified as the insulin
and nutrient-sensitive kinase complex that phosphorylates lipin 1 (Harris et al.,
2007; Peterson et al., 2011). In response to serum and glucose/amino acid
stimulation, lipin 1 is phosphorylated by mTOR on phosphosites known to be
regulated upon insulin stimulation (Peterson et al., 2011).
Lipin has shown to control SREBP-dependent gene expression. Inhibition
of mTOR reduces SREBP target gene expression, including SREBP1c target
genes fatty acid synthase (FASN), acetyl-CoA carboxylase alpha (ACACA), and
stearoyl-CoA decarboxylase (SCD), as well as SREBP2 targets 3-hydroxy-3methylglutaryl-coenzyme A reductase (HMGCR) and farnesyl diphosphate
synthase (FDPS) (Peterson et al., 2011). Lipin 1-deficient mice do not have
elevated SREBP target gene expression in a basal state, but SREBP target gene
expression is unresponsive to mTOR inhibition (Peterson et al., 2011). On the
other hand, expression of dephospho-mimic lipin 1 is sufficient to restore SREBP
response to mTOR inhibition in lipin 1-deficient mouse cells (Peterson et al.,
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2011). These data indicate that lipin 1 represses SREBP-dependent gene
transcription when dephosphorylated. While the mechanism of this repression is
not understood, it is known that phosphorylated lipin is retained in the cytoplasm
and is degraded (Shimizu et al., 2017). It remains to be seen if hyperphosphorylated lipin increases SREBP-dependent gene transcription through
derepression to positively regulate fatty acid synthesis. In CTDNEP1-depleted
cells, derepression of SREBPs by hyperphosphorylated, low-abundance lipin
could lead to increased fatty acid synthesis to feed into membrane biogenesis.
Here, I show that increased fatty acid synthesis and flux of lipid synthesis
into membrane biogenesis increase ER membrane abundance in CTDNEP1depleted cells. I report that CTDNEP1-depleted cells have elevated levels of
membrane glycerophospholipids. I show that inhibition of a SREBP1 target gene
to shut off fatty acid synthesis partially suppresses ER membrane expansion in
CTDNEP1KO cells. I additionally show that supplementation with free fatty acids
restores ER membrane expansion in CTDNEP1KO cells in the absence of fatty
acid synthesis, showing that flux into ER lipid synthesis is also increased. I
explore the contributions of SREBPs 1 and 2 and SREBP1 target gene SCD to
ER membrane expansion in CTDNEP1KO cells to reveal a partial role for
SREBPs in mediating fatty acid synthesis to control ER membrane abundance
through lipin and CTDNEP1. I show that inhibition of fatty acid synthesis
suppresses formation of micronuclei in CTDNEP1KO cells. These findings reveal
multiple mechanisms for CTDNEP1 control of ER membrane abundance via lipid
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synthesis and flux and connect control of fatty acid synthesis to regulation of
mitotic error correction to limit formation of micronuclei.
Results
Lipidomic analysis of total cellular lipids in CTDNEP1KO cells
Depletion of CNEP-1 in C. elegans and PAH1 (lipin) in A. thaliana cells leads
to increased cellular PA/PI and PC, respectively (Bahmanyar et al., 2014;
Craddock et al., 2015). CTDNEP1 has known roles in limiting glycerolipid
synthesis in all organisms tested (Bahmanyar et al., 2014; Craddock et al., 2015;
Siniossoglou et al., 1998; Tange et al., 2002). We sought to determine the lipid
profiles in CTDNEP1-depleted human cells by mass spectrometry lipidomic
analysis. We submitted samples of U2OS cells to Lipotype GmbH, who
performed lipid extraction, sample infusion, mass spectrometry and/or tandem
mass spectrometry analysis, and lipid identification using Lipotype Xplorer. Data
were reported to us as pmols of lipid species per sample (with sample volume
utilized), with species reported in species class-combined chain length-combined
desaturation format (e.g. PC with 18:1 and 16:0 side chains reported as PC
(34:1). Using this information, we were able to extrapolate molar percentage of
lipid classes and, with sample protein concentration, pmols lipid class per mg
protein (Figure 5.2, Figure 5.3).
We first examined molar percentage of lipid classes in control and
CTDNEP1KO U2OS cells to determine if lipid flux favored formation of certain
species over others (Figure 5.2A). From this analysis, in CTDNEP1KO cells, PC
appeared to be increased in its contribution to the lipid profile, and TAG was also
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increased, while cholesterol esters (CE) and sphingomyelin (SM) were
decreased (Figure 5.2A). These results indicated to us that overall the lipidome
was not shifted toward PI/PA accumulation in CTDNEP1-depleted cells as in C.
elegans and brought up the possibility that TAG may be increased in addition to
membrane glycerolipids. To confirm these results, I resubmitted a new set of
samples of control and CTDNEP1KO cells (Figure 5.2B, “-“), this time also with a
sample of CTDNEP1KO cells stably overexpressing wild-type CTDNEP1-HA
(Figure 5.2B, “WT”) to determine what lipidome changes are rescued by
overexpressing CTDNEP1. PC was modestly increased in representation in
CTDNEP1KO cells compared to control cells and the rescue cell line, while other
glycerophospholipid species appeared unchanged in representation (Figure
5.2B). Triglycerides were no longer lower in control cells compared to
CTDNEP1KO cells with analysis of the second submission (Figure 5.2B). CE and
SM molar percentages remained lower in CTDNEP1KO cells relative to control
cells, and these were partially rescued in CTDNEP1KO cells stably expressing
CTDNEP1-HA (Figure 5.2B). These data indicate that representation of lipid
classes is overall similar in CTDNEP1KO cells relative to control except for PC
and lipids that are not synthesized in the ER.
To determine if absolute levels of lipid classes are elevated in CTDNEP1depleted cells, I normalized pmol of lipid classes to mg of protein in samples
(Figure 5.3). This analysis revealed that PC levels (and, to a lesser extent, PE
levels) are higher in CTDNEP1KO cells, and this is rescued by stable expression
of CTDNEP1 (Figure 5.3A). Cholesterol ester and SM levels were lower in
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CTDNEP1KO cells compared to control cells, and CE levels were rescued by
CTDNEP1 expression, whereas lower sphingomyelin levels were not rescued
(Figure 5.3A). These data show that loss of CTDNEP1 leads to increased cellular
PC/PE and decreased cholesterol esters. These data point to a conserved
mechanism for increased PC synthesis in human cells with loss of CTDNEP1
activation of lipin. The similar molar percentage profiles of CTDNEP1KO and
control cells and elevated pmol of lipid classes point to control of fatty acid
synthesis as a possible mechanism for CTDNEP1 regulation of ER membrane
biogenesis.
Inhibition of fatty acid synthesis reduces ER membranes in control cell and
suppresses ER expansion in CTDNEP1KO cells
Acetate incorporation into lipids is increased in CTDNEP1KO cells, indicating
that fatty acid synthesis may be increased with loss of CTDNEP1 (Merta et al.,
2021) (finding by M.E. Granade, supervised by T. Harris). I targeted fatty acid
synthesis to determine if increased fatty acid synthesis feeds into ER membrane
biogenesis in CTDNEP1-depleted cells (Figure 5.4). I used a small molecule
inhibitor of acetyl coenzyme-A carboxylase (ACAC) forms α and β, 5(tetradecyloxy)-2-furancarboxylic acid (TOFA) (IC50 4.5-5.0 μg/ml, (Wang et al.,
2009)) (Figure 5.4). ACAC catalyzes the conversion of acetyl-CoA into malonylCoA in the rate-limiting and committing step for fixation of cellular acetate into
fatty acids in mammalian cells (Tong, 2005). M. E. Granade found that TOFA
reduced acetate incorporation into lipids in control U2OS and CTDNEP1KO U2OS
cells, reflecting reduced acetyl-CoA fixation into lipids (Merta et al., 2021).
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Inhibiting ACAC limits malonyl-CoA formation, which limits fatty acid synthesis
and incorporation into PA, which should decrease ER membrane lipid synthesis
(Figure 5.4). Supplementation with exogenous fatty acids would bypass ACAC,
serving as a control to help determine if changes in ER membranes are due to
altered flux of fatty acid synthesis into ER membrane biogenesis (Figure 5.4).
Treatment of U2OS cells with 10 μM TOFA for 24 hours severely reduces ER
membranes (Figure 5.5A, above). In contrast to DMSO-treated cells, which have
sheet-like perinuclear ER membranes and peripheral reticular ER, TOFA-treated
U2OS cells have thin ER tubules with wide spaces in between or completely lack
a peripheral ER network (Figure 5.5A, red arrows). The remaining ER in these
cells is concentrated around the nucleus and appears thinner than perinuclear
ER in control cells (Figure 5.5A, above). TOFA also suppresses ER membrane
expansion in CTDNEP1KO cells (Figure 5.5A, below). The appearance of the ER
in TOFA-treated CTDNEP1KO cells more closely resembles control U2OS cells’
ER than DMSO-treated CTDNEP1KO cells or TOFA-treated U2OS cells (Figure
5.5A). A peripheral ER network is apparent in the majority of TOFA-treated
CTDNEP1KO cells (Figure 5.5A, blue arrows). These data show that fatty acid
synthesis feeds into ER membrane synthesis to control ER membrane
abundance, and that fatty acid synthesis may be increased in CTDNEP1KO cells.
To quantify the extent to which ER membranes were reduced in control and
CTDNEP1KO cells, I measured the percent area of cytoplasm taken up by ER
membranes as in Figure 2.11 and compared it to previously determined
phenotypic categorization of TOFA-treated control U2OS and CTDNEP1KO cells
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(Figure 5.6A). I found that the percent area of ER of cells categorized as having
“normal ER” is similar in U2OS cells and CTDNEP1KO cells treated with TOFA
(Figure 5.6A). CTDNEP1KO cells categorized as having “reduced” ER have
percent area of ER that falls within the range of areas of cells categorized as
having “reduced” ER, but in line with qualitative findings, the extent of reduced
ER could be much more severe in control U2OS cells (Figure 5.6A). These
findings reflect that the phenotypic categorization is accurate to the abundance of
ER membranes in TOFA-treated cells.
I next sought to determine the time scales at which ACAC inhibition could
cause ER membranes to be reduced in both control and CTDNEP1KO cells
(Figure 5.7). I treated cells with TOFA for 5 hours, 24 hours, and 48 hours
(Figure 5.7A). Treatment with TOFA for 72 hours showed no effect, reflecting that
the drug may be metabolized or degraded around that time (data not shown).
After 5 hours of TOFA treatment, 16.0 ± 10.3 % of U2OS cells have reduced ER
(Figures 5.7A-5.7B). In contrast, after 5 hours, 8.9 ± 1.9 % of DMSO-treated and
77.4 ± 4.5 % of TOFA-treated CTDNEP1KO cells show suppression of ER
membrane expansion to a “normal”-looking ER (Figures 5.7A, 5.7C). This finding
suggests that the ER membranes of CTDNEP1KO cells respond faster to TOFA
treatment than unmodified U2OS cells – either fatty acid synthesis is upregulated
to the extent that ACAC inhibition causes a more pronounced effect faster, or
fatty acid breakdown could be faster in CTDNEP1-depleted cells. In both
unmodified U2OS cells and CTDNEP1KO U2OS cells, the maximum effect of
TOFA treatment is observed after 24 hours (Figures 5.7A-5.7C).
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Fatty acid supplementation restores ER appearance in cells with fatty acid
synthesis inhibition
To determine if reduction of ER membranes in TOFA-treated cells was
indeed caused by lack of fatty acid incorporation into membrane lipids, I treated
cells with TOFA with or without exogenous fatty acid supplementation (Figure
5.8A). To treat cells with exogenous fatty acids, I used a total concentration of
100 μM and a makeup of 1:2:1 palmitic:oleic:linoleic acid, which were conjugated
to 0.5% fatty acid-free bovine serum albumin (BSA) to facilitate solubilization of
fatty acids into the media. The concentration and makeup of fatty acids more
closely resembles physiological extracellular conditions as opposed to mixes
containing only palmitate or oleate (Watt et al., 2012).
Treatment of control U2OS cells with TOFA and exogenous fatty acids
restores the appearance of the peripheral ER compared to cells treated with
TOFA and fatty acid-free BSA (Figures 5.8A-B). Similarly, supplementation with
exogenous fatty acids restores the expanded appearance of the ER in
CTDNEP1KO cells treated with TOFA (Figures 5.8A-B). Treating control or
CTDNEP1KO cells with exogenous fatty acids in the absence of TOFA does not
change ER appearance (Figure 5.9A), so there appears to be a mechanism in
place to keep exogenous fatty acids from being incorporated into excess
membranes that appears to not be as active in CTDNEP1KO cells. Together,
these data support the conclusion that CTDNEP1KO cells have increased fatty
acid synthesis and flux of fatty acids into ER lipid synthesis, and this feeds into
ER membrane biogenesis. Thus, CTDNEP1 limits fatty acid synthesis and
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incorporation of fatty acids into membranes to limit the abundance of ER
membranes.
Depletion of SREBPs and SREBP target genes to assess contribution to
SREBP-controlled fatty acid synthesis to ER membrane expansion
Since it is known that SREBP-mediated transcription is regulated by lipin
depending on its phosphorylation state, we next sought to determine the
contribution of SREBP-dependent transcription on ER membrane biogenesis in
CTDNEP1KO cells. Jake W. Carrasquillo Rodríguez found that mRNAs of
SREBP1 target genes ACACA and SCD are upregulated ~1.3-fold and ~1.5-fold,
respectively, in CTDNEP1KO cells compared to control cells (Merta et al., 2021).
The SREBP1 targets FASN and SREBP2 targets FDPS and HMGCR are not
upregulated (Merta et al., 2021). Although modest, the upregulation of these
SREBP targets could explain the apparent increase in fatty acid synthesis in
CTDNEP1KO cells.
Since ACACA and SCD are SREBP1 target genes, I first sought to deplete
SREBP1 by RNAi in control U2OS and CTDNEP1KO cells to determine if
SREBP1 depletion impacts ER morphology in unmodified U2OS cells or
suppresses ER membrane expansion in CTDNEP1KO cells (Figures 5.10A-B).
U2OS cells did not appear to have altered ER morphology with SREBP1
depletion (Figure 5.10B). Some CTDNEP1KO cells appeared to have suppression
of ER membrane expansion such that the peripheral ER network was visible in
SREBP1 siRNA-treated cells (Figure 5.10B). SREBP1 depletion reduces the
incidence of ER membrane expansion in CTDNEP1KO cells from 98.2 ± 1.6 % of
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cells to 93.4 ± 1.6 % (Figure 5.10C). SREBP1-dependent transcription appears
to at least partially contribute to fatty acid synthesis that feeds into ER membrane
expansion in CTDNEP1-depleted cells. Future experiments to determine if
knockdown of SREBP1 decreases levels of nuclear SREBP1 and decreases
SREBP1-dependent gene transcription will confirm these findings.
Studies in transgenic mice with deletion of either Srebp1 or Srebp2 show that
Srebp1 and Srebp2 can compensate for each other to some extent (Horton et al.,
2002; Vergnes et al., 2016). To determine if SREBP2 upregulation in SREBP1depleted cells could be masking an effect of SREBP1 depletion on ER expansion
in CTDNEP1KO cells, I co-depleted SREBP1 and SREBP2 with RNAi (Figures
5.11A-B). Like with RNAi depletion of SREBP1 alone, some CTDNEP1KO cells
depleted of SREBP1/2 show suppression of ER membrane expansion and
restoration of the reticular peripheral ER (Figure 5.11B). The incidence of the
expanded ER phenotype in CTDNEP1KO cells decreased from 99.7 ± 0.5 % to
96.2 ± 1.2 % with SREBP1/2 knockdown (Figure 5.11C). This reduction is of
similar magnitude as the suppression of ER membrane expansion with depletion
of SREBP1 alone, suggesting that cross-talk between SREBP1/2 does not limit
suppression of ER membrane expansion in CTDNEP1KO cells depleted of
SREBP1. Together, these data support the conclusion that SREBP-mediated
fatty acid synthesis gene transcription is at least partially responsible for
increased fatty acid synthesis and ER membrane expansion in CTDNEP1KO
cells.
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CTDNEP1KO U2OS cells exhibit increased SCD expression relative to control
U2OS cells and is the most upregulated SREBP target gene (Merta et al., 2021)
(finding by Jake W. Carrasquillo Rodríguez). SCD catalyzes the desaturation of
saturated fatty acyl-CoAs like palmitoyl- and stearoyl-CoA at the carbon 9
position to produce Δ9 destaurated fatty acyl-CoAs like palmitoleoyl-CoA and
oleoyl-CoA. While this step is not rate-limiting or committing for fatty acid
synthesis as a whole, it is the rate limiting step for synthesis of monounsaturated
fatty acids that make up a large portion of side chains in cellular glycerolipids
(ALJohani et al., 2017). Thus, upregulation of SCD specifically in CTDNEP1depleted cells could lead to expansion of ER membranes through increased
availability of monounsaturated fatty acids to feed into membrane lipid synthesis.
I depleted SCD in control U2OS and CTDNEP1KO U2OS cells with RNAi (Figure
5.12A-B). Knockdown of SCD reduced the incidence of the expanded ER
phenotype from 88.9 ± 1.7 % of cells to 72.3 ± 4.1 % (Figures 5.12B-C). Thus,
we conclude that expansion of ER membranes in CTDNEP1KO is at least partially
due to specific upregulation of SCD increasing synthesis of fatty acids for
membrane biogenesis. I also observed bright punctae ~1 μm in diameter in the
perinuclear ER of control and CTDNEP1KO U2OS cells depleted of SCD (Figure
5.12B, 5.12D). In cells treated with high concentrations of palmitate, the rough
ER appears distended, and this is thought to be caused by a combination of
changes in membrane properties (membrane stiffening) as palmitate is
incorporated into ER neutral lipids and increased ER stress in response to the
membrane packing defects (Borradaile et al., 2006). Perhaps decreased SCD in
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U2OS cells leads to punctae formation in rough ER because of decreased overall
desaturation of fatty acids in membranes leading to packing defects. These data
show that CTDNEP1 limits fatty acid synthesis and membrane biogenesis partly
through limiting SCD activity to produce monounsaturated fatty acids for
membranes.
Inhibition of fatty acid synthesis restores nuclear shape in CTDNEP1-depleted
cells
It is not known if the role CTDNEP1 plays in limiting fatty acid synthesis
mediates its conserved function for maintaining nuclear morphology. I
suppressed fatty acid synthesis in CTDNEP1KO cells with ACAC inhibition and
found that nuclei appear more round and that nuclear solidity is increased (Figure
5.13A). The proportion of nuclei characterized as having low solidity is reduced
from 20.9 ± 2.3 % in DMSO-treated CTDNEP1KO cells to 2.5 ± 2.6 % in TOFAtreated cells (Figure 5.13B). In control U2OS cells, however, TOFA treatment
does not significantly increase nuclear solidity (Figure 5.14A, 5.14B). This data
supports the conclusion that nuclear shape is at its maximum solidity when
CTDNEP1 is intact, such that limiting membrane lipid synthesis does not take
away from the nucleus’ ability to maintain its shape.
In CTDNEP1KO cells, increased fatty acid synthesis and flux of existing
fatty acids into membranes could result in more membranes feeding into the
nuclear envelope, causing its morphology to take on a more lobed shape. Upon
treatment with the ACAC inhibitor TOFA, decreased fatty acid synthesis could
limit the fatty acid pool that is available to incorporate into the nuclear
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membranes. To confirm that this is the case, I treated CTDNEP1KO cells with
TOFA or DMSO with or without 100 μM exogenous fatty acids (1:2:1
palmitic:oleic:linoleic acid) for 24 hours (Figure 5.14A). As before, TOFA
treatment increases nuclear solidity in CTDNEP1KO cells compared to untreated
cells; in TOFA- and fatty acid-treated cells, however, nuclear solidity is not
significantly changed, though the population values trend toward the solidity of
untreated CTDNEP1KO cells (Figure 5.14B). The incidence of nuclei with solidity
< 1 SD from the control mean is significantly lower in cells treated with TOFA with
exogenous fatty acids compared to cells treated with TOFA alone (Figure 5.14C).
We interpret that this result could be a partial rescue by fatty acid treatment of
the suppression of decreased nuclear solidity that occurs with ACAC inhibition in
CTDNEP1KO cells. This result is somewhat surprising given that fatty acid
supplementation appears to restore ER membrane expansion in TOFA-treated
CTDNEP1KO cells (Figure 5.8). Together, these data show that CTDNEP1 limits
fatty acid synthesis and ER membrane lipid synthesis to control nuclear shape.
Inhibition of fatty acid synthesis decreases formation of micronuclei in CTDNEP1depleted cells
To determine if the role CTDNEP1 plays in limiting fatty acid synthesis
controls formation of micronuclei, I quantified the incidence of micronuclei in
CTDNEP1KO cells treated with DMSO or TOFA (5.15A). I measured the doubling
time of U2OS cells to be 20-22 hours (data not shown). To account for the time
needed for a cell cycle to pass after limiting membrane synthesis, I treated
CTDNEP1KO cells with TOFA for 48 hours, a timeframe during which cells
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continue to show suppression of ER membrane synthesis (Figure 5.7). After 48
hours of ACAC inhibition, the incidence of micronuclei was decreased (3.3 ± 1.4
% of CTDNEP1KO cells treated with TOFA compared to 10.3 ± 2.3 % of cells
treated with DMSO; Figure 5.15). Additionally, I sought to determine if
CTDNEP1’s role in limiting fatty acid synthesis and ER membrane biogenesis
mediates its role in permitting mitotic error correction. I subjected TOFA-treated
CTDNEP1KO cells to nocodazole washout as shown (Figure 5.16A-5.16B). TOFA
treatment reduced the incidence of hyper-micronucleated nuclei (20.1 ± 4.2 % of
TOFA-treated CTDNEP1KO cells compared to 38.8 ± 3.3% of DMSO-treated
cells; Figure 5.16C). Together, these data support the conclusion that
CTDNEP1’s role in permitting mitotic error correct to limit formation of
micronuclei occurs through its roles in limiting fatty acid synthesis and ER
membrane biogenesis.
Discussion
Here, we have identified that CTDNEP1 and lipin 1 limit ER membrane
biogenesis by limiting PC/PE formation and restricting fatty acid synthesis and
flux of fatty acids into ER membrane lipids. We show that this control of
membrane biogenesis by CTDNEP1 permits mitotic error correction to limit
formation of micronuclei.
In C. elegans early embryos, ER sheet formation was found to be due to
loss of LPIN-1 conversion of PA to DAG, resulting in a buildup of PA that then is
synthesized into PI through the CDP-DAG pathway (Bahmanyar et al., 2014).
Knockdown of CDP-DAG synthase, which catalyzes the conversion of PA to
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CDP-DAG, or PI synthase, which catalyzes the conversion of CDP-DAG to PI,
rescues abnormal nuclear shapes caused by depletion of CNEP-1 or LPIN-1
(Bahmanyar et al., 2014). Depletion of CDP-DAG synthase also restores PI and
PA abundance and ER sheet formation in CNEP-1-depleted embryos
(Bahmanyar et al., 2014). Using mass spectrometry lipidomic analysis, we have
found that PI and PA levels are not increased in U2OS CTDNEP1KO cells and
that PE and PC levels are increased. This suggests that loss of lipin’s PA to DAG
conversion alone is not sufficient to explain ER membrane expansion with loss of
CTDNEP1 in human cells. We have found that transcriptional control of fatty acid
synthesis is altered in CTDNEP1KO U2OS cells. Since C. elegans early embryos
are transcriptionally quiescent, CNEP-1 deletion does not lead to upregulated
fatty acid synthesis as in human cells.
Our data support a mechanism of CTDNEP1 limiting ER membrane
biogenesis through multiple modes of regulation (Figure 5.17A-B). First,
expression of SREBP1 target genes ACACA and SCD, which catalyze ratelimiting steps of total fatty acid and monounsaturated fatty acid synthesis, is
limited by CTDNEP1 to limit fatty acid synthesis (Figure 5.17B, “1.”). Addition of
exogenous fatty acids with inhibition of fatty acid synthesis revealed that flux of
fatty acids into membrane lipids is also limited by CTDNEP1 (Figure 5.17B, “2.”).
Different rates of response to fatty acid inhibition raise the question of whether
the rate of fatty acid breakdown is also modulated by CTDNEP1 (Figure 5.17B,
“3.”). The combined effects limit synthesis of ER membrane lipids, especially PC
and PE, to limit membrane biogenesis (Figure 5.17B, “4.” and “5.”).
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It is not clear why fatty acid supplementation does not fully reverse the
suppression of nuclear solidity changes that occurs when CTDNEP1KO cells are
treated with an ACAC inhibitor to shut off fatty acid synthesis, despite fatty acid
supplementation reversing suppression of ER membrane expansion with ACAC
inhibitor treatment. Perhaps the ER’s morphology is responsive to changes in
fatty acid synthesis on a faster time scale than the nuclear envelope. Another
possibility is that exogenously supplied fatty acids are not incorporated into
nuclear envelope lipids as easily as into ER membrane lipids to influence nuclear
shape. The nuclear envelope has shown to be a metabolic territory of lipid
synthesis (Drozdz et al., 2017; Goulbourne et al., 2011; Romanauska and
Köhler, 2018); perhaps its lipid metabolic capacity relies more on fatty acids
synthesized de novo in the interconnected ER. Live imaging studies with acute
ACAC inhibition will help establish whether nuclear envelope shape with regards
to lipid availability is established during mitosis or can be changed during
interphase, the latter of which would lend some support for the hypothesis that
nuclear envelope lipid synthesis plays a role in determining its own shape.
This work has established a role for CTDNEP1 and lipin 1 for limiting ER
membrane biogenesis in human cells through limiting fatty acid synthesis at least
partly through SREBP-mediated gene transcription. This work has additionally
connected control of fatty acid synthesis by CTDNEP1 to controlling formation of
micronuclei (Figure 5.18). CTDNEP1 counteracts the nutrient-sensing kinase
mTOR’s phosphorylation of lipin to stabilize a nuclear pool of active lipin 1 (Merta
et al., 2021) (findings by J. W. Carrasquillo Rodríguez and T. Vitale). This activity
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limits ER membrane biogenesis in interphase and mitosis. Less abundant
membranes are more able to be cleared in mitosis, and cytoplasmic viscosity is
maintained. We hypothesize that limiting cytoplasmic viscosity and limiting the
presence of uncleared membranes permits chromosome movements that are
necessary for mitotic error correction, especially correction of merotelic errors,
which involve rotation of the chromosome (Cimini, 2003) (Figure 5.18). We
propose that membrane clearance and containing cytoplasmic viscosity allows
these error-correcting chromosome movements to occur (Figure 5.18). Finally,
CTDNEP1 limiting mitotic error correction leads to restriction of formation of
micronuclei during mitotic exit (Figure 5.18).
One important future direction for this work will be to determine how
reduction of fatty acid synthesis leads to a reduction in formation of micronuclei in
CTDNEP1KO cells. According to our model, restricting fatty acid synthesis in
CTDNEP1-depleted cells will reduce excess uncleared membranes in mitosis
and maintain cytoplasmic viscosity to allow chromosome movements. An
alternative possibility that remains to be excluded is that reducing fatty acid
synthesis in any context reduces cellular division and thereby limits the
opportunity for cells in a population to form micronuclei. The finding that TOFA
treatment with nocodazole washout in cells subject to mitotic shakeoff reduces
formation of hyper-micronucleated cells suggests that this is not the case. Still,
imaging of membranes in mitosis in TOFA-treated cells can confirm that control
of membrane abundance and localization in mitosis limits formation of
micronuclei.
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Figure 5.1 SREBP transcriptional control of lipid synthesis
A) Schematic of processing of SREBP from ER membranes to the nucleus in
response to cholesterol and membrane packing sensing to upregulate lipid
synthesis gene expression. SREBP, serum response element binding protein;
Insig, Insulin induced gene; SCAP, SREBP cleavage-activating protein; bHLH,
basic helix loop helix; S1P, signal peptidase 1; S2P, signal peptidase 2; SRE,
sterol regulatory element. B) Schematic of how SREBP target genes control lipid
synthesis. SREBP1 target genes (purple) control fatty acid synthesis, while
SREBP2 target genes (orange) control cholesterol synthesis.
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Figure 5.2 Lipidome mole percent composition in CTDNEP1KO cells
compared to control and CTDNEP1-overexpressed cells
A, B) Plots of molar percentage of lipid classes as determined by mass
spectrometry lipid profiling in indicated cell lines. n = 3 technical repeats per
condition. WT refers to stable overexpression of CTDNEP1-HA. Plots in (A) and
(B) are from samples submitted and analyzed on different days.
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Figure 5.3 Lipidome pmol/mg protein lipid makeup in CTDNEP1KO cells
compared to control and CTDNEP1-overexpressed cells
A) Plots of pmol lipid per mg of protein as determined by mass spectrometry lipid
profiling. n = 3 technical repeats per condition. WT refers to stable overexpression
of CTDNEP1-HA.

Figure 5.4 Control of fatty acid synthesis with small molecule inhibition of
acetyl-CoA carboxylase
A) Schematic of how fatty acid synthesis feeds into ER membrane biogenesis and
how it can be modulated using small molecule inhibitors and fatty acid
supplementation. ACAC, acetyl-CoA carboxylase; TOFA, 5-(Tetradecyloxy)-2Furoic Acid; LPA, lyso-phosphatidic acid. Acetyl-CoA is converted to fatty acylCoA by sequential carbon additions and can be additionally desaturated and
elongated. 2 fatty acyl-CoAs can be formed into PA with glycerol, and PA/DAG can
be made into membrane glycerophospholipids.
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Figure 5.5 Inhibition of acetyl-CoA carboxylase suppresses ER expansion
in CTDNEP1KO cells and reduces ER membranes in control U2OS
cells
A) Spinning disk confocal microscopy images of calnexin in immunostained U2OS
cells treated as indicated. Yellow outlines show cell outlines as determined by
manual outline of high-brightness ER signal. Blue arrows point to peripheral ER
tubular networks, and red arrows point to thin or absent tubular networks. Scale
bar 10 μm.
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Figure 5.6 Validation of ER phenotype categorization using ER fluorescent
signal segmentation
A) Plot, percent area quantification of ER signal segmentation from images of fatty
acid-free BSA and DMSO or TOFA (24 hrs)-treated cells with phenotypic
characterization for comparison. Values per cell (n) and phenotypic categorization
are taken from the same dataset as Figure 5.8.
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Figure 5.7 Reduction of ER membranes by acetyl-CoA carboxylase
inhibition over time
A) Spinning disk confocal microscopy image of calnexin in immunostained U2OS
cells treated as indicated. B,C) Quantification of incidence of indicated ER
phenotypes in cells treated as indicated. n = number of cells, N = 3 experimental
repeats. Mean + SD shown. P values, Chi squared tests of total incidences.
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Figure 5.8 Supplementation with exogenous fatty acids restores ER
appearance in cells with acetyl-CoA carboxylase inhibition
A) Spinning disk confocal microscopy images of calnexin in immunostained U2OS
cells treated as indicated. Yellow outlines show cell outlines as determined by
manual outline of high-brightness ER signal. B,C) Quantification of incidence of
indicated ER phenotypes in cells treated as indicated. n = number of cells, N = 3
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experimental repeats. Mean + SD shown. P values, Chi squared tests of total
incidences.

Figure 5.9 Supplementation with exogenous fatty acids does not change
ER appearance in untreated cells
A) Quantification of incidence of indicated ER phenotypes in cells treated as
indicated. n = number of cells, N = 3 experimental repeats. Mean + SD shown. P
values, Chi squared tests of total incidences. Data are taken from the same dataset
as Figure 5.8A-B, including the DMSO controls from 5.8B.
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Figure 5.10 Depletion of SREBP1 partially suppresses expansion of ER
membranes
A) Representative immunoblot of whole cell lysates from cells treated as indicated
with indicated antibodies. Unprocessed SREBP1 is shown. B) Spinning disk
confocal microscopy images of GFP-KDEL transiently expressed in U2OS cells
treated with the indicated siRNAs. Scale bars, 10 µm. C) Quantification of
incidence of expanded ER phenotype in cells from (B). n = number of cells, N = 3
experimental repeats. Mean ± SD shown. P value, Fisher’s exact test of total
incidences.
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Figure 5.11 Depletion of SREBP1/2 partially suppresses expansion of ER
membranes
A) Representative immunoblots of whole cell lysates from cells treated as indicated
with indicated antibodies. Unprocessed SREBP1 and SREPB2 are shown. B)
Spinning disk confocal microscopy images of GFP-KDEL transiently expressed in
U2OS cells treated with the indicated siRNAs. Scale bars, 10 µm. C) Quantification
of incidence of expanded ER phenotype in cells from (B). n = number of cells, N =
3 experimental repeats. Mean ± SD shown. P value, Fisher’s exact test of total
incidences.
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Figure 5.12 Depletion of SCD partially suppresses expansion of ER
membranes and leads to perinuclear ER puncta formation
A) Immunoblot of whole cell lysates from cells treated as indicated with indicated
antibodies. B) Spinning disk confocal microscopy images of GFP-KDEL transiently
expressed in U2OS cells treated with the indicated siRNAs. Scale bars, 10 µm.
Perinuclear ER punctae are shown with red arrows. C) Quantification of incidence
of expanded ER phenotype in cells from (B). n = number of cells, N = 3
experimental repeats. Mean ± SD shown. P value, Fisher’s exact test of total
incidences. D) Quantification of incidence of perinuclear ER punctae phenotype in
cells from (B). n = number of cells, N = 3 experimental repeats. Mean ± SD shown.
P values, Fisher’s exact tests of total incidences.
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Figure 5.13 Inhibition of acetyl-CoA carboxylase rescues nuclear solidity of
CTDNEP1KO cells
A) Plot of solidity of nuclei (n) of cells treated with DMSO or 10 μM TOFA for 24
hrs. N = 3 experimental repeats. Individual values and means ± SD shown. P
value, paired t test of replicate means. B) Quantification of incidence of solidity less
than 1 SD from the mean of control nuclei solidity. n = number of nuclei, N = 3
experimental repeats. Mean ± SD shown. P value, Fisher’s exact test of total
incidences.
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Figure 5.14 Partial suppression of nuclear solidity rescue with acetyl-CoA
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carboxylase inhibition in CTDNEP1KO cells with fatty acid supplementation
A) Epifluorescence images of DAPI/Hoechst staining in cells treated as indicated
with fatty acid-free BSA or fatty acid-free BSA conjugated to 100 μM 1:2:1
palmitic:oleic:linoleic acid and DMSO or 10 μM TOFA for 24 hrs. Scale bar 10 μm.
B) Plots of solidity of nuclei (n) of cells treated as indicated. N = 3 experimental
repeats. Individual values and means ± SD shown. P values, repeated measures
ANOVA with post-hoc Šidák’s multiple comparisons test. C) Quantification of
incidence of solidity less than 1 SD from the mean of control U2OS nuclei solidity.
n = number of cells from N = 3 experimental repeats. Means ± SDs shown. P
values, Fisher’s exact tests of total incidences.

Figure 5.15 Inhibition of acetyl-CoA carboxylase suppresses formation of
micronuclei in CTDNEP1KO cells
A) Quantification of incidence of micronuclei in cells treated with DMSO or 10 μM
TOFA for 48 hrs. n = number of cells from N = 3 experimental repeats. Means ±
SDs shown. P value, Fisher’s exact test of total incidences.
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Figure 5.16 Inhibition of acetyl-CoA carboxylase suppresses hypermicronucleation in CTDNEP1KO cells upon recovery from transient spindle
disassembly
A) Schematic detailing nocodazole washout with TOFA treatment. B)
Epifluorescence (DAPI/Hoechst) and confocal (emerin) images of immunostained
cells treated with 10 μM TOFA or DMSO for 24 hrs (total) and subjected to
nocodazole washout as shown. Scale bar 10 μm. C) Quantification of incidence of
indicated phenotypes in cells treated as shown. n = number of cells from N = 3
experimental repeats. Means ± SDs shown. P value, Chi squared test of total
incidences
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Figure 5.17 Mechanisms for expansion of ER membranes in CTDNEP1KO
cells
A) Schematic of showing how control of fatty acid synthesis by CTDNEP1/lipin 1
mediated by SREBP1 target gene expression can feed into ER membrane
synthesis. B) Schematic showing how increased expression of SREBP1 target
genes (“1.”), increased flux into fatty acid and ER membrane lipid synthesis (“2.”,
“4.”), and impacts on lipid breakdown (“3.”) can lead to increased ER membrane
biogenesis in cells lacking CTDNEP1 (“5.”).
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Figure 5.18 Excess membranes in CTDNEP1-depleted cells impact mitotic
error correction to lead to formation of micronuclei
A) Schematic showing how excess ER membranes in CTDNEP1KO cells caused
by insufficient dephosphorylation of mTOR phosphorylation sites on lipin 1 disrupts
mitotic error correction to lead to formation of micronuclei. Dark green = nuclear
envelope; light green = ER; pink = DNA, and blue = mitotic spindle. In insets,
chromosomes are gray and opposite kinetochores are orange and dark blue.
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Chapter 6: Conclusions and Future Perspectives
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Human CTDNEP1’s role in regulating lipid synthesis, ER membrane
biogenesis, and nuclear morphology
Lipid synthesis is important for organelle maintenance, cell growth, and
division, yet regulation of lipid synthesis in human cells is not fully understood.
This work has elucidated some of the functions of CTDNEP1 in controlling ER
lipid synthesis in human cells. We have established that human CTDNEP1
restricts synthesis of PC and PE to limit ER membrane biogenesis through
dephosphorylation of lipin 1 (Figure 6.1). Without CTDNEP1, lipin 1 is less able
to repress SREBP-dependent fatty acid synthesis gene transcription, and flux
into fatty acid and membrane lipid synthesis is increased (Figure 6.1). These
mechanisms lead to the expansion of ER membranes in CTDNEP1-depleted
cells.
An important future direction for determining how CTDNEP1 limits ER
membrane biogenesis will be determining the mechanism for how flux into
PC/PE is increased with CTDNEP1 deletion in human cells (Figure 6.1). One
aspect of this regulation that is known is that Mg2+-independent PAP activity is
increased in CTDNEP1KO U2OS cells, likely to compensate for decreased Mg2+dependent PAP activity that also occurs (Merta et al., 2021) (finding by Mitchell
E. Granade). Mammalians have 3 lipin genes, and these lipins are known to
compensate for each other in mice by increased expression of the other lipins
when one is depleted, although this can depend on tissue specific-lipin
expression (Grimsey et al., 2008; Gropler et al., 2009). While loss of CTDNEP1
can potentially limit activation all lipins, negating the effect of lipin-lipin
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compensation, it is known that the PAP activities of lipin 2 and lipin 3 are
unaffected by phosphoregulation (Boroda et al., 2017; Eaton et al., 2013). Thus,
PAP activity of lipins 2 and 3 may continue conversion of PA to DAG in the
absence of lipin 1 activation by CTDNEP1 to help shunt fatty acids into ER
membrane lipids. As a whole, PAP activity not dependent on lipin 1 could
contribute to increased membrane biogenesis in CTDNEP1-depleted cells
(Figure 6.1).
Another possibility for how CTDNEP1 limits flux of fatty acids into ER
membrane biogenesis might be regulation of CCTα activity (Figure 6.1). The
increase in PC and PE in CTDNEP1KO cells points to the possibility that CCTα
activity may be increased with loss of lipin activity as in A. thaliana cells
(Craddock et al., 2015). It is unclear if such activation would occur through PA
activating CCTα or a more general sensing of membrane packing with increased
fatty acid synthesis. Measuring CDP-choline output in CTDNEP1KO cells would
help determine if CCTα activity is increased to raise PC synthesis. Other
possibilities for how CTDNEP1 limits the flux of fatty acids into PC and PE could
be regulation of fatty acid uptake by the cell or negative regulation of other
processes that lead to breakdown of lipids, like lipophagy and autophagy in
general. Determining the extent of these activities and measuring expression of
related genes will elucidate their involvement in control of ER membrane
biogenesis by CTDNEP1 and lipin 1.
One remaining question is whether lipid breakdown is regulated by
CTDNEP1/lipin 1 in human cells (Figure 6.1). It is known that lipin 1 can
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positively regulate PPARα-mediated transcription to upregulate fatty acid
oxidation genes in mouse liver cells (Finck et al., 2006). Lipin deficiency in
humans causes symptoms that closely resemble those of fatty acid oxidation
disorders (Knottnerus et al., 2018; Zeharia et al., 2008). I previously showed that
PPARα binding-deficient lipin 1 can still rescue ER membrane expansion in
CTDNEP1KO cells (Figure 2.15). In order to determine whether CTDNEP1 limits
lipin 1 activation of lipid oxidation gene transcription, future studies should test for
the expression of these genes, which include fatty acid transporters and fatty
acid-metabolizing enzymes, in CTDNEP1KO cells and determine if
overexpression can suppress ER membrane expansion.
CTDNEP1’s control of nuclear morphology is also dependent on control of
fatty acid synthesis— multilobed nuclear morphology in CTDNEP1KO cells is
suppressed by inhibiting fatty acid synthesis. Future experiments should
determine to what extent nuclear envelope morphology is established during
nuclear envelope reassembly as opposed to remodeling during interphase.
Future experiments can also determine if there is an interaction between
CTDNEP1 control of lipid synthesis and other players in establishing nuclear
envelope structure, such as the nuclear lamina, nuclear sealing, and connections
to the cytoskeleton.
How the study of CTDNEP1 has informed our knowledge of how membrane
dynamics in mitosis are important for chromosome segregation
This work uncovers a previously unknown role for CTDNEP1 in regulating
mitotic error correction to limit formation of micronuclei. We show that CTDNEP1
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limits ER membrane biogenesis to restrict ER membrane abundance in mitosis
(Figure 6.2). With intact CTDNEP1, ER membrane abundance is limited in
interphase and mitosis, and ER membranes can properly clear from the mitotic
spindle and chromosomes (Figure 6.2, “Control”). Mitotic error correction can
proceed as normal, and nuclear envelope assembly ensures formation of single
nuclei of the correct size and shape (Figure 6.2, “Control”). Without CTDNEP1,
ER membranes are expanded due to increased membrane lipid synthesis, and
ER membrane expansion persists through mitosis, when cytoplasmic viscosity is
also increased (Figure 6.2, “Loss of CTDNEP1”). Consistent with findings in other
organisms, expanded membranes in CTDNEP1-depleted human cells are less
cleared during prometaphase. Prometaphase chromosome average velocity is
also decreased, consistent with a prometaphase delay seen in other studies and
corroborated in this study. Merotelic kinetochore attachment errors are less able
to be corrected in CTDNEP1-depleted cells, contributing to formation of
micronuclei (Figure 6.2, “Loss of CTDNEP1”). We propose that cytoplasmic
viscosity and less cleared membranes limit chromosome movements, which in
turn limits merotelically attached chromosomes from rotating to promote error
correction, which then leads to the formation of micronuclei. Additionally,
CTDNEP1-depleted cells are less able to limit membrane extensions from
forming inside of nuclei during mitotic exit and to limit nuclear expansion (Figure
6.2, “Loss of CTDNEP1”). Thus, CTDNEP1 controls ER membrane biogenesis
and membrane dynamics to promote mitotic error correction that limits formation
of micronuclei.
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Connecting lipid synthesis to chromosomal instability in cancer through
CTDNEP1
Cancer cells frequently exhibit increased lipid synthesis and are prone to
forming micronuclei, and these are conventionally thought to be separately
occurring events. This work establishes a case in which formation of micronuclei
depends on the extent of membrane lipid synthesis, with the deletion of a gene
that is commonly mutated in medulloblastoma, CTDNEP1.
Our work shows that cells deleted of CTDNEP1 have upregulation of
SREBP1-target fatty acid synthesis genes that are frequently upregulated in
cancer. We show that increased fatty acid synthesis feeds into membrane lipid
synthesis, which interferes with mitotic progression and error correction. We
propose a mechanism for formation of micronuclei via improperly cleared and
more abundant membranes contributing to higher cytoplasmic viscosity, all of
which reduces chromosome motions to impede kinetochore attachment error
correction.
CTDNEP1 truncating mutations occur frequently in Group 3
medulloblastoma, a subgroup associated with young age at presentation and
poor prognosis (CTDNEP1 frameshift, premature stop single-nucleotide
variations, or splice site-altering mutations in 5% of cases) (Jones et al., 2012;
Northcott et al., 2012, 2017). CTDNEP1 mutations primarily occur in the absence
of known driver mutations in Group 3 medulloblastomas, including amplification
of the pro-growth transcription factor MYC (Northcott et al., 2017) and
homozygous tumor suppressor p53 deletion (Jones et al., 2012). At the same

171

time, CTDNEP1 mutations occur with loss of heterozygosity at 17p, where
CTDNEP1 and TP53 reside (Jones et al., 2012). It is possible that loss-offunction mutations in a cell with one copy of CTDNEP1 would lead to increased
lipid synthesis that supports cancer cell proliferation, along with decreased
mitotic error correction leading to formation of micronuclei. These characteristics
could contribute to cancer progression that leads to poor prognoses in the Group
3 medulloblastoma subgroup.
An alternative hypothesis is that CTDNEP1 could control phosphorylation of
substrates besides lipin 1. CTDNEP1 was identified in Xenopus embryos as a
gene required for neural development through negative regulation of bone
morphogenic protein (BMP) signaling (Satow et al., 2002). BMP signaling in this
case occurs when BMP binds to its plasma membrane receptor, which then
phosphorylates Smads, which then bind other Smads and enter the nucleus to
act as transcription factors for genes important for tissue development (Derynck
and Zhang, 2003). Later studies implicated CTDNEP1 in limiting phospho-Smad
abundance in kidney, bone, and heart tissues in Xenopus and mice (Darrigrand
et al., 2020; Hayata et al., 2015; Sakaguchi et al., 2013). Evidence suggests that
CTDNEP1 dephosphorylates Smad in Drosophila, but direct evidence of
phosphorylation of Smads by CTDNEP1 is lacking in other organisms (Urrutia et
al., 2016). The well-characterized role of CTDNEP1 in regulating lipid synthesis
also needs to be ruled out in these developmental contexts, as lipid composition
of membranes can impact cell signaling (Sunshine and Iruela-Arispe, 2017).
CTDNEP1 does not control BMP signaling in all tissues; in mouse primordial
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germ cells, CTDNEP1 does not regulate BMP/Smads (Tanaka et al., 2013). In
human medulloblastomas, BMP signaling can be upregulated or downregulated,
though the reason for this is unclear (Caja et al., 2015). It is possible that loss of
CTDNEP1 leads to attenuation of BMP signaling that might contribute to cancer
development, although the mechanism for this may not be straightforward. At the
same time, we have shown that key phenotypes associated with cancer in
CTDNEP1-depleted cells are suppressed with lipin 1 dephospho-mimic
overexpression, which is consistent with the idea that CTDNEP1’s role in cancer
is more related to its role in controlling lipid synthesis. Future studies of
CTDNEP1 in cancer will clarify if there are multiple roles for CTDNEP1 in
controlling cancer progression.
These findings suggest the existence of a paradox between regulation of cell
metabolism and chromosomal instability. Limiting membrane synthesis limits a
cell’s ability to proliferate, but these data show that it also appears to limit
chromosomal instability, which is detrimental to cell survival at high levels (Giam
and Rancati, 2015; Sansregret et al., 2017). Why do cancer cells frequently
exhibit upregulation of lipid synthesis if it could confer a survival disadvantage? It
is possible that this is the case merely because the benefit of increased
proliferation overcomes any negative aspects of increased lipid synthesis. It has
also been proposed that mechanisms that promote chromosomal instability at a
low level are adaptive for cancer cells because they provide tolerable levels of
chromosome missegregation that promote genetic heterogeneity (Giam and
Rancati, 2015). I propose that the solution to this paradox in cancer cells lacking
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functional CTDNEP1 is that cells having increased membrane lipid synthesis that
can support proliferation subsequently have increased genetic heterogeneity that
is adaptive for tumor progression. This conclusion strengthens the case for
CTDNEP1 as a candidate tumor suppressor in Group 3 medulloblastomas.
Remaining Questions and Future Directions
We have shown that increased lipid synthesis producing excess ER
membranes can change the physical properties of the cytoplasm in mitotic cells.
What remains to be seen is whether cytoplasmic viscosity is also increased in
interphase cells, or whether other properties of the cytoplasm are changed as
well. It will be interesting to know how ER taking up more space in the cytoplasm
to increase cytoplasmic viscosity impacts more cell functions, like movements of
organelles and the cytoskeleton.
The fatty acid makeup of membranes in CTDNEP1-depleted cells has not
been studied, as our lipidomic analysis did not include subspecies fatty acid
chain information. The length and saturation of fatty acids in membrane lipids
greatly impacts the physical properties of the membrane, so it will be important to
determine the impact of fatty acid composition in excess membranes in cells
lacking CTDNEP1. Desaturation of membrane fatty acids is associated with
membrane fluidity; perhaps more Δ9-unsaturated fatty acids with SCD
upregulation in CTDNEP1KO cells could make expanded ER membranes more
fluid and less able to be cleared to the cell periphery in mitosis.
Lipid synthesis in the ER generates membrane lipids for other organelles
and performs biogenesis of peroxisomes and lipid droplets (Holthuis and Menon,
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2014; Thiam et al., 2013; van der Zand et al., 2012). One remaining question is
whether increased membrane biogenesis in the ER of CTDNEP1-depleted cells
leads to increased size or altered composition of other organelles. Future studies
should examine the appearance and function of organelles— like mitochondria,
endosomes and lysosomes, peroxisomes, lipid droplets, and the plasma
membrane— that derive lipids from the ER.
A major future direction for studying roles of CTDNEP1 in human cells will
be to characterize CTDNEP1 structure and functions on the molecular level. One
important step will be to optimize purification of CTDNEP1 for antibody synthesis
and in vitro dephosphorylation assays. Further, another important future direction
will be to determine all proteins that are dephosphorylated by CTDNEP1 by
proteomic analysis. Proteins that are determined to be more phosphorylated in
the absence of CTDNEP1 can be verified by in vitro dephosphorylation of
peptides or purified proteins. If they are not directly dephosphorylated by
CTDNEP1, one can determine if their dephosphorylation occurs as a result of
limiting lipid synthesis by targeting lipin 1 or overexpressing/knocking down
SREBP1 target genes. CTDNEP1 has a putative transmembrane domain in its N
terminus; domain-mutation analyses can determine if its transmembrane
domains and certain residues (outside of the active site) are important for lipin
dephosphorylation, targeting to the nuclear envelope and ER, and binding with
NEP1R1.
Finally, more studies should be performed to elucidate further how control
of lipid synthesis controls formation of micronuclei. As mentioned previously,
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tracking membranes in cells in which fatty acid synthesis has been shut off can
determine if decreasing membranes in mitosis limits chromosome
missegregation. Nocodazole washout leads to increased formation and
persistence of merotelic attachments, but upstream of this phenomenon is
delayed spindle bipolarity and possible imbalance between contributions of
centrosome-nucleated and chromosome-nucleated microtubules to the spindle
(Gregan et al., 2011; Silkworth and Cimini, 2012). Future experiments can
determine if these upstream events can contribute to chromosome
missegregation in ways other than by increasing merotelic attachments, such as
by disrupting spindle architecture. Analyses of kinetochore architecture during
nocodazole washout in mitotic exit in CTDNEP1KO cells can confirm that lagging
chromosomes are due to merotelic kinetochore attachments. These studies can
also determine how many chromosomes are contained in nuclei that are not the
primary nucleus in hyper-micronucleated cells. Average chromosome velocity is
slower in prometaphase CTDNEP1KO cells; this may reflect slower chromosome
diffusion in viscous cytoplasm in the presence of uncleared membranes, but it
could also reflect slower spindle microtubule motions. Further studies of live
imaging of tubulin can also determine how mitotic spindle growth and movements
are affected by the presence of excess ER membranes in mitotic cells depleted
of CTDNEP1. These studies can cement the role of regulating membrane
biogenesis in controlling chromosome segregation, which will help our
understanding of how these events are misregulated in human cancers.
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Conclusion
These data have implicated control of membrane lipid synthesis by the lipin 1
phosphatase CTDNEP1 to control of mitotic error correction to ensure mitotic
fidelity. This finding represents the first connection between alterations in lipid
synthesis that can occur in cancer and formation of micronuclei that also
contribute to cancer progression. These findings and future studies will enlighten
our understanding of how control of cell metabolism is orchestrated with mitotic
events to allow controlled cell division.
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Figure 6.1 Mechanisms for increased ER membrane lipid synthesis with
loss of CTDNEP1
Schematic of how CTDNEP1 control of lipin 1 at the nuclear envelope controls
ER membrane biogenesis. With loss of CTDNEP1, lipin 1 is less abundant and
less active, yet multiple mechanisms feed into increased PC/PE synthesis that lead
to increased membrane biogenesis. Black boxes, mechanisms increasing
membrane biogenesis established in this work. Blue boxes, putative mechanisms
for how DAG-derived lipids are increased with less lipin 1 activity.
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Figure 6.2 CTDNEP1 limits ER membrane abundance to promote proper
nuclear assembly
Schematic for how increased ER membrane biogenesis in the absence of
CTDNEP1 leads to abnormal nuclear assembly and formation of micronuclei. ER
membranes, light green; nuclear envelope, dark green; Centrosomes and spindle
microtubules, blue; DNA, pink.

179

Materials and Methods
Mammalian cell lines
U2OS and RPE-1 cells were obtained from ATCC or the source specified. Cells
were grown at 37°C in 5% CO2 in DMEM low glucose (Gibco 11885) (U2OS), or
DMEM:F12+HEPES (Gibco 113300)(RPE-1) supplemented with 2 mM Lglutamine (Sigma 59202C) (RPE-1) supplemented with 10% heat inactivated FBS
(F4135) and 1% antibiotic-antimycotic (Gibco 15240112). Cells were cultured
without antibiotics during transfections, RNAi, and treatments for experiments.
Cells were used for experiments before passage 30 (20 for RPE-1). Cells were
tested for mycoplasma upon initial thaw and generation of new cell lines (Southern
Biotech 13100-01), and untreated cells were continuously profiled for
contamination by assessment of extranuclear DAPI/Hoechst 33258 staining.
U2OS IBB-GFP H2B-mCherry was generated by transfection of the plasmids using
Lipofectamine 2000 (Thermo Fisher Scientific 11668), then plated into 10 cm
dishes at ~100 cells per dish. Dishes were treated with 2 ug/ml puromycin and 400
ug/ml G418 in antibiotic-free media for 1.5-2 weeks until visible colonies of >100
cells formed. Non-overlapping colonies were isolated using sterile filter paper discs
(Bel-Art F37847-0001) dipped in 0.25% trypsin-EDTA (Sigma 59428C or Gibco
25200) and applied to colonies for 30 s after washing dish with PBS. Isolated
colonies were grown in 24 well plates under 1 ug/ml puromycin and 200 ug/ml
G418 selection until confluent, after which colonies were imaged for fluorescence,
expanded, and frozen down.
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To generate U2OS GFP-Sec61β H2B-mCherry, U2OS GFP-Sec61β were
transfected with H2B-mCherry-IRES-puro2v2.0 for 48 hours, then plated into 10
cm dishes at <100 cells/ml and selected with 0.5 μg/ml puromycin for 2 weeks.
Colonies were trypsinized and picked with 1/8 in sterile cloning discs (Bel-Art
F37847-0001) and grown to confluence in a T25 flask before imaging confirmation
of marker expression.
Transfection and RNAi
Most transfections were performed with Lipofectamine 2000 (Thermo Fisher
Scientific

11668)

in

Opti-MEM

(Gibco

31985)

using

a

1:2

ratio

of

DNA:lipofectamine with DNA concentrations ranging from 0.05-0.3 μg DNA per
cm2 of growth surface. Briefly, DNA and lipofectamine were added to 10 μl
OptiMEM per cm2 of growth surface in separate borosilicate glass tubes (Thermo
Fisher Scientific STT-13100-S). After 5 minutes incubation, DNA solution was
added to lipofectamine solution. After 15 minutes, DNA:lipofectamine mix was
added dropwise to cells plated 16-24 hrs prior to transfection in fresh antibioticfree media (1 ml/9.6 cm2 growth surface). Media was exchanged for antibiotic-free
media after 6 hours. To increase transfection efficiency, plasmids used for live
imaging were purified using the Zymopure II Plasmid Midi Prep kit, including a 10
min final elution at 56°C and use of the Zymopure endotoxin removal columns.
Transfections for lipin 1 overexpression were performed using PolyJet in vitro DNA
transfection reagent (Signagen SL100688) using a 1:3 ratio of DNA:Polyjet using
0.1 μg DNA per cm2 of growth surface. Protocol is identical to previous transfection
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protocol except for using 5 μl OptiMEM per cm2 of growth surface for mixes and
no incubation before mixing reagents.
For experiments involving transient CTDNEP1 and/or NEP1R1 overexpression,
pcDNA3.0 was used as an empty vector negative control. For experiments
involving phenotype rescue with transient FLAG-lipin 1β construct overexpression,
GFP-KDEL was used as a co-transfection marker, and untransfected cells within
the same experiment were used as a negative control for effects of lipin 1β
overexpression.
RNAi was performed using Dharmafect 1 (Horizon Discovery T-2001) in Opti-MEM
according to the manufacturer’s protocol. U2OS Sec61β/H2B-mCherry and U2OS
IBB-GFP/H2B-mCherry were treated with 40 nM CTDNEP1 single siRNA
(Dharmacon) or Ambion Silencer negative control 1 for 48 hours; all others were
treated with 20 nM CTDNEP1 siGENOME SMARTpool or control pool #2 siRNA
(Horizon Discovery) for 72 hours.
For RTN1/RTN3 knockdown, cells were treated with either 80 nM Ambion Silencer
Select negative control #1 siRNA or 40 nM both Silencer Select RTN1 siRNA and
Silencer Select RTN3 siRNA for 48 hours.
For SREBP1 or SCD knockdown, cells were treated with 20 nM Silencer Select
negative control #1 siRNA or 20 nM Silencer Select SREBP1 or SCD siRNA for 72
hours. For SREBP1/2 knockdown, cells were treated with 40 nM Silencer Select
negative control #1 siRNA or 20 nM both Silencer Select SREBP1 siRNA and
Silencer Select SREBP2 siRNA for 72 hours.
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RNAi knockdown efficiency was determined by qPCR or immunoblot analysis or
by presence of expanded ER sheets in the RTN4KO RTN1/3 knockdown.
CRISPR/Cas9 genome editing
All guide RNA sequences were designed using the online CRISPR tool
http://crispr.mit.edu and reported no off-target matches. Nup160EN-Halo:
CACGGGATTTATTATATCGT
CTDNEP1EN-GFP:

RTN4KO:

CGTTCAAGTACCAGTTCGTG

GGGCATCAGACGGCATCCCA

CTDNEP1KO:

ATGAAGTCAGGAGGCGTACC. The guide RNA sequences were synthesized as
two oligos with BbsI overhangs and an additional guanidine base 5’ to the
protospacer sequence, and the oligos were phosphorylated with calf alkaline
intestine phosphatase (New England BioLabs #M0290) and annealed by heating
to 95°C and cooling to room temperature. The annealed oligos were cloned into
pSPCas9(BB)-2A-Puro (PX459) v2.0 (a gift from Feng Zhang, Addgene plasmid
#62988) that had been digested with BbsI-HF (New England BioLabs #R3539).
For generation of KO cell lines, the vectors were transfected into U2OS cells using
Lipofectamine 2000 and selected with 3 ug/ml puromycin (Invitrogen) for 48 hours.
The remaining cells were grown up and gDNA isolated from the bulk population
using a QiaAmp DNA Mini kit (Qiagen 51304). Genotyping was performed by
sequencing

and

screening

for

indels

using

TIDE

deconvolution

(https://www.deskgen.com/landing/tide.html) (Brinkman et al., 2014). Once indels
were detected in the bulk population, the cells were plated at <100 cells/ml into 10
cm dishes (RTN4KO) or 96 well plates (CTDNEP1KO) and grown in antibiotic-free
DMEM with 10% FBS for 2 weeks. Colonies were trypsinized and picked with 1/8
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in sterile cloning discs (Bel-Art) if in 10 cm dishes. Colonies were grown in 24-well
plates until more than 10,000 cells could be harvested for gDNA sequencing and
TIDE analysis to genotype for frameshift mutations. The RTN4KO clonal cell line
used in experiments showed to have -5bp deletions in >80% of alleles and 0% WT
alleles as determined by TIDE deconvolution of sequencing and showed no
expression of RTN4 by immunofluorescence (antigen is upstream of indel). The
CTDNEP1KO clonal cell line used in experiments showed to have +1 insertions in
>80% of alleles and 0% WT alleles as determined by TIDE deconvolution. The
homology-directed repair template for Nup160EN-Halo was generated to add a 5glycine linker and HaloTag7 sequence to the 3’ end of the NUP160 gene, fusing
Halo to the C terminus of all NUP160 isoforms. The HDR template was engineered
using a 4-piece Gibson assembly: 1) the vector backbone was EGFP-N1
(Clontech) amplified with oligos (listed below) so that the CMV promoter, MCS,
and GFP sequence had been removed; 2) the left homology arm was an IDT
gblock containing 800 bp upstream of the NUP160 stop codon with a silent
mutation

to

the

PAM

sites

of

1

potential

guide

RNA

and

a

GGAGGCGGCGGCGGC linker and was flanked by 20-bp overhangs that
overlapped with the EGFP-N1 backbone and HaloTag7; 3) HaloTag7 was
amplified from Halo-N1 using oligos listed below (a silent mutation in aspartic acid
was included in the forward primer to facilitate amplification of the gene); 4) the
right homology arm was an IDT gblock containing 800 bp downstream of the
NUP160 stop codon with 2 point mutations in the PAM sites of potential guide
RNAs that was flanked by 20-bp overlap with HaloTag7 and the EGFP-N1
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backbone. The CTDNEP1EN-GFP homology-directed repair template was
generated to add a 6-glycine linker and GFP sequence to the 3’ end of the
CTDNEP1 gene, fusing GFP to the C terminus of all CTDNEP1 isoforms. The HDR
template was engineered using a 4-piece Gibson assembly: 1) the vector
backbone was EGFP-N1 (Clontech) amplified with oligos (listed below) so that the
CMV promoter, multiple cloning site, and GFP sequences had been removed; 2)
the left homology arm was an IDT gblock containing 800 bp upstream of the
CTDNEP1 stop codon with silent mutations to the PAM sites of 2 potential guide
RNAs and a GGTGGCGGTGGCGGTGGC linker and was flanked by 20-bp
overhangs that overlapped with the EGFP-N1 backbone and GFP; 3) GFP was
amplified from EGFP-N1 using oligos listed below 4) the right homology arm was
an IDT gblock containing 800 bp downstream of the CTDNEP1 stop codon with 2
point mutations in the PAM sites of potential guide RNAs that was flanked by 20bp overlap with GFP and the EGFP-N1 backbone.
To make endogenously tagged cells, the PX459v2.0 vector containing the guide
sequences and the HDR templates were transfected into U2OS cells using
Lipofectamine 2000 and treated with 3 ug/ml puromycin (Invitrogen) in antiobioticfree media for 48 hours. The remaining cells were sorted for the top 1-2% of
fluorescent cells (Nup160EN-Halo cells were labeled with HaloTag TMR ligand
(Promega). The sorted cells were plated at <100 cells/ml into 10 cm dishes, grown
in antibiotic-free media for 2 weeks. Colonies were trypsinized and picked with 1/8
in sterile cloning discs (Bel-Art F37847-0001) and grown to confluence in a T75
flask, after which the gDNA was harvested using a Qiagen QiaAmp Mini kit.
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For Nup160EN-Halo clones, the Nup160 region was amplified with combinations of
primers 1, 2, and 3 to determine correct placement, orientation, and presence of
wild-type alleles in clonal cell lines. Protein lysates of the bulk and clonal
populations were run on an 8% polyacrylamide gel and transferred to a
nitrocellulose membrane for western blot with rabbit anti-HaloTag (Promega
#G9281) to confirm that the tagged protein is full-length.
For CTDNEP1EN-GFP clones, the CTDNEP1 region was amplified with the
specified primer pairs to determine correct placement, orientation, and presence
of wild-type alleles in clonal cell lines. Regions were additionally amplified and
sequenced with the specified primers. Clone 1 used for experiments showed
minimal

presence

of

wild-type

CTDNEP1

sequences

in

sequencing

chromatograms. CTDNEP1EN-GFP cells treated with 20nM of CTDNEP1 siRNA
for 48 hours also show reduced nuclear envelope GFP fluorescence compared to
control siRNA-treated CTDNEP1EN-GFP cells (data not shown).
Plasmid generation
GFP-KDEL was modified from pDsRed2-ER (Clontech), which contains a signal
peptide and ER retention sequence (KDEL), by PCR of GFP with AgeI and HindIII
sites, digestion of the insert and pDeRed2 with AgeI/HindIII (NEB R0552, R3104),
and ligation. CTDNEP1-HA was modified from CTDNEP1-v5-His (Han et al.,
2012). pRK5 FLAG-lipin 1β 19xA PAP dead was modified from pRK5 FLAG-lipin
1β 19xA using Quickchange Mutagenesis to make the following mutations: D712E,
D714E. For pRK5 FLAG-lipin 1β-NLS and -NES, the NLS of nucleoplasmin or NES
of PKIα were appended to the C terminus of lipin 1β using In-Fusion (Takara Bio).
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Lipidomics
Early-passage cells were counted by hemocytometer, suspended in PBS at a
concentration of 3x106 cells/ml, and flash frozen in liquid nitrogen. Triplicate
samples were submitted for each condition. When noted, corresponding triplicate
samples were lysed and protein extracted and protein concentration determined
by Pierce BCA assay. Sample processing and lipidomics were performed and
obtained at Lipotype GmbH. Samples were spiked with lipid class internal
standards, and lipids were extracted using chloroform-methanol extraction using a
Hamilton Robotics STARlet. Samples were infused using an Advion Triversa
Nanomate automated nano-flow electrospray ion source with positive and negative
ion mode utilized. Mass spectra were acquired using a Thermo Scientific QExactive hybrid quadruple/Orbitrap mass spectrometer in MS-only mode and
tandem MS mode. Lipid species were identified using LipotypeXplorer, and data
was processed using Lipotype LIMS and LipotypeZoom. Lipid class pmols/mg
protein was determined using protein concentration and sample volume analyzed
from each replicate.
Mitotic shakeoff, micronuclei enrichment, and small molecule inhibitor
treatment
For mitotic shakeoff, cells were grown to at least 50% confluence in 75 cm2 flasks.
Cells were washed with PBS or antibiotic-free media to clear debris, then flasks
were whacked repeatedly on all sides and tapped on the bottom surface with a
reflex hammer (DR Instruments S72118) until at least 50% of mitotic cells were
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dislodged. The cell media was collected and centrifuged at 300xg for 5 min, then
cells were additionally washed or plated.
For nocodazole washout, cells at 50-80% confluence in 75 cm2 flasks were
washed with 37°C PBS to clear debris and then treated with 100 ng/ml nocodazole
(Sigma M1404) in antibiotic free media for 6 hours (Liu et al., 2018). Cells were
subject to mitotic shakeoff without washing, then washed 3x with 37°C PBS. After
the final wash, cells were plated onto acid-washed coverslips (coated with 1 ug/ml
poly-D-lysine (Sigma P7886) for short-term washout) and incubated for 45 min-60
min (short-term) or 18-20 hours (long-term) before immunofluorescence
processing.
For RO-3306/MPS1i micronuclei enrichment, cells were treated with 9 μM RO3306 (Calbiochem 217699) for 19 hours, washed 7 times, then treated with 1 μM
NMS-P715 (MPS1i) (Calbiochem 475949) for 18 hours before processing for
immunofluorescence (Liu et al., 2018). Ki values mentioned above were obtained
from Calbiochem.
For imaging cells arrested at the G2/M transition, cells in ibidi 8 well plates were
treated with 9 μM RO-3306 for 18-20 hours and washed 7 times with Fluorobrite
DMEM + FBS on the microscope stage, then imaged immediately.
Fatty acid synthesis inhibition and fatty acid supplementation
To inhibit fatty acid synthesis, cells were treated with 10 μM TOFA (Cayman Chem)
in DMSO. Cells were treated with TOFA for 24 hours with or without fatty acid
supplementation for ER and nucleus visualization or for 5-48 hours for ER
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visualization over time. Cells were treated with TOFA for 48 hours for micronuclei
quantification.
For fatty acid supplementation, cells were plated at a density of 200,000 cells/ml
in 6 well plates. Stocks of oleic acid, linoleic acid, and palmitic acid were made in
methanol and pipetted into a 50 ml conical vial, then dried with an ambient air
stream. Pre-warmed DMEM containing 0.5% fatty acid-free BSA (Sigma
Cat#A8806) was added to a final concentration of 25 μM palmitic acid, 50 μM oleic
acid, and 25 μM linoleic acid (100 μM total fatty acid concentration; 1:2:1 ratio of
palmitic:oleic:linoleic acid). The solution was incubated at 37°C for 30 min, then
held to the bottom of a sonicating bath for 30 s, then incubated at 37°C for 10 min
until solution was clear. FBS was added to a final concentration of 10% v/v. Cells
were treated with DMEM with 10% FBS and 0.5% BSA alone or DMEM with 10%
FBS 0.5% BSA, and 100 μM fatty acids with DMSO or 10 μM TOFA in DMSO for
24 hrs prior to immunofluorescence processing.
Quantitative real-time PCR
RNA was harvested using the RNeasy Mini kit (Qiagen 74104) using the
manufacturer’s protocol, using Qiashredder columns (Qiagen 79654) for tissue
homogenization and with additional RNase-free DNase (Qiagen 79254) treatment
after the first RW1 wash and subsequently adding another RW1 wash. RNA was
eluted with RNAse-free water and diluted to 50 ng/μl. RNA was subject to reverse
transcription using the iScript Reverse Transcription Supermix (Bio-Rad 1708840)
with 400 ng RNA per reaction. The subsequent cDNA was diluted 1:5 for RTqPCR. cDNA was analyzed for RT-qPCR using the iTaq universal SYBR Green
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Supermix (Bio-Rad 1725120). Cycle threshold values were analyzed using the Δ
ΔCt method. Statistical testing was performed on ΔCt values.
Immunofluorescence
Cells were washed 2x with warm PBS and fixed in 4% paraformaldehyde (+0.1%
glutaraldehyde for ER structure analyses) in PBS for 15 min, permeabilized in
0.5% Triton X-100 for 5 min, then washed 3 times with PBS and blocked in 3%
BSA in PBS for 30 min. Samples were transferred to a humidity chamber and
incubated with primary antibodies in 3% BSA in PBS for 1 hour at room
temperature with rocking. Samples were washed with PBS 3 times for 5 min, then
incubated with secondary antibodies in 3% BSA in PBS for 1 hour at room
temperature in the dark with rocking. Samples were then washed with PBS 3 times
for 5 min in the dark. For experiments visualizing nuclear structure and/or
micronuclei, cells were additionally stained with 1 μg/ml Hoechst 33258 (Thermo
Fisher Scientific H3569) in PBS for 1 min followed by one PBS wash. Coverslips
were mounted with ProLong Gold Antifade reagent + DAPI (Thermo Fisher
P36935) and sealed with clear nail polish. For samples treated with goat primary
antibodies, 5% normal donkey serum (Sigma D9663) was used in place of 3%
BSA.
When indicated, cells were fixed and stained to visualize kinetochore microtubules
(Thompson and Compton, 2011) by extracting in 100 mM PIPES, 1 mM MgCl2, 1
mM CaCl2, 0.5% Triton X-100, pH 6.8 for 4 min, then fixing in 1% glutaraldehyde
in PBS for 10 min and quenched 2 times with 0.1% NaBH4 in TBS for 10 min each.
Cells were washed twice with 10 mM Tris, 150 mM NaCl, 10% BSA and then
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stained with tubulin antibody for 1.5 hours, washed with PBS, then stained with
secondary antibody for 1 hour, washed with PBS, then mounted with ProLong Gold
+ DAPI.
Immunoblot
Lysis buffers used were: 1% SDS in 2mM Tris-HCl pH 7.2 (RTN4KO, NUP160); 1%
NP-40, 150 mM NaCl, and 1 tablet/50 ml cOmplete protease inhibitor cocktail
(Roche 11836170001) in 20 mM Tris pH 7.5 (calnexin, calreticulin, BiP, RTN4); or
RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl,
and 1 tablet/50 ml cOmplete protease inhibitor cocktail in 25 mM Tris pH 7.4)
(SREBP1, SREBP2, SCD; protein concentration determination for lipidomic
analysis). Cell lysates were removed from growth surfaces by scraping with a
rubber policeman after incubation in lysis buffer or by adding lysis buffer to cell
pellets collected by trypsinization and centrifugation at 300xg for 5 min followed by
1-2 PBS washes. Lysates were homogenized by pushing through a 23G needle
30 times and then centrifuged at >20,000xg for 10 min at 4°C, then protein
concentration was determined using the Pierce BCA Protein assay kit (Thermo
Scientific 23225). 10-30 μg of lysates/lane were run on 8-15% polyacrylamide gels
dependent on target size, and protein was wet transferred to 0.22 μm nitrocellulose
(<100 kDa) or PVDF (>100 kDa) membranes. For SREBP and SCD knockdown
assessment, Ponceau S staining was used to visualize transfer efficiency, then
washed with TBS or DI water. Membranes were blocked in 5% nonfat dry milk or
BSA in TBS for 1 hour. Membranes were briefly washed in TBS-0.1% Tween 20
(TBS-T) then incubated with primary antibodies in 5% milk for 1 hour at room
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temperature or overnight at 4°C with rocking. Membranes were washed 3 times
for 5 min in TBS-T, then incubated with anti-HRP secondary antibodies in 5% milk
in TBS-T for 1 hour at room temperature with rocking. Membranes were washed 3
times for 5 min in TBS-T. Clarity or Clarity Max ECL reagent (Bio-Rad 1705060S,
1705062S) was used to visualize chemiluminescence, and images were taken with
a Bio-Rad ChemiDoc or ChemiDoc XRS+ system. Exposure times of images used
for analysis or presentation were maximum exposure before saturation of pixels
around or within target bands.
Live cell imaging
For live imaging, cells were plated in Willco Wells 35 mm dishes (Willco Wells
HBST-3522), ibidi 2 well imaging chambers (ibidi 80287) with DIC lid (ibidi 80055);
or ibidi 8 well imaging chambers (ibidi 80827). Samples were imaged in a CO2-,
temperature-, and humidity-controlled Tokai Hit Stage Top Incubator. Objectives
were also heated to 37°C. For CO2-controlled imaging, the imaging media used
was Fluorobrite DMEM (Gibco A1896701) supplemented with 10% FBS. U2OS
IBB-GFP/H2B-mCherry and U2OS GFP-Sec61β/H2B-mCherry mitotic cells
(except cells treated with RO-3306) were imaged using a custom aluminum stage
insert (P. Forscher) heated to 37°C with heating tape and temperature monitored
using a Physitemp thermistor (BAT7001H) and probe (IT-18), with objective
heating and using 140 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 20
mM HEPES, 15 mM glucose, pH 7.4 as the live cell imaging solution. When
indicated, cells were treated with 1 μM SiR-DNA (Cytoskeleton, Inc. CY-SC007)
for 1 hour prior to imaging and kept in SiR-DNA-containing live imaging media
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during imaging. For STED imaging, cells were labeled with 0.5 μM 647-SiR (NEB
S9102S) for 30 min at 37°C, followed by a >15 min washout at 37°C, prior to
imaging.
Microscopy
Samples were imaged on an inverted Nikon Ti microscope equipped with a
Yokogawa CSU-X1 confocal scanner unit with solid state 100-mW 488-nm and 50mW 561-nm lasers, using a 60×1.4 NA plan Apo objective lens (or 10x 0.25 NA
ADL objective with 1.5x magnification), and a Hamamatsu ORCA R-2 Digital CCD
Camera.
Samples with SiR-DNA/GFP-KDEL, FLAG-lipin/calnexin staining, telophase
nocodazole washout, SREBP depletion, or 20x images were imaged on an
inverted Nikon Ti Eclipse microscope equipped with a Yokogawa CSU-W1
confocal scanner unit with solid state 100 mW 405, 488, 514, 594, 561, 594, and
640 nm lasers, using a 60x 1.4 NA plan Apo objective lens and/or 20x plan Fluor
0.75 NA multi-immersion objective lens, and a prime BSI sCMOS camera.
Images for ER sheet/nanohole visualization were imaged on a Leica SP8 gated
STED 3x with a SuperK Extreme EXW-12 pulsed white light laser (excitation) and
Onefive Katana-08HP pulsed 775 nm laser (depletion) with a HyD hybrid detector;
imaging was performed using a 100x plan Apo 1.4 NA oil objective. SiR
fluorescence was imaged with 633 nm excitation and 775 nm depletion wavelength
and collected between 650-750 nm with the detector. Pixel size of STED images
was 18.9 nm. STED images were processed by applying a 1.0 pixel-radius
Gaussian filter.
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Image analysis
Image analysis was performed using FIJI/ImageJ unless otherwise noted. For
scoring of ER phenotypes, cells expressing moderate levels of GFP-KDEL with no
overexpression artifacts (dense fluorescent clumps in ER or nuclei) were included
for analysis. For scoring of interphase ER expansion, cells with a network of
peripheral ER tubules visualized with GFP-KDEL or calnexin staining were
considered “normal”, while cells with ER sheets and tubules extending into the
periphery with a lack of any tubular network were considered to have “expanded
ER”. Additionally, cells with the appearance of thin ER tubules, large gaps between
tubules, and a smaller cluster of perinuclear ER were considered to have “reduced
ER” with TOFA treatment. These phenotypes were additionally quantified with
percent abundance of cytoplasmic KDEL/calnexin signal: for cells with the entire
ER captured within 0.3-0.5 μm interval z stacks, 8-bit maximum intensity
projections were made of the whole field of view. To ensure the different ER
morphologies were all accounted for after thresholding, the 8-bit max projections
were subject to unsharp masking with a radius of 2 and mask of 0.6. The max
intensity projection was thresholded using the Huang threshold of object fuzziness
(Huang and Wang, 1995). The cell border and nuclear border for each cell were
manually traced using ER fluorescent signal, and the percent of KDEL-positive
pixels per nucleus-free cell area was measured. RPE-1 ER and ER phenotypes in
SCD-depleted cells were scored blindly. With SCD depletion, cells were
additionally blindly scored for the presence of GFP-KDEL punctae in the
perinuclear region that are brighter than the surrounding perinuclear ER.
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For scoring of intracellular ER membranes in prometaphase cells, whole 75 cm2
flasks of cells were transfected with GFP-KDEL and imaged 48 hours later after
mitotic shakeoff and plating into 1 well per flask of an ibidi 8-well imaging chamber.
Cells expressing GFP-KDEL in prometaphase up until metaphase (determined by
DIC chromatin appearance) were imaged with 0.5 μm stacks for 20 μm total z
height. 90x images of cells expressing GFP-KDEL and subject to mitotic shakeoff
were blindly categorized for presence of a) no intracellular ER membranes
(“cleared”), (b) few ER tubules within the cell interior (“partially cleared”); or c) large
(>2 μm length) sheets and/or several tubules within the cell interior (“not cleared”).
For scoring of intranuclear ER membranes in telophase nuclei, cell nuclei were
scored 25 m post anaphase onset or in early G1 for presence of membrane
extensions dimmer than the nuclear rim (extensions the same intensity as the
nuclear rim were considered invaginations of the INM/ONM that are common in
control U2OS cells). In analysis of intranuclear membrane extensions including
categories, “mild” refers to cells with 1-2 extensions, while “severe” cases have
several intranuclear membrane extensions.
For scoring of mitotic profiles in control and CTDNEP1KO U2OS cells, 20x images
of DAPI and tubulin-stained asynchronous, untreated cell populations were
analyzed. For scoring of mitotic profiles in nocodazole washout (1 hour) control
and CTDNEP1KO U2OS cells, 60x images of DAPI and tubulin-stained cell
populations were analyzed. Mitotic cells were identified by DAPI appearance as
relatively bright mitotic chromatin and tubulin appearance of duplicated
centrosomes and presence of mitotic spindle. Staging was performed based on
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the following criteria. Prometaphase: DAPI condensed into visible chromosomes
not yet aligned into single metaphase plate, centrosomes duplicated and building
spindle visible (in nocodazole washout, chromosome condensation and lack of
metaphase-telophase spindle features was used to score prometaphase cells due
to spindle rebuilding after nocodazole treatment); Metaphase: chromosomes
aligned on metaphase plate and bipolar mitotic spindle present; Anaphase: visible
separation of chromosome masses with bipolar mitotic spindle that may be
elongated; Telophase/cytokinesis: chromosome masses separated into two
daughter cells with apparent cytokinesis and spindle midzone visible in tubulin
staining; early G1: chromatin decondensed, cytokinesis nearly complete with
spindle midbody present.
For quantification of micronuclei, images taken at 60x were scored for presence of
micronuclei (DNA fragments encased in an emerin or calnexin-positive rim apart
from

main

nucleus

<~20%

in

size

of

the

main

nucleus).

Severely

lobulated/partitioned “hypermicronucleated” nuclei (DNA fragments/lobes apart
from the main nucleus >~20% in size of the main nucleus) and micronuclei were
scored through oculars or in 60x images of cells with nuclear envelope staining.
Nuclei

with

both

lobes/partitions

and

micronuclei

were

considered

hypermicronucleated. For quantification of peripheral chromosome/tubulin masses
in cells subjected to short-term nocodazole washout, 60x images of cells
processed

for

immunofluorescence

without

non-kinetochore

microtubule

depolymerization were scored for the presence of chromosome masses with
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microtubules extending to them that were to away to the cell periphery compared
to the primary nuclei chromosome masses.
Nuclear solidity was quantified as described (Fonseca et al., 2019). Briefly,
DAPI/Hoechst images were thresholded with the ImageJ default setting, then the
magic wand tool was used to select segmented nuclei. Nuclei that were unable to
be segmented due to poor signal:noise, adjacent nuclei touching, or presence of
a micronucleus touching the main nucleus were not included in the analysis.
Segmented and selected nuclei were measured using the ImageJ shape
descriptors measurement metric. Data were expressed as % of nuclei with a
solidity value less than the control U2OS average minus 1 standard deviation.
To quantify the percent of mitotic cell diameter that is occupied by ER membranes
in cells expressing GFP-Sec61β/H2B-mCherry or GFP-KDEL/SiR-DNA, 60x
image stacks of cells at anaphase onset (determined by first frame of visible
chromatid separation) were obtained. Image background was subtracted using the
average value of 3 boxes from surrounding the cell (but not within adjacent cells).
A 10-pixel thick line was drawn encompassing the cell diameter along the
metaphase plate (in the center of the dividing chromatin masses, along the division
plane), and a profile plot was generated. The local maxima of theSec61β/KDEL
peaks for each side of the cell was determined, and the width of the half maxima
for each of the 2 Sec61β/KDEL peaks was quantified and added together. This
value was divided by the diameter of the cell (determined by the bounds of the
Sec61β/KDEL half maxima) to determine the % of the cell diameter occupied by
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ER signal. For representation, plot profiles shown are normalized to minimum and
maximum of ER and DNA signal.
For quantification of nuclear import/size during mitotic exit with CTDNEP1 RNAi in
U2OS IBB-GFP/H2B/mCherry cells,15x time lapse images were taken. Cells that
were not overlapping, were fully in the imaging plane in z, had bright enough signal
to distinguish from background, and did not experience z drift were included for
analysis. IBB background intensity was taken from the first frame of the time lapse
from a box in a cell-free area and subtracted from all frames. Nuclear size over
time after anaphase onset was measured using the thresholded H2B-positive
regions (using imageJ default algorithm) every 30 sec 3-30 min after anaphase
onset. Integrated IBB-GFP intensity was measured for the entire thresholded
chromatin (H2B positive) mass every 30 sec from 3-30 min after anaphase onset.
IBB values were normalized to the minimum and maximum measured values for
integrated intensity and size, then divided by the value at 3 min to be expressed
as fold change. Values from both nuclei per daughter cell were averaged when
applicable.
To quantify lagging chromosomes in U2OS GFP-Centrin2/GFP-CENPA/mCherryα tubulin cells, cells were imaged immediately after mitotic shakeoff. 60x image
stacks encompassing the whole cell volume of late anaphase and telophase cells
expressing all markers and lacking large open vacuoles (an overexpression
artifact) were included for analysis. Cell images were blindly categorized as having
GFP punctae apart from the segregating chromosome masses that did not have
associated bright tubulin (which would indicate a Centrin2 puncta). Metaphase cell
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images were taken at the same time for spindle pole-pole distance measurements.
To

measure

spindle

pole-pole

distance

in

U2OS

GFP-Centrin2/GFP-

CENPA/mCherry-α tubulin cells, 60x images stacks encompassing the whole cell
volume of metaphase cells that had no spindle tilt were analyzed to determine the
central z plane to take measurements. A line was drawn from the center of the
Centrin2 punctae (or brightest tubulin punctae if Centrin2 not expressed) and used
to measure the pole-pole distance.
Statistical analysis
GraphPad Prism 8 was used for all statistical analysis. Continuous data was tested
for normality using a Shapiro-Wilk test. For experimental setups in which > 10
samples (n) per experimental replicate (N) were able to be collected consistently,
continuous data was measured with paired t tests of experimental replicate means.
Superplot format was used for representing percent of ER-positive pixels in
cytoplasm area (Lord et al., 2020). Experimental replicates of discrete data were
plotted with shapes indicating separate replicates to display reproducibility, and
incidences between groups (replicates pooled) were tested for significance using
Fisher’s exact test (2 categories) or Chi square test (>2 categories). Statistical tests
used, sample sizes, definitions of n and N, and p values (p<0.05 as significance
cutoff) are reported in figures and/or figure legends. For quantification of all data
where >10 samples could be gathered within an experimental repeat, sample size
calculations using the online tool (https://clincalc.com/stats/samplesize.aspx)
determined the adequate sample size for number of cells to analyze for sufficient
(80%) power.
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Key Resources Table
Plasmid or siRNA
EGFP-N1
Halo-N1
pSPCas9(BB)-2APuro (PX459) v2.0
GFP-KDEL
SNAP-KDEL
IBB-eGFP
pH2B_mCherry_IRE
S_puro2
pRK5 FLAG-lipin 1β
(Mm)
pRK5 FLAG-lipin 1β
19xA
pRK5 FLAG-lipin 1β
19xA PAP dead
pRK5 FLAG-NLSlipin 1β
pRK5 FLAG-NESlipin 1β
CTDNEP1-HA
CTDNEP1 D67E-HA
FLAG-NEP1R1
CTDNEP1 custom
single siRNA FWD,
no modifications
CTDNEP1
SMARTpool siRNA
siGENOME Nontargeting siRNA Pool
#2
Silencer Negative
control siRNA #1
Silencer Select
negative control
siRNA #1
Silencer Select Rtn1
siRNA

Source
Takara Bio, Inc. 6085-1
Bewersdorf lab
Addgene #62988

notes

(Merta et al., 2021) (L.K.
Schroeder)
(Schroeder et al., 2018)
EUROSCARF P30631
Addgene 21045

ssGFP-KDEL

(Peterson et al., 2011)

Addgene #32005

(Peterson et al., 2011)

Addgene #32007

(Merta et al., 2021) (M.
Deline)
This study (S. Lee)
This study
(Merta et al., 2021) (M.
Deline)
(Merta et al., 2021) (C.L.
Hu)
(Merta et al., 2021) (M.
Deline)
Dharmacon

AGGCAGAUCCGCACGG
UAA

Dharmacon M-017869-000005
Dharmacon D-001206-1405
Invitrogen AM4611
Life Technologies 4390843
Life Technologies
4427037-s12378
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Silencer Select Rtn3
siRNA
Silencer Select
SREBF1
(SREBP1a/c) siRNA
Silencer Select
SREBF2 (SREBP2)
siRNA
Oligo name
EGFP-N1 backbone
FWD
EGFP-N1 backbone
REV
HaloTag7 FWD
HaloTag7 REV
GFP FWD
GFP REV
Nup160EN-Halo
genotyping PCR
FWD 1
Nup160EN-Halo
genotyping PCR
REV 2
Nup160EN-Halo
genotyping PCR
REV 3
CTDNEP1EN-GFP
genotyping PCR
FWD 1
EGFP-N1 backbone
FWD
EGFP-N1 backbone
REV
HaloTag7 FWD
HaloTag7 REV
GFP FWD

Life Technologies
4427037-s20162
Life Technologies
4427038-s129
Life Technologies
4427038-s29
Sequence
CCTCCCCCTGAACCTGA
AAC
GGCTATGAACTAATGAC
CCCGT
ATGGACCCGAAATCGGT
ACT
GCCGGAAATCTCTAGCG
TC
ATGGTGAGCAAGGGCG
AG
TTACTTGTACAGCTCGT
CCATGC
AGCAGTTACACCTTACA
GCTTG

notes

upstream of left homology
arm

AGGACTTCCACATAATG
GGG

within Nup160-Halo

AACTCAAGAAGGGTCAA
AAGGCT

downstream of right
homology arm

CCTAGATTATCCCTAGTT Upstream of left homology
TGCTGTA
arm
CCTCCCCCTGAACCTGA
AAC
GGCTATGAACTAATGAC
CCCGT
ATGGACCCGAAATCGGT
ACT
GCCGGAAATCTCTAGCG
TC
ATGGTGAGCAAGGGCG
AG
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GFP REV
Nup160EN-Halo
genotyping PCR
FWD 1
Nup160EN-Halo
genotyping PCR
REV 2
Nup160EN-Halo
genotyping PCR
REV 3
CTDNEP1EN-GFP
genotyping PCR
FWD 1
CTDNEP1EN-GFP
genotyping PCR
REV 1
CTDNEP1EN-GFP
genotyping PCR
FWD 2
CTDNEP1EN-GFP
genotyping PCR
REV 2
CTDNEP1EN-GFP
genotyping
sequencing FWD
CTDNEP1EN-GFP
genotyping
sequencing REV
Rtn4 KO genotyping
sequencing FWD

TTACTTGTACAGCTCGT
CCATGC
AGCAGTTACACCTTACA
GCTTG

upstream of left homology
arm

AGGACTTCCACATAATG
GGG

within Nup160-Halo

AACTCAAGAAGGGTCAA
AAGGCT

downstream of right
homology arm

CCTAGATTATCCCTAGTT Upstream of left homology
TGCTGTA
arm
GCTGAACTTGTGGCCGT
TTA

within GFP

AAGTGAGGCACAATGGC
AGT

in CTDNEP1 left
homology arm

AAGGACCTAAGGCCGCT
TTG

In CTDNEP1 right
homology arm

GGCTGTGGGCAAATTGA
ACC

in CTDNEP1 left
homology arm

CCAGTCCTGCCTCTTCA
CAA

In CTDNEP1 right
homology arm

TTCGTGGTCAAAAATAAA
GGTGTT

Rtn4KO genotyping
sequencing REV

TCCTCATCAAACCTACC
CATGTT

CTDNEP1KO
genotyping
sequencing FWD
CTDNEP1KO
genotyping
sequencing REV
Hs CTDNEP1 qPCR
FWD
Hs CTDNEP1 qPCR
REV

CCCGGAATCGGCTAGGT
AAG
AGAGGGCGATGCCATAC
AAG
CATTTACCTTCTGCGGA
GGC
CACCTGGGCTAGCCGAT
TC

Spans exon 1
Spans exon 2 and 3

202

Hs GAPDH qPCR
FWD
Hs GAPDH qPCR
REV
Antibody
Mouse α-tubulin
DM1A
mouse α FLAG
Rabbit α HA

GTCTCCTCTGACTTCAA
CAGCG
ACCACCCTGTTGCTGTA
GCCAA
Source
Millipore Sigma 05-829

notes
1:5000 IB, 1:1000 IF

Sigma F3165
Cell Signaling
Technologies 3724T
Santa Cruz sc-11032
(discontinued)
Santa Cruz sc-271878
Promega G9281
Proteintech 10351
Abcam Ab22595
Abcam Ab2907

1:4000 IB, 1:1000 IF
1:1000 IB, 1:800 IF

Hyman lab
Proteintech 10205-2-AP
GeneTex GTX28245
Abcam Ab21685

1:1000
1:5000
1:1000-1:2000
1:400

Santa Cruz sc-13551X

1:250

Abcam ab30682
Santa Cruz sc-2354

1:2500

Thermo Fisher 31430

1:10000

Thermo Fisher 31460

1:10000

Jackson Immuno 715-295150

1:250

Jackson Immuno 115-095146
Jackson Immuno 111-095003

1:250

FITC Donkey anti
Goat IgG

Jackson Immuno 705-095147

1:250

Rhodamine RedX
goat anti rabbit IgG

Jackson Immuno 111-295003

1:250

Goat α Rtn4/NogoA
Mouse α RTN4
Rabbit α-HaloTag
Rabbit α-emerin
Rabbit anti-calnexin
Rabbit anticalreticulin
Goat α GFP
Rabbit anti-PCNA
Mouse anti-GAPDH
Rabbit anti-BiP
(Grp78)
Rabbit α SREBP1
(2A4)
Rabbit α SREBP2
Mouse anti-goat
IgG-HRP
Goat anti mouse
IgG-HRP
Goat anti rabbit IgGHRP
Rhodamine RedX
Donkey α mouse
IgG
FITC Goat α mouse
IgG
FITC Goat anti
rabbit IgG

1:200
1:200
1:1000
1:200
1:1000
1:1000

1:250
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Alexa Fluor 488
Donkey anti mouse
IgG
Alexa Fluor 647 goat
anti mouse 647
Cell lines
U2OS
RPE-1
U2OS GFP-Sec61β
U2OS GFP-Sec61β
H2B-mCherry
U2OS IBB-GFP
H2B-mCherry
U2OS GFP-Centrin
2 GFP-CENPA
mCherry-α tubulin
U2OS CTDNEP1KO
U2OS CTDNEP1KO
CTDNEP1-HAstable
U2OS RTN4KO
U2OS CTDNEP1ENGFP
U2OS NUP160ENHalo
Chemicals,
Peptides, and
Recombinant
Proteins
Nocodazole
RO-3306
TOFA
NMS-P715
SiR-DNA
Puromycin HCl
G418
Blasticidin
Palmitic acid
Oleic acid
Linoleic acid
SNAP-Cell 647-SiR
HaloTag-TMR
Critical commercial
assays
Zymopure II plasmid
Midi prep kit

Jackson Immuno 715-545150

1:250

Jackson Immuno 115-605003
Source
Slack lab
Breslow lab
Rapoport lab
(Merta et al., 2021)

1:250

This study

N/A

(Yu et al., 2019)

N/A

(Merta et al., 2021)
(Merta et al., 2021) (J.W.
Carrasquillo Rodríguez)
(Schroeder et al., 2018)
This study

N/A
N/A

(Schroeder et al., 2018)

N/A

Source

Cat#

Sigma
EMD Millipore
Cayman Chemicals
EMD Millipore
Cytoskeleton, Inc.
Thermo Fisher
EMD Millipore
Sigma
Sigma
Sigma
Sigma
NEB
Promega
Source

Cat#M1404
Cat#217699
Cat#10005263
Cat#475949
Cat#CY-SC007
Cat#A1113803
Cat#345810
Cat#R21001
Cat#P0500
Cat#O1008
Cat#L5900
Cat# S9102S
Cat#G8252
Cat#

Zymogen

Cat#D4200

notes
N/A
N/A
N/A
N/A

N/A
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Pierce BCA Protein
Assay kit
Software
FIJI
GraphPad Prism 8/9

Thermo Scientific

Cat#23225

(Schindelin et al., 2012)
GraphPad Software

https://imagej.net/Fiji
https://www.graphpad.co
m/scientificsoftware/prism/
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